Processing 00000000.tx.1: Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress Darren J. 

Phrase: "Association of DJ-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "mediated by pathogenic DJ-1 mutations"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C1424222:DJ-1 [Gene or Genome]
   790   C3541418:DJ-1 [Gene or Genome]
   753   C0012836:DJ [Geographic Area]
   753   C0026882:Mutations [Genetic Function]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0450254:Pathogenic [Organism]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "oxidative stress Darren J."
Processing 00000000.tx.2: Moore1,2, Li Zhang1,2, Juan Troncoso2,3, Michael K. 

Phrase: "Moore1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "Li Zhang1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "Juan Troncoso2,"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "Michael K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.3: Lee3, Nobutaka Hattori6, Yoshikuni Mizuno6, Ted M. 

Phrase: "Lee3,"

Phrase: "Nobutaka Hattori6,"

Phrase: "Yoshikuni Mizuno6,"

Phrase: "Ted M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.4: Dawson1,4 and Valina L. 

Phrase: "Dawson1,"

Phrase: "4"

Phrase: "and"

Phrase: "Valina L."
Processing 00000000.tx.5: Dawson1,2,4,5,* 1Institute for Cell Engineering, 2Department of Neurology, 3Department of Pathology, 4Department of Neuroscience and 5Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA and 6Department of Neurology, Juntendo University School of Medicine, Bunkyo-ku, Tokyo 113-0033, Japan * To whom correspondence should be addressed at: Department of Neurology, Institute for Cell Engineering, Johns Hopkins University School of Medicine, 733 N. 

Phrase: "Dawson1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "4,"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "* 1Institute for Cell Engineering,"

Phrase: "2Department of Neurology,"

Phrase: "3Department of Pathology,"

Phrase: "4Department of Neuroscience"

Phrase: "and"

Phrase: "5Department of Physiology,"

Phrase: "Johns Hopkins University School of Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0036375:School [Manufactured Object,Organization]
   753   C0041740:University [Manufactured Object,Organization]

Phrase: "Baltimore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004716:Baltimore [Geographic Area]

Phrase: "MD,"

Phrase: "21205,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "and"

Phrase: "6Department of Neurology,"

Phrase: "Juntendo University School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036375:School [Manufactured Object,Organization]

Phrase: "Bunkyo-ku,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1532717:ku [Quantitative Concept]
   861   C1881335:kU [Quantitative Concept]

Phrase: "Tokyo 113-0033,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040371:Tokyo [Geographic Area]

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed at"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0376649:Address [Intellectual Product]
   799   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Department of Neurology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0587475:Neurology department [Health Care Related Organization]
   790   C1704729:Department [Organization]

Phrase: "Institute for Cell Engineering,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "Johns Hopkins University School of Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0036375:School [Manufactured Object,Organization]
   753   C0041740:University [Manufactured Object,Organization]

Phrase: "733 N."
Processing 00000000.tx.6: Broadway, Suite 731, Baltimore, MD 21205, USA. 

Phrase: "Broadway,"

Phrase: "Suite 731,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553446:Suite [Intellectual Product]

Phrase: "Baltimore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004716:Baltimore [Geographic Area]

Phrase: "MD 21205,"

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.7: Tel: +1 4106143359; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+1 4106143359"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.8: Fax: +1 4106149568; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+1 4106149568"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.9: Email: vdawson{at}jhmi.edu Received June 6, 2004; 

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "vdawson{at}jhmi.edu Received June 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0059804:EDU [Organic Chemical,Pharmacologic Substance]
   795   C1514756:Received [Qualitative Concept]

Phrase: "2004"

Phrase: ";"
Processing 00000000.tx.10: Revised August 11, 2004; 

Phrase: "Revised August 11,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "2004"

Phrase: ";"
Processing 00000000.tx.11: Accepted October 22, 2004  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  The identification of rare monogenic forms of Parkinson's disease (PD) has provided tremendous insight into the molecular pathogenesis of this disorder. 

Phrase: "Accepted October 22,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "2004  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The identification of rare monogenic forms of Parkinson's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0020792:Identification [Mental Process]
   742   C0205396:Identification [Qualitative Concept]

Phrase: "(PD)"

Phrase: "has"

Phrase: "provided tremendous insight into the molecular pathogenesis of this disorder."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0233820:Insight [Mental Process]
Processing 00000000.tx.12: Heritable mutations in -synuclein, parkin, DJ-1 and PINK1 cause familial forms of PD. 

Phrase: "Heritable mutations in -synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "parkin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "and"

Phrase: "PINK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422771:PINK1 [Gene or Genome]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "familial forms of PD."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   816   C1832428:Familial form [Finding]
   770   C0348078:forms [Qualitative Concept]
   770   C0376315:Forms [Manufactured Object]
   737 E C1522492:Form [Functional Concept]
Processing 00000000.tx.13: In the more common sporadic form of PD, oxidative stress and derangements in mitochondrial complex-I function are considered to play a prominent role in disease pathogenesis. 

Phrase: "In the more common sporadic form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0348078:Form [Qualitative Concept]
   812   C0376315:Form [Manufactured Object]
   812   C1522492:Form [Functional Concept]

Phrase: "of PD,"

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "derangements in mitochondrial complex-I function"

Phrase: "are"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a prominent role in disease pathogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.14: However, the relationship of DJ-1 with other PD-linked genes and oxidative stress has not been explored. 

Phrase: "However,"

Phrase: "the relationship of DJ-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]

Phrase: "with other PD-linked genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0314613:Linked gene [Genetic Function]
   827   C0017337:Genes [Gene or Genome]

Phrase: "and"

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "explored."
Processing 00000000.tx.15: Here, we show that pathogenic mutant forms of DJ-1 specifically but differentially associate with parkin, an E3 ubiquitin ligase. 

Phrase: "Here,"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that pathogenic mutant forms of DJ-1 specifically"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0348078:forms [Qualitative Concept]
   744   C0376315:Forms [Manufactured Object]
   711 E C1522492:Form [Functional Concept]

Phrase: "but"

Phrase: "differentially"

Phrase: "associate with parkin,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0750490:Associate [Idea or Concept]
   790   C1418270:PARKIN [Gene or Genome]
   790   C1706221:Associate [Professional or Occupational Group]
   790   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "an E3 ubiquitin ligase."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0077678:E3 Ubiquitin Ligase [Amino Acid, Peptide, or Protein,Enzyme]
           E3 Ligase
  1000   C1418270:E3 ubiquitin ligase [Gene or Genome]
   827   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.16: Chemical cross-linking shows that pathogenic DJ-1 mutants exhibit impairments in homo-dimer formation, suggesting that parkin may bind to monomeric DJ-1. 

Phrase: "Chemical"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220806:Chemical [Chemical]
  1000   C3272558:Chemical [Intellectual Product]

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that pathogenic DJ-1 mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "impairments in homo-dimer formation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0684336:Impairments [Pathologic Function]
   760   C2598156:Impairments [Clinical Attribute]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "bind to monomeric DJ-1."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1424222:DJ-1 [Gene or Genome]
   806   C3541418:DJ-1 [Gene or Genome]
   760   C0012836:DJ [Geographic Area]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]
Processing 00000000.tx.17: Parkin fails to specifically ubiquitinate and enhance the degradation of L166P and M26I mutant DJ-1, but instead promotes their stability in cultured cells. 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "fails"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to specifically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "ubiquitinate"

Phrase: "and"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the degradation of L166P"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "M26I mutant DJ-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1424222:DJ-1 [Gene or Genome]
   861   C3541418:DJ-1 [Gene or Genome]
   812   C0012836:DJ [Geographic Area]
   812   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "but"

Phrase: "instead"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "their stability in cultured cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205360:Stability [Qualitative Concept]
   760   C2347098:Stability [Qualitative Concept]
Processing 00000000.tx.18: The interaction of parkin with L166P DJ-1 may involve a larger protein complex that contains CHIP and Hsp70, perhaps accounting for the lack of parkin-mediated ubiquitination. 

Phrase: "The interaction of parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "with L166P DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]

Phrase: "may"

Phrase: "involve"

Phrase: "a larger protein complex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1523872:protein complex [Cell Component]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "that"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "CHIP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600596:Chip [Research Device]

Phrase: "and"

Phrase: "Hsp70,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243043:HSP 70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415760:HSP70 [Gene or Genome]
  1000   C1527149:HSP70 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "perhaps"

Phrase: "accounting for the lack of parkin-mediated ubiquitination."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   744   C0000938:Accounting [Occupational Activity]
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C0332268:lack [Qualitative Concept]
   744   C1418270:PARKIN [Gene or Genome]
   744   C1519751:Ubiquitination [Molecular Function]
   744   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   711 E C1551359:account [Idea or Concept]
   711 E C2741673:Account # [Clinical Attribute]
   711 E C2981730:Account [Classification]
Processing 00000000.tx.19: Oxidative stress also promotes an interaction between DJ-1 and parkin, but this does not result in the ubiquitination or degradation of DJ-1. 

Phrase: "Oxidative stress also"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   827   C0038435:Stress [Finding]
   827   C0311404:Oxidative [Functional Concept]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "an interaction between DJ-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "parkin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "but"

Phrase: "this"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "result in the ubiquitination"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1274040:Result [Functional Concept]
   770   C1519751:Ubiquitination [Molecular Function]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "or"

Phrase: "degradation of DJ-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]
Processing 00000000.tx.20: Parkin-mediated alterations in DJ-1 protein stability may be pathogenically relevant as DJ-1 levels are dramatically increased in the detergent-insoluble fraction from sporadic PD/DLB brains, but are reduced in the insoluble fraction from parkin-linked autosomal recessive juvenile-onset PD brains. 

Phrase: "Parkin-mediated alterations in DJ-1 protein stability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1515926:Alteration [Idea or Concept]

Phrase: "may"

Phrase: "be"

Phrase: "pathogenically relevant as DJ-1 levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2347946:Relevant [Qualitative Concept]

Phrase: "are"

Phrase: "dramatically"

Phrase: "increased in the detergent-insoluble fraction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0011740:Detergent [Chemical Viewed Functionally]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C1264633:Fraction [Quantitative Concept]
   753   C1554103:Fraction [Idea or Concept]

Phrase: "from sporadic PD/DLB brains,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   861   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   812   C0085200:Lewy Bodies [Cell Component]
   793   C0006104:Brains [Body Part, Organ, or Organ Component]
   793   C0011265:dementia [Mental or Behavioral Dysfunction]
   793   C0205422:Sporadic [Temporal Concept]
   793   C0242821:bodies [Human]
   793   C0497327:Dementia [Mental or Behavioral Dysfunction]
   793   C1517320:From [Qualitative Concept]
   793   C1995017:Bodies [Cell Component]
   760 E C0460148:Body [Anatomical Structure]
   760 E C1268086:Body [Anatomical Structure]
   760 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "but"

Phrase: "are"

Phrase: "reduced in the insoluble fraction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0392756:Reduced [Qualitative Concept]
   760   C1264633:Fraction [Quantitative Concept]
   760   C1554103:Fraction [Idea or Concept]

Phrase: "from parkin-linked autosomal recessive juvenile-onset PD brains."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   793   C0006104:Brains [Body Part, Organ, or Organ Component]
   760 E C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.21: These data potentially link DJ-1 and parkin in a common molecular pathway at multiple levels that may have important implications for understanding the pathogenesis of inherited and sporadic PD.  

Phrase: "These data potentially"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "link"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "and"

Phrase: "parkin in a common molecular pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1418270:PARKIN [Gene or Genome]
   753   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "at multiple levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "that"

Phrase: "may"

Phrase: "have"

Phrase: "important implications for understanding"

Phrase: "the pathogenesis of inherited"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0543483:pathogenesis [Functional Concept]
   770   C0699748:Pathogenesis [Pathologic Function]

Phrase: "and"

Phrase: "sporadic PD."
Processing 00000000.tx.22: INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Parkinson's disease (PD) is a chronic neurodegenerative disorder affecting 1% of the population at the age of 65 rising to 4% of the population at the age of 85 (1,2). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "(PD)"

Phrase: "is"

Phrase: "a chronic neurodegenerative disorder"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0008679:Chronic disorder [Disease or Syndrome]
   901   C0524851:Neurodegenerative Disorder [Disease or Syndrome]
   827   C0012634:Disorder [Disease or Syndrome]

Phrase: "affecting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affecting [Functional Concept]
  1000   C1314939:Affecting [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "1% of the population"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0032659:Population [Quantitative Concept]
   770   C1257890:Population [Population Group]
   770   C2827734:1+ [Quantitative Concept]
   770   C2981698:1+ [Classification]

Phrase: "at the age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "of 65 rising"

Phrase: "to 4%"

Phrase: "of the population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]

Phrase: "at the age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "of 85"

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.23: PD is a movement disorder that is mainly due to the degeneration of dopaminergic neurons in the substantia nigra pars compacta, which leads to rigidity, resting tremor, bradykinesia, postural instability and, in a subset of patients, cognitive and autonomic dysfunction (1,2). 

Phrase: "PD"

Phrase: "is"

Phrase: "a movement disorder"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0026650:Movement disorder [Disease or Syndrome]
   861   C0012634:Disorder [Disease or Syndrome]
   861   C0026649:Movement [Organism Function]

Phrase: "that"

Phrase: "is"

Phrase: "mainly due to the degeneration of dopaminergic neurons"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0678226:Due to [Functional Concept]
           due
   770   C1512035:Dopaminergic Neurons [Cell]
   767   C0027746:degeneration neurons [Cell or Molecular Dysfunction]
   744   C0011164:Degeneration [Pathologic Function]
   744   C0027882:Neurons [Cell]
   744   C0282151:Dopaminergic [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   744   C1880269:Degeneration [Functional Concept]
   744   C3146286:Due [Idea or Concept]

Phrase: "in the substantia nigra pars compacta,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0175412:Substantia nigra pars compacta [Body Part, Organ, or Organ Component]
           Pars compacta
   902   C0222661:Substantia compacta [Tissue]
   861   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
   861   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]
   812   C0032405:PARS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1414437:PARS [Gene or Genome]
   812   C3283876:Compacta [Eukaryote]
   779 E C1417826:PAR [Gene or Genome]
   779 E C1514229:PAR [Quantitative Concept]
   779 E C1705885:PAR [Gene or Genome]

Phrase: "which"

Phrase: "leads to rigidity,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C0026837:Rigidity, NOS [Sign or Symptom]
   790   C0181586:leads [Medical Device]
   790   C0700109:rigidity [Natural Phenomenon or Process]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]
   718 E C0231517:Rigid [Individual Behavior]
   718 E C1882952:RIGID [Phenomenon or Process]

Phrase: "resting tremor,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0234379:Resting Tremor [Sign or Symptom]
   861   C0035253:Resting [Daily or Recreational Activity]
   861   C0040822:Tremor [Sign or Symptom]
   861   C1512899:resting [Cell]
   861   C1963252:Tremor [Finding]
   827 E C1622890:ResT [Molecular Function]

Phrase: "bradykinesia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0233565:Bradykinesia [Sign or Symptom]

Phrase: "postural instability"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1843921:Postural instability [Finding]
   861   C1444783:Instability [Finding]

Phrase: "and"

Phrase: ","

Phrase: "in a subset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515021:Subset [Classification]

Phrase: "of patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "cognitive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516691:Cognitive [Functional Concept]

Phrase: "and"

Phrase: "autonomic dysfunction"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0741307:Autonomic dysfunction [Pathologic Function]
   861   C0004388:Autonomic [Body System]
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.24: Pathologically, PD is characterized by the presence of intracytoplasmic proteinaceous inclusions termed Lewy bodies, as well as Lewy neurites, that are immunoreactive for -synuclein (3). 

Phrase: "Pathologically,"

Phrase: "PD"

Phrase: "is"

Phrase: "characterized by the presence of intracytoplasmic proteinaceous inclusions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C1880022:Characterized [Activity]
   711   C1512693:Inclusion [Qualitative Concept]

Phrase: "termed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1515273:Term [Temporal Concept]
   966   C1705313:Term [Idea or Concept]
   966   C2826302:TERM [Intellectual Product]

Phrase: "Lewy bodies,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "as well as"

Phrase: "Lewy neurites,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C3548404:Lewy neurite [Cell Component]
   861   C0085103:Neurites [Cell Component]

Phrase: "that"

Phrase: "are"

Phrase: "immunoreactive for -synuclein"

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.25: The cause of PD remains unknown, and although the majority of cases appear sporadic in nature, rare monogenic forms of PD have provided tremendous insight into the pathogenesis of this disease (4,5). 

Phrase: "The cause of PD remains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0015127:cause [Functional Concept]
   760   C1524003:Cause [Conceptual Entity]

Phrase: "unknown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]

Phrase: "and"

Phrase: "although"

Phrase: "the majority of cases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680220:majority [Social Behavior]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "sporadic in nature,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205422:Sporadic [Temporal Concept]

Phrase: "rare monogenic forms of PD"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0348078:forms [Qualitative Concept]
   760   C0376315:Forms [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "have"

Phrase: "provided tremendous insight into the pathogenesis of this disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0233820:Insight [Mental Process]

Phrase: "(4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.26: Four genes, -synuclein, parkin, DJ-1 and PINK1 have been unambiguously linked to familial PD (69). 

Phrase: "Four genes, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "parkin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "and"

Phrase: "PINK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422771:PINK1 [Gene or Genome]

Phrase: "have"

Phrase: "been"

Phrase: "unambiguously"

Phrase: "linked to familial PD (69"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   760   C0450388:69 [Intellectual Product]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.27: Missense mutations (A53T, A30P and E46K) in -synuclein, as well as whole gene multiplications, have been linked to autosomal dominant PD (6,1013). 

Phrase: "Missense mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0599155:Mutations, Missense [Genetic Function]
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(A53T,"

Phrase: "A30P"

Phrase: "and"

Phrase: "E46K"

Phrase: ")"

Phrase: "in -synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as well as"

Phrase: "whole gene multiplications,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2911648:Multiplication [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "linked to autosomal dominant PD (6,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0443147:Autosomal dominant [Intellectual Product]
   753   C0596142:autosomal [Cell Component]
   753   C1527180:Dominant [Functional Concept]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]

Phrase: "1013"

Phrase: ")."
Processing 00000000.tx.28: Mutations in parkin cause autosomal recessive juvenile-onset PD (AR-JP) and are the most common cause of inherited PD, accounting for up to 50% of all recessive early-onset PD cases (7,14,15). 

Phrase: "Mutations in parkin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0026882:Mutations [Genetic Function]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "autosomal recessive juvenile-onset PD (AR-JP)"

Phrase: "and"

Phrase: "are"

Phrase: "the most common cause of inherited PD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0015127:cause [Functional Concept]
   748   C1524003:Cause [Conceptual Entity]

Phrase: "accounting for"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   833   C0000938:Accounting [Occupational Activity]
   799 E C1551359:account [Idea or Concept]
   799 E C2741673:Account # [Clinical Attribute]
   799 E C2981730:Account [Classification]

Phrase: "up to 50%"

Phrase: "of all recessive early-onset PD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   804   C0868928:Cases [Functional Concept]
   804   C1533148:Cases [Quantitative Concept]
   771 E C1706255:CASE [Medical Device]
   771 E C1706256:Case [Conceptual Entity]

Phrase: "(7,"

Phrase: "14,"

Phrase: "15"

Phrase: ")."
Processing 00000000.tx.29: A large number of pathogenic mutations have been identified in parkin and include exonic deletions, duplications and a variety of missense mutations and truncations. 

Phrase: "A large number of pathogenic mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "identified in parkin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0205396:Identified [Qualitative Concept]
   790   C1418270:PARKIN [Gene or Genome]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]
   790   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "exonic deletions,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1880274:Deletions [Activity]
   827 E C1442161:Deletion [Cell or Molecular Dysfunction]
   827 E C1511760:Deletion [Genetic Function]

Phrase: "duplications"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332597:duplications [Functional Concept]
   966 E C1705960:Duplication [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "a variety of missense mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1883525:Variety [Conceptual Entity]
   760   C2346866:Variety [Conceptual Entity]

Phrase: "and"

Phrase: "truncations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706395:Truncation [Cell or Molecular Dysfunction]
Processing 00000000.tx.30: Parkin may function in the ubiquitin-proteasomal system (UPS) as an E2-dependent E3 ubiquitin ligase (1618). 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "function in the ubiquitin-proteasomal system (UPS)"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0031843:function [Physiologic Function]
   753   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0449913:System [Functional Concept]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]
   753   C1705273:Function [Intellectual Product]

Phrase: "as an E2-dependent E3 ubiquitin ligase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0077678:E3 Ubiquitin Ligase [Amino Acid, Peptide, or Protein,Enzyme]
           E3 Ligase
   884   C1418270:E3 ubiquitin ligase [Gene or Genome]
   804   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(1618"

Phrase: ")."
Processing 00000000.tx.31: A number of putative substrates for parkin exist, but their pathogenic role in PD remains elusive (16,1926). 

Phrase: "A number of putative substrates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "for parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "exist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: ","

Phrase: "but"

Phrase: "their pathogenic role in PD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "remains"

Phrase: "elusive"

Phrase: "(16,"

Phrase: "1926"

Phrase: ")."
Processing 00000000.tx.32: The large number of parkin substrates may relate to the ability of parkin to form protein complexes with components of the UPS and chaperone systems. 

Phrase: "The large number of parkin substrates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "may"

Phrase: "relate to the ability of parkin to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0085732:Ability [Organism Attribute]
   748   C0163712:Relate [Organic Chemical]
   748   C1418270:PARKIN [Gene or Genome]
   748   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "protein complexes with components of the UPS"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   785   C1179436:Component of protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Protein complex component
   773   C1179435:Component of protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Protein Component
   745   C1180347:complex protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1704241:Complexes [Chemical Viewed Structurally]
   731 E C1523872:protein complex [Cell Component]
   708 E C0439855:Complex [Qualitative Concept]

Phrase: "and"

Phrase: "chaperone systems."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   777 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.33: For example, parkin associates with the E3 ubiquitin ligase, CHIP, and the molecular chaperone, Hsp70, which together control the ubiquitination and degradation of the parkin substrate Pael-R (27). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "associates with the E3 ubiquitin ligase,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0077678:E3 Ubiquitin Ligase [Amino Acid, Peptide, or Protein,Enzyme]
           E3 Ligase
   833   C1418270:E3 ubiquitin ligase [Gene or Genome]
   753   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0750490:Associate [Idea or Concept]
   753   C1537525:E3 [Gene or Genome]
   753   C1706221:Associate [Professional or Occupational Group]

Phrase: "CHIP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600596:Chip [Research Device]

Phrase: "and"

Phrase: "the molecular chaperone,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243041:Molecular Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Chaperone

Phrase: "Hsp70,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243043:HSP 70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415760:HSP70 [Gene or Genome]
  1000   C1527149:HSP70 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "which together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the ubiquitination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519751:Ubiquitination [Molecular Function]

Phrase: "and"

Phrase: "degradation of the parkin substrate Pael-R (27"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0243125:degradation [Functional Concept]
   744   C0699900:Degradation [Organism Function]

Phrase: ")."
Processing 00000000.tx.34: Mutations in DJ-1 are linked with autosomal recessive early-onset PD and at least initially appear to be a rare cause of familial PD, perhaps accounting for 12% of all early-onset cases (2830). 

Phrase: "Mutations in DJ-1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0026882:Mutations [Genetic Function]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "linked with autosomal recessive early-onset PD"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0441748:Autosomal recessive [Intellectual Product]
   778   C1833334:Early-onset [Finding]
   748   C0332162:Onset [Qualitative Concept]
   748   C0596142:autosomal [Cell Component]
   748   C1279919:Early [Temporal Concept]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]

Phrase: "and at least initially"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205265:Initially [Temporal Concept]
   770   C1515981:And [Idea or Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a rare cause of familial PD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015127:cause [Functional Concept]
   753   C1524003:Cause [Conceptual Entity]

Phrase: "perhaps"

Phrase: "accounting for 12% of all early-onset cases"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   770   C1833334:Early-onset [Finding]
   744   C0000938:Accounting [Occupational Activity]
   744   C0332162:Onset [Qualitative Concept]
   744   C0868928:Cases [Functional Concept]
   744   C1279919:Early [Temporal Concept]
   744   C1533148:Cases [Quantitative Concept]
   711 E C1551359:account [Idea or Concept]
   711 E C1706255:CASE [Medical Device]
   711 E C1706256:Case [Conceptual Entity]
   711 E C2741673:Account # [Clinical Attribute]
   711 E C2981730:Account [Classification]

Phrase: "(2830"

Phrase: ")."
Processing 00000000.tx.35: A number of pathogenic mutations have been identified in DJ-1 and include exonic deletions, truncations and homozygous (L166P and M26I) and heterozygous (A104T and D149A) missense mutations (8,2831). 

Phrase: "A number of pathogenic mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "identified in DJ-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1424222:DJ-1 [Gene or Genome]
   833   C3541418:DJ-1 [Gene or Genome]
   770   C0012836:DJ [Geographic Area]
   770   C0205396:Identified [Qualitative Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]

Phrase: "and"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "exonic deletions,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1880274:Deletions [Activity]
   827 E C1442161:Deletion [Cell or Molecular Dysfunction]
   827 E C1511760:Deletion [Genetic Function]

Phrase: "truncations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706395:Truncation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "homozygous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019904:Homozygous [Organism Attribute]

Phrase: "(L166P"

Phrase: "and"

Phrase: "M26I"

Phrase: ")"

Phrase: "and"

Phrase: "heterozygous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019425:Heterozygous [Organism Attribute]

Phrase: "(A104T"

Phrase: "and"

Phrase: "D149A"

Phrase: ")"

Phrase: "missense mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0599155:Mutations, Missense [Genetic Function]
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(8,"

Phrase: "2831"

Phrase: ")."
Processing 00000000.tx.36: A rare polymorphism (R98Q) has also been identified although this is not associated with PD (32). 

Phrase: "A rare polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]

Phrase: "(R98Q"

Phrase: ")"

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "although"

Phrase: "this"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associated with PD (32"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: ")."
Processing 00000000.tx.37: The L166P mutant protein is impaired in its ability to form homo-dimers and exhibits markedly reduced protein stability, leading to enhanced proteasomal degradation (3337). 

Phrase: "The L166P mutant protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "impaired in its ability to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0085732:Ability [Organism Attribute]
   760   C0221099:Impaired [Functional Concept]
   760   C0684336:Impaired [Pathologic Function]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "homo-dimers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0596448:dimers [Chemical Viewed Structurally]
   861   C1300203:Homo [Mammal]
   861   C3245470:HOMO [Finding]

Phrase: "and"

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "markedly reduced protein stability,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C2350440:Protein Stability [Qualitative Concept]
   812   C0205360:Stability [Qualitative Concept]
   812   C2347098:Stability [Qualitative Concept]
   741 E C1547311:Stable [Intellectual Product]

Phrase: "leading to enhanced proteasomal degradation"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   760   C0243125:degradation [Functional Concept]
   760   C0332152:Leading [Temporal Concept]
   760   C0699900:Degradation [Organism Function]
   760   C1522538:Leading [Functional Concept]
   760   C2349975:Enhanced [Activity]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(3337"

Phrase: ")."
Processing 00000000.tx.38: The biological function of DJ-1 remains obscure. 

Phrase: "The biological function of DJ-1 remains"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0031845:Biological function, NOS [Physiologic Function]
   748   C0005532:Biological [Biomedical Occupation or Discipline]
   748   C0031843:function [Physiologic Function]
   748   C0205460:biological [Qualitative Concept]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "obscure."
Processing 00000000.tx.39: DJ-1 is a highly conserved protein present in a diverse number of organisms and belongs to the DJ-1/ThiJ/PfpI protein superfamily. 

Phrase: "DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "is"

Phrase: "a highly conserved protein present in a diverse number of organisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0150312:Present [Quantitative Concept]
   738   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "belongs to the DJ-1/ThiJ/PfpI protein superfamily."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   784   C3538910:Protein DJ-1 [Amino Acid, Peptide, or Protein]
   764   C1424222:DJ-1 [Gene or Genome]
   764   C3541418:DJ-1 [Gene or Genome]
   742   C0012836:DJ [Geographic Area]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1883220:Superfamily [Conceptual Entity]
Processing 00000000.tx.40: The crystal structure of human DJ-1 has been resolved and shows that DJ-1 exists in solution as a homo-dimer and the L166P mutation disrupts DJ-1 dimerization (3842). 

Phrase: "The crystal structure of human DJ-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0444626:Crystal Structure [Chemical Viewed Structurally]
           Crystal
   748   C0427896:Crystal [Body Substance]
   748   C0678594:Structure [Spatial Concept]
   748   C1533132:Crystal [Body Substance]
   748   C1704641:Crystal [Manufactured Object]

Phrase: "has"

Phrase: "been"

Phrase: "resolved"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514893:Resolved [Idea or Concept]
  1000   C2699488:Resolved [Conceptual Entity]

Phrase: "and"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "exists"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: "in solution as a homo-dimer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0037633:Solution [Substance]
   753   C0150312:In [Quantitative Concept]
   753   C0332285:In [Spatial Concept]
   753   C0525069:Solution [Biomedical or Dental Material]

Phrase: "and"

Phrase: "the L166P mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "disrupts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "DJ-1 dimerization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0376525:Dimerization [Natural Phenomenon or Process]
   734   C1424222:DJ-1 [Gene or Genome]
   734   C3541418:DJ-1 [Gene or Genome]

Phrase: "(3842"

Phrase: ")."
Processing 00000000.tx.41: The crystal structure of DJ-1 closely resembles that of Escherichia coli and yeast Hsp31 (42,43). 

Phrase: "The crystal structure of DJ-1 closely"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0444626:Crystal Structure [Chemical Viewed Structurally]
           Crystal
   748   C0427896:Crystal [Body Substance]
   748   C0678594:Structure [Spatial Concept]
   748   C1533132:Crystal [Body Substance]
   748   C1704641:Crystal [Manufactured Object]

Phrase: "resembles"

Phrase: "that of Escherichia coli"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0014834:Escherichia coli [Bacterium]
   770   C0014833:Escherichia [Bacterium]

Phrase: "and"

Phrase: "yeast Hsp31"

Phrase: "(42,"

Phrase: "43"

Phrase: ")."
Processing 00000000.tx.42: The crystal structure of DJ-1 also highlights a Cys-106/His-126 catalytic dyad indicative of protease activity. 

Phrase: "The crystal structure of DJ-1 also"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0444626:Crystal Structure [Chemical Viewed Structurally]
           Crystal
   748   C0427896:Crystal [Body Substance]
   748   C0678594:Structure [Spatial Concept]
   748   C1533132:Crystal [Body Substance]
   748   C1704641:Crystal [Manufactured Object]

Phrase: "highlights"

Phrase: "a Cys-106/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010654:Cys [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "His-126 catalytic dyad"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0870454:dyad [Population Group]

Phrase: "indicative of protease activity."
Processing 00000000.tx.43: Preliminary studies in vitro are consistent with the suggestion that DJ-1 may possess both chaperone activity and weak proteolytic activity (37,42). 

Phrase: "Preliminary studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0439611:Preliminary [Temporal Concept]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "are"

Phrase: "consistent with the suggestion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "may"

Phrase: "possess"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0850310:possess [Mental or Behavioral Dysfunction]
  1000   C3154893:Possess [Idea or Concept]

Phrase: "both chaperone activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1149552:chaperone activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "weak proteolytic activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C0597304:Proteolytic [Molecular Function]
   827   C1561536:*Activity [Idea or Concept]
   827   C1947941:proteolytic [Enzyme]

Phrase: "(37,"

Phrase: "42"

Phrase: ")."
Processing 00000000.tx.44: DJ-1 may also function as an anti-oxidant protein and/or as a redox sensor as it exhibits an acidic shift in pI-value under oxidative stress, owing mainly to oxidative modification of cysteine residues (4447). 

Phrase: "DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "may"

Phrase: "also"

Phrase: "function as an anti-oxidant protein"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C0815043:function protein [Amino Acid, Peptide, or Protein]
   783   C1527118:Protein Function [Molecular Function]
   753   C0031843:function [Physiologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0085403:oxidant [Chemical Viewed Functionally]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "and/or as a redox sensor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1706528:And/Or [Conceptual Entity]
   753   C0030012:Redox [Molecular Function]
   753   C0183210:Sensor [Medical Device]
   753   C1515981:And [Idea or Concept]
   753   C1705193:Sensor [Manufactured Object]

Phrase: "as"

Phrase: "it"

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "an acidic shift in pI-value"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333051:Shift [Functional Concept]
   753   C2347509:Shift [Phenomenon or Process]

Phrase: "under oxidative stress,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "owing"

Phrase: "mainly to oxidative modification of cysteine residues"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0311404:Oxidative [Functional Concept]
   748   C0392747:Modification [Functional Concept]
   748   C1554963:modification [Qualitative Concept]
   714   C1709915:Residue [Conceptual Entity]
   714   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "(4447"

Phrase: ")."
Processing 00000000.tx.45: Moreover, in cultured cells, overexpression of DJ-1 protects against oxidative injury, whereas DJ-1 knockdown enhances the susceptibility to oxidative stress (45,48). 

Phrase: "Moreover,"

Phrase: "in cultured cells,"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0007600:cultured cells [Cell]
  1000   C0007635:Cultured Cells [Cell]
  1000   C3282338:Cells, Cultured [Cell]
   966 E C0007585:culture cell [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "overexpression of DJ-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "protects against oxidative injury,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0311404:Oxidative [Functional Concept]
   770   C3263722:Injury [Injury or Poisoning]
   770   C3263723:Injury [Injury or Poisoning]

Phrase: "whereas"

Phrase: "DJ-1 knockdown"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C1424222:DJ-1 [Gene or Genome]
   734   C3541418:DJ-1 [Gene or Genome]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the susceptibility to oxidative stress"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0012655:Susceptibility [Clinical Attribute]
   760   C0220898:Susceptibility [Organism Attribute]
   760   C1264642:Susceptibility [Functional Concept]
   760   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "(45,"

Phrase: "48"

Phrase: ")."
Processing 00000000.tx.46: There has been tremendous interest from researchers in attempting to link the familial-associated gene products in a common pathogenic pathway of neuronal degeneration in PD. 

Phrase: "There"

Phrase: "has"

Phrase: "been"

Phrase: "tremendous interest from researchers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0543488:Interest [Mental Process]

Phrase: "in attempting to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1516084:Attempt [Event]

Phrase: "link"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "the familial-associated gene products in a common pathogenic pathway of neuronal degeneration"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   735   C0017337:Gene [Gene or Genome]
   735   C1514468:Products [Entity]
   717   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   713   C1517488:Gene Family [Gene or Genome]
   702 E C1704444:Product [Quantitative Concept]

Phrase: "in PD."
Processing 00000000.tx.47: Suggestions that there might be a converging or common molecular pathway are the observations that parkin ubiquitinates the -synuclein-interacting protein, synphilin-1, and participates in the ubiquitination of inclusions that are formed in the presence of -synuclein and synphilin-1 (20). 

Phrase: "Suggestions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0038659:Suggestions [Idea or Concept]
   966 E C1705535:suggestion [Idea or Concept]

Phrase: "that there"

Phrase: "might"

Phrase: "be"

Phrase: "a converging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700387:Converging [Activity]

Phrase: "or"

Phrase: "common molecular pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1704259:molecular pathway [Molecular Function]
           Pathway
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "are"

Phrase: "the observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "ubiquitinates"

Phrase: "the -synuclein-interacting protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "synphilin-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420277:SYNPHILIN 1 [Gene or Genome]
           synphilin
  1000   C3541909:Synphilin-1 [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "participates in the ubiquitination of inclusions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1519751:Ubiquitination [Molecular Function]
   719   C1512693:Inclusion [Qualitative Concept]

Phrase: "that"

Phrase: "are"

Phrase: "formed in the presence of -synuclein"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205431:Formed [Functional Concept]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   719 E C0348078:Form [Qualitative Concept]
   719 E C0376315:Form [Manufactured Object]
   719 E C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "synphilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420277:SYNPHILIN 1 [Gene or Genome]
           synphilin
  1000   C3541909:Synphilin-1 [Amino Acid, Peptide, or Protein]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.48: Furthermore, parkin may also ubiquitinate a rare O-glycosylated form of -synuclein (19). 

Phrase: "Furthermore,"

Phrase: "parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "also"

Phrase: "ubiquitinate"

Phrase: "a rare O-glycosylated form of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.49: In the more common sporadic form of PD, oxidative stress and derangements in mitochondrial complex-I function are thought to play a prominent role in the demise of dopaminergic neurons (49,50). 

Phrase: "In the more common sporadic form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0348078:Form [Qualitative Concept]
   812   C0376315:Form [Manufactured Object]
   812   C1522492:Form [Functional Concept]

Phrase: "of PD,"

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "derangements in mitochondrial complex-I function"

Phrase: "are"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a prominent role in the demise of dopaminergic neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "(49,"

Phrase: "50"

Phrase: ")."
Processing 00000000.tx.50: Recent observations suggest that -synuclein and derangements in complex-I function may converge in a common pathway as inhibition of complex-I leads to -synuclein aggregation and toxicity both in vitro and in vivo (5156). 

Phrase: "Recent observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "derangements in complex-I function"

Phrase: "may"

Phrase: "converge in a common pathway"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205214:Common [Quantitative Concept]
   760   C1522138:Common [Functional Concept]
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]
   760   C2700387:Converge [Activity]
   760   C3245511:common [Intellectual Product]

Phrase: "as inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of complex-I"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2245017:Complex I [Cell Component]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "leads"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
  1000   C0181586:leads [Medical Device]
  1000   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
  1000   C1522538:Lead [Functional Concept]
  1000   C2348269:Lead [Element, Ion, or Isotope]
  1000   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to -synuclein aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332621:Aggregation [Functional Concept]
   827   C0439168:% aggregation [Quantitative Concept]
   755 E C0205418:Aggregate [Qualitative Concept]

Phrase: "and"

Phrase: "toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0040539:toxicity [Qualitative Concept]
  1000   C0600688:Toxicity [Injury or Poisoning]
   928 E C1407029:Toxic [Qualitative Concept]
   907 E C0032346:Poison [Hazardous or Poisonous Substance]
   907 E C1548769:Poison [Intellectual Product]
   907 E C1550590:poison [Idea or Concept]

Phrase: "both in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(5156"

Phrase: ")."
Processing 00000000.tx.51: Oxidative stress can also modify the normal function of parkin, because S-nitrosylation of parkin impairs its E3 ubiquitin ligase activity (57). 

Phrase: "Oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "can"

Phrase: "also"

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the normal function of parkin,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "because"

Phrase: "S-"

Phrase: "nitrosylation of parkin"

Phrase: "impairs"

Phrase: "its E3 ubiquitin ligase activity"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C1150685:ubiquitin-ligase activity [Molecular Function]
   875   C1325411:ubiquitin activity [Molecular Function]
   861   C1150651:ligase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0077678:E3 Ubiquitin Ligase [Amino Acid, Peptide, or Protein,Enzyme]
           E3 Ligase
   756   C1418270:E3 ubiquitin ligase [Gene or Genome]

Phrase: "(57"

Phrase: ")."
Processing 00000000.tx.52: The role of DJ-1 in such a pathway and its relationship with parkin, -synuclein and oxidative stress has not been explored. 

Phrase: "The role of DJ-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in such"

Phrase: "a pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathway [Molecular Function]
  1000   C1705987:Pathway [Conceptual Entity]

Phrase: "and"

Phrase: "its relationship with parkin, -"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439849:Relationship [Qualitative Concept]
   770   C1705630:Relationship [Idea or Concept]
   770   C1706279:Relationship [Idea or Concept]
   770   C3540605:Relationship [Intellectual Product]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "explored."
Processing 00000000.tx.53: Here, we show that parkin selectively interacts with DJ-1 harboring pathogenic mutations, as well as following various forms of oxidative stress. 

Phrase: "Here,"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that parkin selectively"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "interacts with DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1424222:DJ-1 [Gene or Genome]
   833   C3541418:DJ-1 [Gene or Genome]
   770   C0012836:DJ [Geographic Area]

Phrase: "harboring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475311:Harbor [Manufactured Object]

Phrase: "pathogenic mutations,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "as well as"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "various forms of oxidative stress."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0348078:forms [Qualitative Concept]
   760   C0376315:Forms [Manufactured Object]
   726 E C1522492:Form [Functional Concept]
Processing 00000000.tx.54: These interactions potentially link parkin, DJ-1 and oxidative stress in a common molecular pathway.  

Phrase: "These interactions potentially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]

Phrase: "link"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "parkin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "and"

Phrase: "oxidative stress in a common molecular pathway."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1518762:Oxidative Stress Pathway [Molecular Function]
   778   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   748   C0038435:Stress [Finding]
   748   C0311404:Oxidative [Functional Concept]
Processing 00000000.tx.55: RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Parkin specifically but differentially interacts with pathogenic DJ-1 mutants To investigate the relationship between DJ-1 and -synuclein or parkin, co-immunoprecipitation experiments were performed (Fig.1). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Parkin specifically"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "but"

Phrase: "differentially"

Phrase: "interacts with pathogenic DJ-1 mutants To"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1424222:DJ-1 [Gene or Genome]
   778   C3541418:DJ-1 [Gene or Genome]
   748   C0012836:DJ [Geographic Area]
   748   C0450254:Pathogenic [Organism]
   748   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the relationship between DJ-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]

Phrase: "and -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "parkin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "co-immunoprecipitation experiments"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C1449705:Co-Immunoprecipitation [Laboratory Procedure]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Fig.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.56: SH-SY5Y cells were co-transfected with HA-tagged wild-type (WT) -synuclein together with C-terminal myc-tagged DJ-1 (WT or L166P) followed by immunoprecipitation (IP) with anti-myc antibody (Fig.1A). 

Phrase: "SH-SY5Y cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "co-transfected with HA-tagged wild-type (WT) -synuclein"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C1883559:Wild Type [Organism Attribute]
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0332307:Type [Qualitative Concept]
   744   C0445392:Wild [Intellectual Product]
   744   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   744   C1547052:*Type [Quantitative Concept]
   744   C1708632:Tagged [Qualitative Concept]
   711 E C0037293:Tag [Neoplastic Process]
   711 E C0181496:Tag [Manufactured Object]
   711 E C1710492:TAG [Gene or Genome]

Phrase: "together with C-terminal myc-tagged DJ-1"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   827   C1424222:DJ-1 [Gene or Genome]
   827   C1707271:C-Terminal [Amino Acid Sequence]
   827   C3541418:DJ-1 [Gene or Genome]
   822   C1413560:TAG-1 [Gene or Genome]
   799   C0012836:DJ [Geographic Area]
   799   C0205088:Terminal [Temporal Concept]
   799   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   799   C1705314:Terminal [Manufactured Object]
   799   C1705315:Terminal [Spatial Concept]
   799   C1708632:Tagged [Qualitative Concept]
   766 E C0037293:Tag [Neoplastic Process]
   766 E C0181496:Tag [Manufactured Object]
   766 E C1710492:TAG [Gene or Genome]

Phrase: "(WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "L166P"

Phrase: ")"

Phrase: "followed by immunoprecipitation (IP)"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with anti-myc antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Fig.1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.57: WT -synuclein fails to co-immunoprecipitate with WT or L166P DJ-1 (Fig.1A). 

Phrase: "WT -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "fails to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0231175:fail [Functional Concept]

Phrase: "co-immunoprecipitate with WT"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0301871:Immunoprecipitate [Immunologic Factor]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "L166P DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]

Phrase: "(Fig.1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.58: In additional experiments, WT and L166P DJ-1 also fail to interact with -synuclein pathogenic mutants (A30P or A53T) or UCH-L1 (data not shown). 

Phrase: "In additional experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "L166P DJ-1 also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1424222:DJ-1 [Gene or Genome]
   861   C3541418:DJ-1 [Gene or Genome]
   812   C0012836:DJ [Geographic Area]

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with -synuclein pathogenic mutants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0450254:Pathogenic [Organism]
   760   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "(A30P"

Phrase: "or"

Phrase: "A53T"

Phrase: ")"

Phrase: "or"

Phrase: "UCH-L1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1421309:Uch-L1 [Gene or Genome]
  1000   C3539585:UCH-L1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3541328:Uch-L1 [Gene or Genome]
   861   C0164005:UCH [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.59: Similar experiments were performed with FLAG-tagged parkin and myc-tagged WT or mutant DJ-1 (Fig.1B). 

Phrase: "Similar experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed with FLAG-tagged parkin"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   760   C0884358:Performed [Functional Concept]
   760   C1418270:PARKIN [Gene or Genome]
   760   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   760   C1708067:Flag [Functional Concept]
   760   C1708632:Tagged [Qualitative Concept]
   760   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   726 E C0037293:Tag [Neoplastic Process]
   726 E C0181496:Tag [Manufactured Object]
   726 E C1710492:TAG [Gene or Genome]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "myc-tagged WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1883559:Wild Type [Organism Attribute]
   812   C0332307:Type [Qualitative Concept]
   812   C0445392:Wild [Intellectual Product]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "mutant DJ-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]
   827   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(Fig.1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.60: Intriguingly, parkin specifically interacts with pathogenic mutant forms of DJ-1 (Fig.1B). 

Phrase: "Intriguingly,"

Phrase: "parkin specifically"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "interacts with pathogenic mutant forms of DJ-1"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C1424222:DJ-1 [Gene or Genome]
   770   C3541418:DJ-1 [Gene or Genome]
   744   C0012836:DJ [Geographic Area]
   744   C0348078:forms [Qualitative Concept]
   744   C0376315:Forms [Manufactured Object]
   744   C0450254:Pathogenic [Organism]
   744   C0596988:Mutant [Cell or Molecular Dysfunction]
   711 E C1522492:Form [Functional Concept]

Phrase: "(Fig.1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.61: In particular, the interaction of parkin with L166P DJ-1 is particularly robust, whereas that with other pathogenic mutants (M26I, A104T and D149A) are considerably weaker, producing an interaction profile of L166P>>M26I>A104T=D149A. 

Phrase: "In particular,"

Phrase: "the interaction of parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "with L166P DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]

Phrase: "is"

Phrase: "particularly robust,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986815:Robust [Qualitative Concept]

Phrase: "whereas"

Phrase: "that with other pathogenic mutants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0450254:Pathogenic [Organism]
   760   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "(M26I,"

Phrase: "A104T"

Phrase: "and"

Phrase: "D149A"

Phrase: ")"

Phrase: "are"

Phrase: "considerably weaker,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0004093:Weak [Sign or Symptom]
   827   C1762617:Weak [Qualitative Concept]

Phrase: "producing"

Phrase: "an interaction profile of L166P"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1979963:Profile [Laboratory Procedure]
   760   C2003903:Profile [Functional Concept]

Phrase: ">"

Phrase: ">M26I"

Phrase: ">A104T"

Phrase: "=D149A."
Processing 00000000.tx.62: WT DJ-1 and non-pathogenic R98Q DJ-1 fail to interact with parkin (Fig.1B); 

Phrase: "WT DJ-1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   875   C0441729:Type 1 [Classification]
   861   C1424222:DJ-1 [Gene or Genome]
   861   C1883559:Wild Type [Organism Attribute]
   861   C3541418:DJ-1 [Gene or Genome]
   812   C0012836:DJ [Geographic Area]
   812   C0332307:Type [Qualitative Concept]
   812   C0445392:Wild [Intellectual Product]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "non-pathogenic R98Q DJ-1"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   840   C1424222:DJ-1 [Gene or Genome]
   840   C3541418:DJ-1 [Gene or Genome]
   804   C0012836:DJ [Geographic Area]
   804   C0450254:Pathogenic [Organism]
   804   C1518422:Non [Functional Concept]
   733 E C0030657:pathogenicity [Qualitative Concept]
   733 E C1136169:Pathogenicity [Organism Attribute]

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1418270:PARKIN [Gene or Genome]
   790   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Fig.1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.63: on the other hand, parkin also fails to interact with non-pathogenic K130R DJ-1 (data not shown). 

Phrase: "on the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "parkin also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "fails"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with non-pathogenic K130R DJ-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1424222:DJ-1 [Gene or Genome]
   778   C3541418:DJ-1 [Gene or Genome]
   748   C0012836:DJ [Geographic Area]
   748   C0450254:Pathogenic [Organism]
   748   C1518422:Non [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.64: As L166P DJ-1 has a number of N-terminal truncation products that may result from proteolytic processing (Fig.1B) (33,36), we next examined whether parkin interacts with full-length or truncated forms of DJ-1 by performing co-immunoprecipitation experiments. 

Phrase: "As L166P DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]

Phrase: "has"

Phrase: "a number of N-terminal truncation products"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "that"

Phrase: "may"

Phrase: "result from proteolytic processing"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1514570:Proteolytic Processing [Molecular Function]
   770   C0597304:Proteolytic [Molecular Function]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C1709694:Processing [Activity]
   770   C1947941:proteolytic [Enzyme]
   770   C2825142:Result [Finding]

Phrase: "(Fig.1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")"

Phrase: "(33,"

Phrase: "36"

Phrase: ")"

Phrase: ","

Phrase: "we next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "interacts with full-length"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0443225:Full [Qualitative Concept]
   770   C1444754:Length [Quantitative Concept]
   770   C1706316:LENGTH [Research Activity]

Phrase: "or"

Phrase: "truncated forms of DJ-1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0348078:forms [Qualitative Concept]
   760   C0376315:Forms [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "by performing co-immunoprecipitation experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.65: Parkin interacts robustly with full-length L166P DJ-1 but only weakly with truncated L166P DJ-1, in addition to truncated WT DJ-1 (Fig.1C), suggesting that full-length L166P DJ-1 primarily associates with parkin. 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "interacts"

Phrase: "robustly with full-length L166P DJ-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1424222:DJ-1 [Gene or Genome]
   778   C3541418:DJ-1 [Gene or Genome]
   748   C0012836:DJ [Geographic Area]
   748   C0443225:Full [Qualitative Concept]
   748   C1444754:Length [Quantitative Concept]
   748   C1706316:LENGTH [Research Activity]

Phrase: "but"

Phrase: "only weakly with truncated L166P DJ-1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1424222:DJ-1 [Gene or Genome]
   778   C3541418:DJ-1 [Gene or Genome]
   748   C0012836:DJ [Geographic Area]
   748   C0205171:Only [Quantitative Concept]
   748   C1720467:Only [Intellectual Product]

Phrase: "in addition to truncated WT DJ-1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   853   C0441729:Type 1 [Classification]
   840   C1424222:DJ-1 [Gene or Genome]
   840   C1883559:Wild Type [Organism Attribute]
   840   C3541418:DJ-1 [Gene or Genome]
   804   C0012836:DJ [Geographic Area]
   804   C0332307:Type [Qualitative Concept]
   804   C0445392:Wild [Intellectual Product]
   804   C1547052:*Type [Quantitative Concept]

Phrase: "(Fig.1C"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that full-length L166P DJ-1 primarily"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   827   C1424222:DJ-1 [Gene or Genome]
   827   C3541418:DJ-1 [Gene or Genome]
   799   C0012836:DJ [Geographic Area]
   799   C0443225:Full [Qualitative Concept]
   799   C1444754:Length [Quantitative Concept]
   799   C1706316:LENGTH [Research Activity]
   727 E C0205166:Long [Qualitative Concept]
   727 E C1522425:Longest [Qualitative Concept]
   727 E C1706317:Long [Qualitative Concept]

Phrase: "associates with parkin."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0750490:Associate [Idea or Concept]
   790   C1418270:PARKIN [Gene or Genome]
   790   C1706221:Associate [Professional or Occupational Group]
   790   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.66: In additional experiments, L166P DJ-1 fails to co-immunoprecipitate with various modular domains of parkin, including the RING box motif and ubiquitin-like domain (data not shown), suggesting that full-length parkin is probably required for the interaction with L166P DJ-1. 

Phrase: "In additional experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "L166P DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]

Phrase: "fails to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0231175:fail [Functional Concept]

Phrase: "co-immunoprecipitate with various modular domains of parkin,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0301871:Immunoprecipitate [Immunologic Factor]
   744   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   744   C1418270:PARKIN [Gene or Genome]
   744   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   711   C1880389:Domain [Functional Concept]
   711   C1883221:Domain [Conceptual Entity]
   711   C3541951:Domain [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the RING box motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514562:Motif [Amino Acid Sequence]

Phrase: "and"

Phrase: "ubiquitin-like domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that full-length parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1418270:PARKIN [Gene or Genome]
   827   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "required for the interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1514873:Required [Functional Concept]
   770   C1704675:Interaction [Functional Concept]

Phrase: "with L166P DJ-1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]
Processing 00000000.tx.67: To determine whether the interaction of parkin with pathogenic mutant forms of DJ-1 is associated with alterations in DJ-1 protein stability or homo-dimer formation, we examined the steady-state levels of myc-tagged WT and mutant DJ-1, as well as the capacity of myc-tagged WT and mutant DJ-1 to associate, and therefore homo-dimerize with FLAG-tagged WT DJ-1 (Fig.1D and E). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the interaction of parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "with pathogenic mutant forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0348078:forms [Qualitative Concept]
   827   C0376315:Forms [Manufactured Object]
   793 E C1522492:Form [Functional Concept]

Phrase: "of DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "is"

Phrase: "associated with alterations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756   C1515926:Alteration [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in DJ-1 protein stability"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C2350440:Protein Stability [Qualitative Concept]
   812   C0205360:Stability [Qualitative Concept]
   812   C2347098:Stability [Qualitative Concept]
   741 E C1547311:Stable [Intellectual Product]

Phrase: "or"

Phrase: "homo-dimer formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the steady-state levels of myc-tagged WT"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   764   C0678587:steady state [Natural Phenomenon or Process]
   748   C0683927:state level [Spatial Concept]
   742   C0205361:Steady [Qualitative Concept]
   742   C0441889:Levels [Qualitative Concept]
   742   C1301808:State [Geographic Area]
   742   C1442792:State [Functional Concept]
   742   C3148680:State [Geographic Area]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "mutant DJ-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]
   827   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "as well as"

Phrase: "the capacity of myc-tagged WT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1516240:Capacity [Quantitative Concept]

Phrase: "and"

Phrase: "mutant DJ-1 to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1424222:DJ-1 [Gene or Genome]
   861   C3541418:DJ-1 [Gene or Genome]
   812   C0012836:DJ [Geographic Area]
   812   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "associate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750490:Associate [Idea or Concept]
  1000   C1706221:Associate [Professional or Occupational Group]

Phrase: ","

Phrase: "and"

Phrase: "therefore homo-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1300203:Homo [Mammal]
   861   C3245470:HOMO [Finding]

Phrase: "dimerize with FLAG-tagged WT DJ-1"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   770   C1424222:DJ-1 [Gene or Genome]
   770   C1883559:Wild Type [Organism Attribute]
   770   C3541418:DJ-1 [Gene or Genome]
   767   C0441729:Type 1 [Classification]
   750   C1413560:TAG-1 [Gene or Genome]
   744   C0012836:DJ [Geographic Area]
   744   C0332307:Type [Qualitative Concept]
   744   C0376525:Dimerize [Natural Phenomenon or Process]
   744   C0445392:Wild [Intellectual Product]
   744   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   744   C1547052:*Type [Quantitative Concept]
   744   C1708067:Flag [Functional Concept]
   744   C1708632:Tagged [Qualitative Concept]
   711 E C0037293:Tag [Neoplastic Process]
   711 E C0181496:Tag [Manufactured Object]
   711 E C1710492:TAG [Gene or Genome]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]

Phrase: "1D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416886:1D [Gene or Genome]
  1000   C1442449:1D [Temporal Concept]

Phrase: "and"

Phrase: "E"

Phrase: ")."
Processing 00000000.tx.68: As previously reported (33), L166P DJ-1 is highly unstable, exhibiting markedly reduced steady-state levels, and fails to form homo-dimers, whereas most other DJ-1 mutants exhibit comparable steady-state levels to WT protein and share the capacity to form homo-dimers (Fig.1D and E). 

Phrase: "As"

Phrase: "previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(33"

Phrase: ")"

Phrase: ","

Phrase: "L166P DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]

Phrase: "is"

Phrase: "highly unstable,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443343:Unstable [Finding]
   861   C1883468:UNSTABLE [Phenomenon or Process]

Phrase: "exhibiting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:exhibiting [Intellectual Product]

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "steady-state levels,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   901   C0678587:steady state [Natural Phenomenon or Process]
   884   C0683927:state level [Spatial Concept]
   827   C0205361:Steady [Qualitative Concept]
   827   C0441889:Levels [Qualitative Concept]
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "fails"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "homo-dimers,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0596448:dimers [Chemical Viewed Structurally]
   861   C1300203:Homo [Mammal]
   861   C3245470:HOMO [Finding]

Phrase: "whereas"

Phrase: "most other DJ-1 mutants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0596988:mutants [Cell or Molecular Dysfunction]
   734   C1424222:DJ-1 [Gene or Genome]
   734   C3541418:DJ-1 [Gene or Genome]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "comparable steady-state levels to WT protein"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   770   C0678587:steady state [Natural Phenomenon or Process]
   754   C0683927:state level [Spatial Concept]
   750   C0428479:Protein level [Laboratory or Test Result]
   744   C0205361:Steady [Qualitative Concept]
   744   C0441889:Levels [Qualitative Concept]
   744   C1301808:State [Geographic Area]
   744   C1442792:State [Functional Concept]
   744   C3148680:State [Geographic Area]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "the capacity to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516240:Capacity [Quantitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "homo-dimers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0596448:dimers [Chemical Viewed Structurally]
   861   C1300203:Homo [Mammal]
   861   C3245470:HOMO [Finding]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]

Phrase: "1D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416886:1D [Gene or Genome]
  1000   C1442449:1D [Temporal Concept]

Phrase: "and"

Phrase: "E"

Phrase: ")."
Processing 00000000.tx.69: A mild reduction in the steady-state levels of M26I DJ-1 is also noted, as described previously (33). 

Phrase: "A mild reduction in the steady-state levels of M26I DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C0301630:Reduction [Natural Phenomenon or Process]
   736   C0392756:Reduction [Qualitative Concept]
   736   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "also"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: ","

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.70: Taken together, these results suggest that parkin interacts specifically with pathogenic mutant forms of DJ-1, particularly the L166P mutant, but this does not initially appear to relate to their intrinsic protein stability or their capacity to form homo-dimers. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "interacts"

Phrase: "specifically with pathogenic mutant forms of DJ-1,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C1424222:DJ-1 [Gene or Genome]
   770   C3541418:DJ-1 [Gene or Genome]
   744   C0012836:DJ [Geographic Area]
   744   C0348078:forms [Qualitative Concept]
   744   C0376315:Forms [Manufactured Object]
   744   C0450254:Pathogenic [Organism]
   744   C0596988:Mutant [Cell or Molecular Dysfunction]
   711 E C1522492:Form [Functional Concept]

Phrase: "particularly"

Phrase: "the L166P mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "but"

Phrase: "this"

Phrase: "does"

Phrase: "not initially"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205265:Initially [Temporal Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "relate to their intrinsic protein stability"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C2350440:Protein Stability [Qualitative Concept]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0163712:Relate [Organic Chemical]
   753   C0205102:Intrinsic [Spatial Concept]
   753   C0205360:Stability [Qualitative Concept]
   753   C0439674:Intrinsic [Functional Concept]
   753   C2347098:Stability [Qualitative Concept]

Phrase: "or"

Phrase: "their capacity to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516240:Capacity [Quantitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "homo-dimers."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0596448:dimers [Chemical Viewed Structurally]
   861   C1300203:Homo [Mammal]
   861   C3245470:HOMO [Finding]
Processing 00000000.tx.71: View larger version (57K): [in this window] [in a new window]  Figure1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(57K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure1."
Processing 00000000.tx.72: Parkin differentially associates with pathogenic DJ-1 mutants. 

Phrase: "Parkin differentially"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "associates with pathogenic DJ-1 mutants."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1424222:DJ-1 [Gene or Genome]
   790   C3541418:DJ-1 [Gene or Genome]
   753   C0012836:DJ [Geographic Area]
   753   C0450254:Pathogenic [Organism]
   753   C0596988:mutants [Cell or Molecular Dysfunction]
   753   C0750490:Associate [Idea or Concept]
   753   C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.73: (A) DJ-1 fails to interact with -synuclein. 

Phrase: "(A) DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]

Phrase: "fails"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with -synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.74: Lysates from SH-SY5Y cells co-transfected with myc-tagged DJ-1 (WT or L166P) and HA-tagged WT -synuclein were subjected to IP with anti-myc antibody. 

Phrase: "Lysates from SH-SY5Y cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "co-transfected with myc-tagged DJ-1"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   778   C1424222:DJ-1 [Gene or Genome]
   778   C3541418:DJ-1 [Gene or Genome]
   757   C1413560:TAG-1 [Gene or Genome]
   748   C0012836:DJ [Geographic Area]
   748   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   748   C1708632:Tagged [Qualitative Concept]
   714 E C0037293:Tag [Neoplastic Process]
   714 E C0181496:Tag [Manufactured Object]
   714 E C1710492:TAG [Gene or Genome]

Phrase: "(WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "L166P"

Phrase: ")"

Phrase: "and"

Phrase: "HA-tagged WT -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "subjected to IP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with anti-myc antibody."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.75: IP and input lysates (1% total soluble lysate) were analyzed by western blotting (WB) with anti-HA and anti-myc antibodies. 

Phrase: "IP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "input lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "(1% total soluble lysate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1881488:Lysate [Physical Object]

Phrase: ")"

Phrase: "were"

Phrase: "analyzed by western blotting (WB)"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with anti-HA"

Phrase: "and"

Phrase: "anti-myc antibodies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.76: (B) Interaction of parkin with pathogenic DJ-1 mutants. 

Phrase: "(B) Interaction of parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "with pathogenic DJ-1 mutants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.77: SH-SY5Y lysates co-expressing myc-tagged WT or mutant (L166P, M26I, A104T, D149A or R98Q) DJ-1 or control plasmid, together with FLAG-tagged parkin, were subjected to IP with anti-myc antibody, and IP and input lysates were analyzed by WB with anti-FLAG and anti-myc antibodies. 

Phrase: "SH-SY5Y lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1881488:Lysate [Physical Object]

Phrase: "co-expressing"

Phrase: "myc-tagged WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1883559:Wild Type [Organism Attribute]
   812   C0332307:Type [Qualitative Concept]
   812   C0445392:Wild [Intellectual Product]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(L166P,"

Phrase: "M26I,"

Phrase: "A104T,"

Phrase: "D149A"

Phrase: "or"

Phrase: "R98Q"

Phrase: ")"

Phrase: "DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "or"

Phrase: "control plasmid,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "together with FLAG-tagged parkin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1418270:PARKIN [Gene or Genome]
   827   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "subjected to IP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with anti-myc antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "IP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "input lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "analyzed by WB"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with anti-FLAG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708067:Flag [Functional Concept]

Phrase: "and"

Phrase: "anti-myc antibodies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.78: (C) Parkin interacts primarily with full-length L166P DJ-1. 

Phrase: "(C) Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "interacts"

Phrase: "primarily with full-length L166P DJ-1."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1424222:DJ-1 [Gene or Genome]
   778   C3541418:DJ-1 [Gene or Genome]
   748   C0012836:DJ [Geographic Area]
   748   C0443225:Full [Qualitative Concept]
   748   C1444754:Length [Quantitative Concept]
   748   C1706316:LENGTH [Research Activity]
Processing 00000000.tx.79: SH-SY5Y lysates co-expressing myc-tagged DJ-1 (WT or L166P) together with FLAG-tagged parkin or control plasmid were subjected to IP with anti-FLAG antibody, and IP and input lysates were analyzed by WB with anti-myc and anti-FLAG antibodies. 

Phrase: "SH-SY5Y lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1881488:Lysate [Physical Object]

Phrase: "co-expressing"

Phrase: "myc-tagged DJ-1"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   861   C1424222:DJ-1 [Gene or Genome]
   861   C3541418:DJ-1 [Gene or Genome]
   858   C1413560:TAG-1 [Gene or Genome]
   812   C0012836:DJ [Geographic Area]
   812   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   812   C1708632:Tagged [Qualitative Concept]
   779 E C0037293:Tag [Neoplastic Process]
   779 E C0181496:Tag [Manufactured Object]
   779 E C1710492:TAG [Gene or Genome]

Phrase: "(WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "L166P"

Phrase: ")"

Phrase: "together with FLAG-tagged parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1418270:PARKIN [Gene or Genome]
   827   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "control plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "subjected to IP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with anti-FLAG antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "IP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "input lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "analyzed by WB"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with anti-myc"

Phrase: "and"

Phrase: "anti-FLAG antibodies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.80: Full-length (FL) and N-terminally truncated (N1 and N2) myc-tagged DJ-1 species are indicated by arrows. 

Phrase: "Full-length (FL)"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0443225:Full [Qualitative Concept]
   861   C1444754:Length [Quantitative Concept]
   861   C1706316:LENGTH [Research Activity]
   789 E C0205166:Long [Qualitative Concept]
   789 E C1522425:Longest [Qualitative Concept]
   789 E C1706317:Long [Qualitative Concept]

Phrase: "and"

Phrase: "N-terminally"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "truncated"

Phrase: "(N1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441962:N1 [Finding]

Phrase: "and"

Phrase: "N2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441960:N2 [Finding]

Phrase: ")"

Phrase: "myc-tagged DJ-1 species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1705920:Species [Conceptual Entity]

Phrase: "are"

Phrase: "indicated by arrows."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0336721:arrows [Manufactured Object]
   790   C1444656:Indicated [Finding]
Processing 00000000.tx.81: (D) Analysis of steady-state protein levels of DJ-1 mutants. 

Phrase: "("

Phrase: "D)"

Phrase: "Analysis of steady-state protein levels of DJ-1 mutants."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C1514534:Protein Analysis [Molecular Biology Research Technique]
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0936012:Analysis [Research Activity]
   739   C1524024:analysis [Functional Concept]
Processing 00000000.tx.82: Lysates from SH-SY5Y cells transfected with myc-tagged WT or mutant (L166P, M26I, A104T, D149A or R98Q) DJ-1 were analyzed by WB with anti-myc antibody or with anti-actin antibody to demonstrate equal loading. 

Phrase: "Lysates from SH-SY5Y cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "transfected with myc-tagged WT"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C1883559:Wild Type [Organism Attribute]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   753   C1547052:*Type [Quantitative Concept]
   753   C1708632:Tagged [Qualitative Concept]
   719 E C0037293:Tag [Neoplastic Process]
   719 E C0181496:Tag [Manufactured Object]
   719 E C1710492:TAG [Gene or Genome]

Phrase: "or"

Phrase: "mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(L166P,"

Phrase: "M26I,"

Phrase: "A104T,"

Phrase: "D149A"

Phrase: "or"

Phrase: "R98Q"

Phrase: ")"

Phrase: "DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "were"

Phrase: "analyzed by WB"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with anti-myc antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "or with anti-actin antibody to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0369998:Anti-actin antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C1718641:Actin Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "demonstrate"

Phrase: "equal loading."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708715:Loading [Activity]
Processing 00000000.tx.83: (E) Analysis of dimerization of DJ-1 mutants. 

Phrase: "(E) Analysis of dimerization of DJ-1 mutants."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]
Processing 00000000.tx.84: Lysates from SH-SY5Y cells co-transfected with myc-tagged WT or mutant (L166P, M26I, A104T, D149A or R98Q) DJ-1 or control plasmid, together with FLAG-tagged WT DJ-1, were subjected to IP with anti-myc antibody, and IP and input lysates were analyzed by WB with anti-FLAG and anti-myc antibodies. 

Phrase: "Lysates from SH-SY5Y cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "co-transfected with myc-tagged WT"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   778   C1883559:Wild Type [Organism Attribute]
   748   C0332307:Type [Qualitative Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   748   C1547052:*Type [Quantitative Concept]
   748   C1708632:Tagged [Qualitative Concept]
   714 E C0037293:Tag [Neoplastic Process]
   714 E C0181496:Tag [Manufactured Object]
   714 E C1710492:TAG [Gene or Genome]

Phrase: "or"

Phrase: "mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(L166P,"

Phrase: "M26I,"

Phrase: "A104T,"

Phrase: "D149A"

Phrase: "or"

Phrase: "R98Q"

Phrase: ")"

Phrase: "DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "or"

Phrase: "control plasmid,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "together with FLAG-tagged WT DJ-1,"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   859   C1413560:TAG-1 [Gene or Genome]
   839   C0441729:Type 1 [Classification]
   827   C1424222:DJ-1 [Gene or Genome]
   827   C1883559:Wild Type [Organism Attribute]
   827   C3541418:DJ-1 [Gene or Genome]
   799   C0012836:DJ [Geographic Area]
   799   C0332307:Type [Qualitative Concept]
   799   C0445392:Wild [Intellectual Product]
   799   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   799   C1547052:*Type [Quantitative Concept]
   799   C1708067:Flag [Functional Concept]
   799   C1708632:Tagged [Qualitative Concept]
   766 E C0037293:Tag [Neoplastic Process]
   766 E C0181496:Tag [Manufactured Object]
   766 E C1710492:TAG [Gene or Genome]

Phrase: "were"

Phrase: "subjected to IP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with anti-myc antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "IP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "input lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "analyzed by WB"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with anti-FLAG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708067:Flag [Functional Concept]

Phrase: "and"

Phrase: "anti-myc antibodies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.85: Molecular weight markers are indicated in kDa. 

Phrase: "Molecular weight markers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0005516:molecular markers [Clinical Attribute]
           Marker
   734   C0026385:Molecular Weight [Quantitative Concept]

Phrase: "are"

Phrase: "indicated in kDa."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1444656:Indicated [Finding]
   790   C1532717:kDa [Quantitative Concept]
Processing 00000000.tx.86: All experiments were replicated three times with similar results.  

Phrase: "All experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "replicated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205173:replicated [Functional Concept]
   966 E C0205341:Replicate [Functional Concept]
   966 E C1883725:Replicate [Qualitative Concept]

Phrase: "three times with similar results."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]
Processing 00000000.tx.87: Pathogenic DJ-1 mutants share a reduced capacity to form homo-dimers Parkin interacts robustly with L166P DJ-1, however, this mutant exists largely in a monomeric form through its inability to form homo-dimers owing to protein instability (33,38). 

Phrase: "Pathogenic DJ-1 mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "a reduced capacity to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1516240:Capacity [Quantitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "homo-dimers Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1418270:PARKIN [Gene or Genome]
   827   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "interacts"

Phrase: "robustly with L166P DJ-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1424222:DJ-1 [Gene or Genome]
   806   C3541418:DJ-1 [Gene or Genome]
   760   C0012836:DJ [Geographic Area]

Phrase: "however,"

Phrase: "this mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "exists"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: "largely in a monomeric form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]

Phrase: "through its inability to"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "homo-dimers owing to protein instability"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0596448:dimers [Chemical Viewed Structurally]
   753   C1300203:Homo [Mammal]
   753   C3245470:HOMO [Finding]

Phrase: "(33,"

Phrase: "38"

Phrase: ")."
Processing 00000000.tx.88: We reasoned therefore that parkin might interact preferentially with monomeric DJ-1 and that pathogenic mutations in DJ-1, other than L166P, might reduce but not completely abrogate the capacity of DJ-1 to form homo-dimers. 

Phrase: "We"

Phrase: "reasoned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0392360:Reason [Idea or Concept]

Phrase: "therefore"

Phrase: "that parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "might"

Phrase: "interact"

Phrase: "preferentially with monomeric DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1424222:DJ-1 [Gene or Genome]
   806   C3541418:DJ-1 [Gene or Genome]
   760   C0012836:DJ [Geographic Area]

Phrase: "and"

Phrase: "that pathogenic mutations in DJ-1,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "other than L166P,"

Phrase: "might"

Phrase: "reduce"

Phrase: "but"

Phrase: "not completely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205197:Completely [Qualitative Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "abrogate"

Phrase: "the capacity of DJ-1 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1516240:Capacity [Quantitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "homo-dimers."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0596448:dimers [Chemical Viewed Structurally]
   861   C1300203:Homo [Mammal]
   861   C3245470:HOMO [Finding]
Processing 00000000.tx.89: To investigate this possibility, SH-SY5Y cells were transfected with myc-tagged DJ-1 (WT or L166P) and soluble cell lysates were treated with the covalent chemical cross-linking agent disuccinimidyl suberate (DSS). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "this possibility,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "SH-SY5Y cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with myc-tagged DJ-1"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C1424222:DJ-1 [Gene or Genome]
   790   C3541418:DJ-1 [Gene or Genome]
   767   C1413560:TAG-1 [Gene or Genome]
   753   C0012836:DJ [Geographic Area]
   753   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   753   C1708632:Tagged [Qualitative Concept]
   719 E C0037293:Tag [Neoplastic Process]
   719 E C0181496:Tag [Manufactured Object]
   719 E C1710492:TAG [Gene or Genome]

Phrase: "(WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "L166P"

Phrase: ")"

Phrase: "and"

Phrase: "soluble cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "treated with the covalent chemical cross-linking agent disuccinimidyl suberate (DSS)."
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   760   C0058479:disuccinimidyl suberate [Organic Chemical,Pharmacologic Substance]
   760   C0332220:Cross-linking [Functional Concept]
   760   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   743 E C0178576:Cross link [Natural Phenomenon or Process]
   739   C0220806:Chemical [Chemical]
   739   C0450442:Agent [Chemical Viewed Functionally]
   739   C0947344:Suberate [Organic Chemical]
   739   C1254351:Agent [Pharmacologic Substance]
   739   C1511539:Covalent [Molecular Function]
   739   C1521826:Agent [Intellectual Product]
   739   C1522326:Treated [Functional Concept]
   739   C2828360:Cross [Conceptual Entity]
   739   C3272558:Chemical [Intellectual Product]
   706 E C1292734:TREAT [Functional Concept]
   706   C1517892:Link [Intellectual Product]
   706   C1704666:Link [Intellectual Product]
Processing 00000000.tx.90: As expected, myc-tagged WT DJ-1 forms homo-dimers in a dose-dependent manner concomitant with a progressive decrease in monomeric DJ-1, whereas L166P DJ-1 fails to form homo-dimers (Fig.2A), consistent with our co-immunoprecipitation studies (Fig.1E). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "myc-tagged WT DJ-1 forms homo-dimers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   791   C0596448:dimers [Chemical Viewed Structurally]
   791   C1300203:Homo [Mammal]
   791   C3245470:HOMO [Finding]

Phrase: "in a dose-dependent manner"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1512045:Dose-dependent [Quantitative Concept]

Phrase: "concomitant with a progressive decrease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0521115:Concomitant [Temporal Concept]

Phrase: "in monomeric DJ-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]
   755   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "whereas"

Phrase: "L166P DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]

Phrase: "fails"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "homo-dimers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0596448:dimers [Chemical Viewed Structurally]
   861   C1300203:Homo [Mammal]
   861   C3245470:HOMO [Finding]

Phrase: "(Fig.2A"

Phrase: ")"

Phrase: ","

Phrase: "consistent with our co-immunoprecipitation studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(Fig.1E"

Phrase: ")."
Processing 00000000.tx.91: Incidentally, the level of monomeric L166P DJ-1 also decreases in a dose-dependent manner, but fails to appear at a higher molecular weight (Fig.2A), perhaps suggesting that it becomes incorporated into an insoluble protein complex. 

Phrase: "Incidentally,"

Phrase: "the level of monomeric L166P DJ-1 also"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0456947:Level 1 [Intellectual Product]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "decreases in a dose-dependent manner,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C1512045:Dose-dependent [Quantitative Concept]
   753   C0178602:Dose [Quantitative Concept]
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]
   753   C0851827:Dependent [Qualitative Concept]
   753   C0869039:Dose [Quantitative Concept]
   753   C1114758:Dose # [Clinical Attribute]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "but"

Phrase: "fails"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "appear at a higher molecular weight"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   816   C1979900:High molecular weight [Qualitative Concept]
   790   C0026385:Molecular Weight [Quantitative Concept]
   767   C0948775:high weight [Sign or Symptom]
   753   C0005910:weight [Organism Attribute]
   753   C0043100:Weight [Quantitative Concept]
   753   C0700364:APPEAR [Qualitative Concept]
   753   C1305866:weight [Diagnostic Procedure]
   753   C1521991:Molecular [Qualitative Concept]
   753   C1705104:Weight [Idea or Concept]
   742 E C0424638:Height & weight [Organism Attribute]
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "(Fig.2A"

Phrase: ")"

Phrase: ","

Phrase: "perhaps"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "it"

Phrase: "becomes"

Phrase: "incorporated into an insoluble protein complex."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1523872:protein complex [Cell Component]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439855:Complex [Qualitative Concept]
   753   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.92: Endogenous DJ-1 also forms robust homo-dimers, whereas hetero-dimer formation appears nominal (Fig.2A). 

Phrase: "Endogenous DJ-1 also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1424222:DJ-1 [Gene or Genome]
   861   C3541418:DJ-1 [Gene or Genome]
   812   C0012836:DJ [Geographic Area]
   812   C0205227:Endogenous [Functional Concept]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "robust homo-dimers,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0596448:dimers [Chemical Viewed Structurally]
   827   C1300203:Homo [Mammal]
   827   C3245470:HOMO [Finding]

Phrase: "whereas"

Phrase: "hetero-dimer formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "nominal"

Phrase: "(Fig.2A"

Phrase: ")."
Processing 00000000.tx.93: These data demonstrate that DJ-1 homo-dimers are amenable to chemical cross-linking and further confirm that L166P DJ-1 fails to form homo-dimers. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "demonstrate"

Phrase: "that DJ-1 homo-dimers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0596448:dimers [Chemical Viewed Structurally]
   812   C1300203:Homo [Mammal]
   812   C3245470:HOMO [Finding]

Phrase: "are"

Phrase: "amenable to chemical"

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that L166P DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]

Phrase: "fails"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "homo-dimers."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0596448:dimers [Chemical Viewed Structurally]
   861   C1300203:Homo [Mammal]
   861   C3245470:HOMO [Finding]
Processing 00000000.tx.94: View larger version (65K): [in this window] [in a new window]  Figure2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(65K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure2."
Processing 00000000.tx.95: Reduced homo-dimerization of pathogenic DJ-1 mutants. 

Phrase: "Reduced homo-dimerization of pathogenic DJ-1 mutants."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0376525:Dimerization [Natural Phenomenon or Process]
   744   C1300203:Homo [Mammal]
   744   C3245470:HOMO [Finding]
Processing 00000000.tx.96: (A) Cross-linking of DJ-1 homo-dimers. 

Phrase: "(A)"

Phrase: "Cross-linking of DJ-1 homo-dimers."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   778   C0332220:Cross-linking [Functional Concept]
   778   C1424222:DJ-1 [Gene or Genome]
   778   C3541418:DJ-1 [Gene or Genome]
   762 E C0178576:Cross link [Natural Phenomenon or Process]
   748   C0012836:DJ [Geographic Area]
   748   C0596448:dimers [Chemical Viewed Structurally]
   748   C1300203:Homo [Mammal]
   748   C2828360:Cross [Conceptual Entity]
   748   C3245470:HOMO [Finding]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]
Processing 00000000.tx.97: Equivalent soluble lysates from SH-SY5Y cells transfected with myc-tagged DJ-1 (WT or L166P) were treated with increasing concentrations of DSS and myc-tagged or endogenous DJ-1 was detected by WB with anti-myc (upper panel) or anti-DJ-1 (N) (lower panel) antibodies, respectively. 

Phrase: "Equivalent soluble lysates from SH-SY5Y cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   741   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "transfected with myc-tagged DJ-1"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C1424222:DJ-1 [Gene or Genome]
   790   C3541418:DJ-1 [Gene or Genome]
   767   C1413560:TAG-1 [Gene or Genome]
   753   C0012836:DJ [Geographic Area]
   753   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   753   C1708632:Tagged [Qualitative Concept]
   719 E C0037293:Tag [Neoplastic Process]
   719 E C0181496:Tag [Manufactured Object]
   719 E C1710492:TAG [Gene or Genome]

Phrase: "(WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "L166P"

Phrase: ")"

Phrase: "were"

Phrase: "treated with increasing concentrations of DSS"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   778   C0058479:disuccinimidyl suberate [Organic Chemical,Pharmacologic Substance]
   778   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   748   C0086045:Concentrations [Mental Process]
   748   C0442808:Increasing [Functional Concept]
   748   C0947344:Suberate [Organic Chemical]
   748   C1522326:Treated [Functional Concept]
   714 E C1292734:TREAT [Functional Concept]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "myc-tagged"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   861   C1708632:Tagged [Qualitative Concept]
   827 E C0037293:Tag [Neoplastic Process]
   827 E C0181496:Tag [Manufactured Object]
   827 E C1710492:TAG [Gene or Genome]

Phrase: "or"

Phrase: "endogenous DJ-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]
   827   C0205227:Endogenous [Functional Concept]

Phrase: "was"

Phrase: "detected by WB"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1705493:Western [Spatial Concept]

Phrase: "with anti-myc (upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0441833:Panel [Idea or Concept]
   812   C1999270:Panel [Intellectual Product]
   812   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "or"

Phrase: "anti-DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]

Phrase: "(N) (lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441833:Panel [Idea or Concept]
   827   C1999270:Panel [Intellectual Product]
   827   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "antibodies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "respectively."
Processing 00000000.tx.98: The corresponding position of myc-tagged (Myc) or endogenous (endo) DJ-1 monomers and homo-dimers are indicated. 

Phrase: "The corresponding position of myc-tagged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0733755:Position [Spatial Concept]

Phrase: "(Myc)"

Phrase: "or"

Phrase: "endogenous (endo) DJ-1 monomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596973:monomers [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "homo-dimers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0596448:dimers [Chemical Viewed Structurally]
   861   C1300203:Homo [Mammal]
   861   C3245470:HOMO [Finding]

Phrase: "are"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.99: (B) Reduced cross-linking of pathogenic DJ-1 mutants. 

Phrase: "(B) Reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0392756:Reduced [Qualitative Concept]

Phrase: "cross-linking of pathogenic DJ-1 mutants."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   778   C0332220:Cross-linking [Functional Concept]
   778   C1424222:DJ-1 [Gene or Genome]
   778   C3541418:DJ-1 [Gene or Genome]
   762 E C0178576:Cross link [Natural Phenomenon or Process]
   748   C0012836:DJ [Geographic Area]
   748   C0450254:Pathogenic [Organism]
   748   C0596988:mutants [Cell or Molecular Dysfunction]
   748   C2828360:Cross [Conceptual Entity]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]
Processing 00000000.tx.100: Equivalent lysates from SH-SY5Y cells transfected with myc-tagged WT or mutant (L166P, M26I, A104T, D149A or R98Q) DJ-1 were treated with 5 mM DSS and homo-dimer formation was assessed by WB with anti-myc antibody. 

Phrase: "Equivalent lysates from SH-SY5Y cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   750   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "transfected with myc-tagged WT"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C1883559:Wild Type [Organism Attribute]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   753   C1547052:*Type [Quantitative Concept]
   753   C1708632:Tagged [Qualitative Concept]
   719 E C0037293:Tag [Neoplastic Process]
   719 E C0181496:Tag [Manufactured Object]
   719 E C1710492:TAG [Gene or Genome]

Phrase: "or"

Phrase: "mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(L166P,"

Phrase: "M26I,"

Phrase: "A104T,"

Phrase: "D149A"

Phrase: "or"

Phrase: "R98Q"

Phrase: ")"

Phrase: "DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "were"

Phrase: "treated with 5 mM DSS"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0058479:disuccinimidyl suberate [Organic Chemical,Pharmacologic Substance]
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0947344:Suberate [Organic Chemical]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "homo-dimer formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "was"

Phrase: "assessed by WB"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1516048:Assessed [Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with anti-myc antibody."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.101: (C) Quantification of homo-dimer levels and normalization to monomer levels from (B) by densitometry reveals a significant reduction in the homo-dimerization of pathogenic DJ-1 mutants. 

Phrase: "(C) Quantification of homo-dimer levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709793:Quantification [Quantitative Concept]

Phrase: "and"

Phrase: "normalization to monomer levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1882115:Normalization [Research Activity]

Phrase: "from"

Phrase: "(B) by densitometry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2347469:/B [Quantitative Concept]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "a significant reduction in the homo-dimerization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "of pathogenic DJ-1 mutants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.102: DJ-1 dimermonomer ratios are expressed as a percentage (%) of WT levels, and bars represent the meanSE of three independent experiments, *P<0.005 when compared with WT levels (Student's t-test). 

Phrase: "DJ-1 dimermonomer ratios"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0456603:Ratios [Quantitative Concept]
   812   C1610540:*Ratios [Quantitative Concept]
   779 E C1547037:Ratio [Intellectual Product]

Phrase: "are"

Phrase: "expressed as a percentage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439165:Percentage [Quantitative Concept]
   770   C1549488:Percentage [Idea or Concept]
   770   C1561533:Percentage [Idea or Concept]

Phrase: "(%"

Phrase: ")"

Phrase: "of WT levels,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "and"

Phrase: "bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the meanSE of three independent experiments,"

Phrase: "*P<0.005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "when"

Phrase: "compared with WT levels"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0441889:Levels [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C1707455:Compared [Activity]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Student's t-test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0022885:Test [Laboratory Procedure]
   827   C0038492:student [Professional or Occupational Group]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C1551041:student [Idea or Concept]
   827   C1552573:student [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.103: (D) Parkin fails to cross-link to pathogenic DJ-1 mutants. 

Phrase: "("

Phrase: "D)"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "fails"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to cross-link to pathogenic DJ-1 mutants."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0178576:Cross link [Natural Phenomenon or Process]
   770   C0332220:cross link [Functional Concept]
   744   C1517892:Link [Intellectual Product]
   744   C1704666:Link [Intellectual Product]
   744   C2828360:Cross [Conceptual Entity]
Processing 00000000.tx.104: SH-SY5Y cells were co-transfected with myc-tagged WT or mutant (L166P, M26I, A104T, D149A or R98Q) DJ-1 or control plasmid, together with FLAG-tagged parkin. 

Phrase: "SH-SY5Y cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "co-transfected with myc-tagged WT"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   778   C1883559:Wild Type [Organism Attribute]
   748   C0332307:Type [Qualitative Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   748   C1547052:*Type [Quantitative Concept]
   748   C1708632:Tagged [Qualitative Concept]
   714 E C0037293:Tag [Neoplastic Process]
   714 E C0181496:Tag [Manufactured Object]
   714 E C1710492:TAG [Gene or Genome]

Phrase: "or"

Phrase: "mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(L166P,"

Phrase: "M26I,"

Phrase: "A104T,"

Phrase: "D149A"

Phrase: "or"

Phrase: "R98Q"

Phrase: ")"

Phrase: "DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "or"

Phrase: "control plasmid,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "together with FLAG-tagged parkin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1418270:PARKIN [Gene or Genome]
   827   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.105: Equivalent lysates were treated with 5mM DSS and then subjected to IP with anti-myc antibody. 

Phrase: "Equivalent lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "treated with 5mM DSS"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0058479:disuccinimidyl suberate [Organic Chemical,Pharmacologic Substance]
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0947344:Suberate [Organic Chemical]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "subjected to IP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with anti-myc antibody."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.106: IP and input lysates were analyzed by WB with anti-FLAG and anti-myc antibodies. 

Phrase: "IP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "input lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "analyzed by WB"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with anti-FLAG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708067:Flag [Functional Concept]

Phrase: "and"

Phrase: "anti-myc antibodies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.107: *NS denotes non-specific band detected with anti-myc antibody. 

Phrase: "*NS"

Phrase: "denotes"

Phrase: "non-specific band"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0175723:Band [Medical Device]
   827   C0439645:Band [Spatial Concept]
   827   C1521913:band [Cell Component]
   734   C0205370:Non-specific [Qualitative Concept]

Phrase: "detected with anti-myc antibody."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.108: Molecular weight markers are indicated in kDa. 

Phrase: "Molecular weight markers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0005516:molecular markers [Clinical Attribute]
           Marker
   734   C0026385:Molecular Weight [Quantitative Concept]

Phrase: "are"

Phrase: "indicated in kDa."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1444656:Indicated [Finding]
   790   C1532717:kDa [Quantitative Concept]
Processing 00000000.tx.109: All experiments were replicated three times with similar results.  

Phrase: "All experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "replicated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205173:replicated [Functional Concept]
   966 E C0205341:Replicate [Functional Concept]
   966 E C1883725:Replicate [Qualitative Concept]

Phrase: "three times with similar results."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]
Processing 00000000.tx.110: Next, the capacity of myc-tagged WT or mutant DJ-1 to form homo-dimers was examined using a non-saturating concentration of DSS (5mM). 

Phrase: "Next,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "the capacity of myc-tagged WT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1516240:Capacity [Quantitative Concept]

Phrase: "or"

Phrase: "mutant DJ-1 to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1424222:DJ-1 [Gene or Genome]
   861   C3541418:DJ-1 [Gene or Genome]
   812   C0012836:DJ [Geographic Area]
   812   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "homo-dimers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0596448:dimers [Chemical Viewed Structurally]
   861   C1300203:Homo [Mammal]
   861   C3245470:HOMO [Finding]

Phrase: "was"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a non-saturating concentration of DSS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0086045:Concentration [Mental Process]
   748   C1446561:Concentration [Quantitative Concept]

Phrase: "(5mM"

Phrase: ")."
Processing 00000000.tx.111: With the exception of L166P DJ-1, WT DJ-1 and the other DJ-1 mutants form varying amounts of homo-dimer following cross-linking (Fig.2B), consistent with our co-immunoprecipitation studies (Fig.1E). 

Phrase: "With the exception"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1554961:exception [Idea or Concept]
  1000   C1705847:Exception [Conceptual Entity]

Phrase: "of L166P DJ-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]

Phrase: "WT DJ-1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   875   C0441729:Type 1 [Classification]
   861   C1424222:DJ-1 [Gene or Genome]
   861   C1883559:Wild Type [Organism Attribute]
   861   C3541418:DJ-1 [Gene or Genome]
   812   C0012836:DJ [Geographic Area]
   812   C0332307:Type [Qualitative Concept]
   812   C0445392:Wild [Intellectual Product]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "the other DJ-1 mutants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0596988:mutants [Cell or Molecular Dysfunction]
   734   C1424222:DJ-1 [Gene or Genome]
   734   C3541418:DJ-1 [Gene or Genome]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "varying amounts of homo-dimer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "(Fig.2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "consistent with our co-immunoprecipitation studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(Fig.1E"

Phrase: ")."
Processing 00000000.tx.112: To obtain a measure of dimerization capacity or efficiency, densitometry was used to generate a ratio of dimer to monomer (Fig.2C). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "a measure of dimerization capacity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079809:Measure [Quantitative Concept]
   760   C0242485:Measure [Functional Concept]

Phrase: "or"

Phrase: "efficiency,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013682:Efficiency [Quantitative Concept]
   928 E C0442799:Efficient [Qualitative Concept]

Phrase: "densitometry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011321:Densitometry [Laboratory Procedure]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "a ratio of dimer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456603:Ratio [Quantitative Concept]
   770   C1547037:Ratio [Intellectual Product]

Phrase: "to monomer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "(Fig.2C"

Phrase: ")."
Processing 00000000.tx.113: When compared with WT DJ-1, pathogenic mutant forms of DJ-1 exhibit a significantly reduced capacity to form homo-dimers, i.e. a reduced ratio of dimer to monomer, whereas dimerization of non-pathogenic R98Q DJ-1 is comparable with WT protein (Fig.2C). 

Phrase: "When"

Phrase: "compared with WT DJ-1,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C1424222:DJ-1 [Gene or Genome]
   790   C1883559:Wild Type [Organism Attribute]
   790   C3541418:DJ-1 [Gene or Genome]
   783   C0441729:Type 1 [Classification]
   753   C0012836:DJ [Geographic Area]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]
   753   C1707455:Compared [Activity]

Phrase: "pathogenic mutant forms of DJ-1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   719 E C1522492:Form [Functional Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "a significantly reduced capacity to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1516240:Capacity [Quantitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "homo-dimers,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0596448:dimers [Chemical Viewed Structurally]
   861   C1300203:Homo [Mammal]
   861   C3245470:HOMO [Finding]

Phrase: "i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "a reduced ratio of dimer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "to monomer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "whereas"

Phrase: "dimerization of non-pathogenic R98Q DJ-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0376525:Dimerization [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "comparable with WT protein"

Phrase: "(Fig.2C"

Phrase: ")."
Processing 00000000.tx.114: Next, to determine whether parkin interacts preferentially with monomeric or dimeric forms of mutant DJ-1, co-immunoprecipitation experiments were performed with DSS cross-linked SH-SY5Y lysates co-transfected with FLAG-tagged parkin and myc-tagged DJ-1 (WT or mutant) (Fig.2D). 

Phrase: "Next,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "interacts"

Phrase: "preferentially with monomeric"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "or"

Phrase: "dimeric forms of mutant DJ-1,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   719 E C1522492:Form [Functional Concept]

Phrase: "co-immunoprecipitation experiments"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C1449705:Co-Immunoprecipitation [Laboratory Procedure]

Phrase: "were"

Phrase: "performed with DSS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0058479:disuccinimidyl suberate [Organic Chemical,Pharmacologic Substance]
   770   C0884358:Performed [Functional Concept]
   770   C0947344:Suberate [Organic Chemical]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "SH-SY5Y lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1881488:Lysate [Physical Object]

Phrase: "co-transfected with FLAG-tagged parkin"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C1418270:PARKIN [Gene or Genome]
   753   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   753   C1708067:Flag [Functional Concept]
   753   C1708632:Tagged [Qualitative Concept]
   753   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   719 E C0037293:Tag [Neoplastic Process]
   719 E C0181496:Tag [Manufactured Object]
   719 E C1710492:TAG [Gene or Genome]

Phrase: "and"

Phrase: "myc-tagged DJ-1"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   861   C1424222:DJ-1 [Gene or Genome]
   861   C3541418:DJ-1 [Gene or Genome]
   858   C1413560:TAG-1 [Gene or Genome]
   812   C0012836:DJ [Geographic Area]
   812   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   812   C1708632:Tagged [Qualitative Concept]
   779 E C0037293:Tag [Neoplastic Process]
   779 E C0181496:Tag [Manufactured Object]
   779 E C1710492:TAG [Gene or Genome]

Phrase: "(WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: ")"

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]

Phrase: "2D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705052:2D [Spatial Concept]
  1000   C2986796:2D [Functional Concept]

Phrase: ")."
Processing 00000000.tx.115: Parkin fails to covalently cross-link to either monomeric or dimeric forms of mutant DJ-1 (Fig.2D), as suggested by the absence of modified forms of DJ-1 or parkin with increased molecular weight. 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "fails"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to covalently cross-link to either monomeric"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0178576:Cross link [Natural Phenomenon or Process]
   778   C0332220:cross link [Functional Concept]
   748   C1517892:Link [Intellectual Product]
   748   C1704666:Link [Intellectual Product]
   748   C2828360:Cross [Conceptual Entity]

Phrase: "or"

Phrase: "dimeric forms of mutant DJ-1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   719 E C1522492:Form [Functional Concept]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]

Phrase: "2D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705052:2D [Spatial Concept]
  1000   C2986796:2D [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "suggested by the absence of modified forms of DJ-1"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   760   C1424222:DJ-1 [Gene or Genome]
   760   C3541418:DJ-1 [Gene or Genome]
   757   C0205349:Modified By [Qualitative Concept]
   739   C0012836:DJ [Geographic Area]
   739   C0332197:absence [Quantitative Concept]
   739   C0348078:forms [Qualitative Concept]
   739   C0376315:Forms [Manufactured Object]
   739   C0392747:Modified [Functional Concept]
   739   C1689985:Absence [Anatomical Abnormality]
   706 E C1522492:Form [Functional Concept]
   706   C1705535:Suggest [Idea or Concept]

Phrase: "or"

Phrase: "parkin with increased molecular weight."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1418270:PARKIN [Gene or Genome]
   760   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.116: These data suggest either an indirect interaction between parkin and DJ-1 mutants, or that particular amino acid side chain residues (e.g. primary amines) are not available for cross-linking at the protein interaction interface. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "either"

Phrase: "an indirect interaction between parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "DJ-1 mutants,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0596988:mutants [Cell or Molecular Dysfunction]
   734   C1424222:DJ-1 [Gene or Genome]
   734   C3541418:DJ-1 [Gene or Genome]

Phrase: "or"

Phrase: "that particular amino acid side chain residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   766   C1709915:Residue [Conceptual Entity]
   766   C1882936:RESIDUE [Phenomenon or Process]
   716 E C1609982:Residual [Qualitative Concept]

Phrase: "("

Phrase: "e.g. primary amines"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0002508:Amines [Organic Chemical]
   827 E C1879694:Amine [Organic Chemical]

Phrase: ")"

Phrase: "are"

Phrase: "not available for"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   882   C1548671:Not available [Idea or Concept]
   790   C0470187:Available [Functional Concept]

Phrase: "cross-linking at the protein interaction interface."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   778   C0332220:Cross-linking [Functional Concept]
   778   C0872079:protein interaction [Molecular Function]
   762 E C0178576:Cross link [Natural Phenomenon or Process]
   757   C0065011:link protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1704675:Interaction [Functional Concept]
   748   C1708533:Interface [Manufactured Object]
   748   C2698172:Interface [Intellectual Product]
   748   C2828360:Cross [Conceptual Entity]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]
Processing 00000000.tx.117: However, pathogenic DJ-1 mutants, especially the L166P mutant, retain the ability to co-immunoprecipitate with full-length parkin in addition to a substantial proportion of high molecular weight (HMW) parkin (>250kDa; Fig.2D), suggesting that (i) a proportion of parkin may exist as part of a large protein complex or is extensively modified, i.e. by auto-ubiquitination and (ii) DJ-1 mutants can differentially associate with both full-length and HMW forms of parkin. 

Phrase: "However,"

Phrase: "pathogenic DJ-1 mutants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "especially"

Phrase: "the L166P mutant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "retain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "the ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0085732:Ability [Organism Attribute]
   718 E C1299581:Able [Finding]

Phrase: "co-immunoprecipitate with full-length parkin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0301871:Immunoprecipitate [Immunologic Factor]
   753   C0443225:Full [Qualitative Concept]
   753   C1418270:PARKIN [Gene or Genome]
   753   C1444754:Length [Quantitative Concept]
   753   C1706316:LENGTH [Research Activity]
   753   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in addition to a substantial proportion"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1709707:Proportion [Quantitative Concept]
   789 E C0205351:Proportional [Qualitative Concept]

Phrase: "of high molecular weight (HMW) parkin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1418270:PARKIN [Gene or Genome]
   812   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1979900:High molecular weight [Qualitative Concept]
   708   C0948775:high weight [Sign or Symptom]

Phrase: "("

Phrase: ">250kDa"

Phrase: "; Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]

Phrase: "2D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705052:2D [Spatial Concept]
  1000   C2986796:2D [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "(i)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "a proportion of parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709707:Proportion [Quantitative Concept]

Phrase: "may"

Phrase: "exist as part of a large protein complex"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1292711:Part of [Spatial Concept]
   770   C1523872:protein complex [Cell Component]
   767   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0439855:Complex [Qualitative Concept]
   744   C0449719:Part [Spatial Concept]
   744   C0549177:Large [Quantitative Concept]
   744   C1704241:Complex [Chemical Viewed Structurally]
   744   C1709471:Part [Quantitative Concept]
   744   C2987476:Exist [Conceptual Entity]

Phrase: "or"

Phrase: "is"

Phrase: "extensively"

Phrase: "modified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: ","

Phrase: "i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "by auto-ubiquitination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519751:Ubiquitination [Molecular Function]

Phrase: "and ("

Phrase: "ii"

Phrase: ")"

Phrase: "DJ-1 mutants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0596988:mutants [Cell or Molecular Dysfunction]
   734   C1424222:DJ-1 [Gene or Genome]
   734   C3541418:DJ-1 [Gene or Genome]

Phrase: "can"

Phrase: "differentially"

Phrase: "associate with both full-length"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0443225:Full [Qualitative Concept]
   760   C0750490:Associate [Idea or Concept]
   760   C1444754:Length [Quantitative Concept]
   760   C1706221:Associate [Professional or Occupational Group]
   760   C1706316:LENGTH [Research Activity]

Phrase: "and"

Phrase: "HMW"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C1979900:High molecular weight [Qualitative Concept]
   913   C0948775:high weight [Sign or Symptom]
   901   C0026385:Molecular Weight [Quantitative Concept]
   827   C0005910:weight [Organism Attribute]
   827   C0043100:Weight [Quantitative Concept]
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C1305866:weight [Diagnostic Procedure]
   827   C1521991:Molecular [Qualitative Concept]
   827   C1705104:Weight [Idea or Concept]
   827   C2700149:HIGH [Intellectual Product]
   755 E C0567416:Molecule [Substance]

Phrase: "forms of parkin."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0348078:Form [Qualitative Concept]
   790   C0376315:Form [Manufactured Object]
   790   C1418270:PARKIN [Gene or Genome]
   790   C1522492:Form [Functional Concept]
   790   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.118: Importantly, using chemical cross-linking, we are unable to determine whether parkin associates preferentially with monomeric or dimeric forms of mutant DJ-1. 

Phrase: "Importantly,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "chemical"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220806:Chemical [Chemical]
  1000   C3272558:Chemical [Intellectual Product]

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: ","

Phrase: "we"

Phrase: "are"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "determine"

Phrase: "whether"

Phrase: "parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "associates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750490:Associate [Idea or Concept]
  1000   C1706221:Associate [Professional or Occupational Group]

Phrase: "preferentially with monomeric"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "or"

Phrase: "dimeric forms of mutant DJ-1."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   719 E C1522492:Form [Functional Concept]
Processing 00000000.tx.119: Collectively, these findings suggest that pathogenic mutant forms of DJ-1 share a reduced capacity to form homo-dimers that strongly correlates with their propensity to interact with parkin, perhaps suggestive of parkin binding preferentially to monomeric DJ-1. 

Phrase: "Collectively,"

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that pathogenic mutant forms of DJ-1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0348078:forms [Qualitative Concept]
   748   C0376315:Forms [Manufactured Object]
   714 E C1522492:Form [Functional Concept]

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "a reduced capacity to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1516240:Capacity [Quantitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "homo-dimers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0596448:dimers [Chemical Viewed Structurally]
   861   C1300203:Homo [Mammal]
   861   C3245470:HOMO [Finding]

Phrase: "that strongly"

Phrase: "correlates with their propensity to"

Phrase: "interact with parkin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1418270:PARKIN [Gene or Genome]
   790   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "perhaps suggestive of parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332299:Suggestive of [Functional Concept]
           suggestive

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "preferentially to monomeric DJ-1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1424222:DJ-1 [Gene or Genome]
   806   C3541418:DJ-1 [Gene or Genome]
   760   C0012836:DJ [Geographic Area]
Processing 00000000.tx.120: Parkin fails to ubiquitinate DJ-1 but instead enhances DJ-1 protein stability As parkin specifically and differentially interacts with pathogenic mutant forms of DJ-1, the ability of parkin to ubiquitinate and to enhance the degradation of these mutants was explored (Fig.3). 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "fails"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ubiquitinate"

Phrase: "DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "but"

Phrase: "instead"

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "DJ-1 protein stability As parkin specifically"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C2350440:Protein Stability [Qualitative Concept]
   748   C0205360:Stability [Qualitative Concept]
   748   C2347098:Stability [Qualitative Concept]

Phrase: "and"

Phrase: "differentially"

Phrase: "interacts with pathogenic mutant forms of DJ-1,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C1424222:DJ-1 [Gene or Genome]
   770   C3541418:DJ-1 [Gene or Genome]
   744   C0012836:DJ [Geographic Area]
   744   C0348078:forms [Qualitative Concept]
   744   C0376315:Forms [Manufactured Object]
   744   C0450254:Pathogenic [Organism]
   744   C0596988:Mutant [Cell or Molecular Dysfunction]
   711 E C1522492:Form [Functional Concept]

Phrase: "the ability of parkin to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "ubiquitinate"

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the degradation of these mutants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "explored"

Phrase: "(Fig.3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.121: We chose to study further the L166P and M26I DJ-1 mutants, because these show the strongest interaction with parkin (Fig.1B). 

Phrase: "We"

Phrase: "chose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Choose [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "the L166P"

Phrase: "and"

Phrase: "M26I DJ-1 mutants,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "because"

Phrase: "these"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the strongest interaction with parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "(Fig.1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.122: To ascertain whether parkin ubiquitinates DJ-1, SH-SY5Y cells were co-transfected with HA-tagged ubiquitin and myc-tagged DJ-1 (WT, L166P or M26I) with and without FLAG-tagged parkin. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ascertain"

Phrase: "whether"

Phrase: "parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "ubiquitinates"

Phrase: "DJ-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "SH-SY5Y cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "co-transfected with HA-tagged ubiquitin"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   753   C1708632:Tagged [Qualitative Concept]
   719 E C0037293:Tag [Neoplastic Process]
   719 E C0181496:Tag [Manufactured Object]
   719 E C1710492:TAG [Gene or Genome]

Phrase: "and"

Phrase: "myc-tagged DJ-1"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   861   C1424222:DJ-1 [Gene or Genome]
   861   C3541418:DJ-1 [Gene or Genome]
   858   C1413560:TAG-1 [Gene or Genome]
   812   C0012836:DJ [Geographic Area]
   812   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   812   C1708632:Tagged [Qualitative Concept]
   779 E C0037293:Tag [Neoplastic Process]
   779 E C0181496:Tag [Manufactured Object]
   779 E C1710492:TAG [Gene or Genome]

Phrase: "(WT, L166P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "or"

Phrase: "M26I"

Phrase: ")"

Phrase: "with"

Phrase: "and without FLAG-tagged parkin."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C1418270:PARKIN [Gene or Genome]
   760   C1515981:And [Idea or Concept]
   760   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   760   C1708067:Flag [Functional Concept]
   760   C1708632:Tagged [Qualitative Concept]
   760   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   726 E C0037293:Tag [Neoplastic Process]
   726 E C0181496:Tag [Manufactured Object]
   726 E C1710492:TAG [Gene or Genome]
Processing 00000000.tx.123: This was followed by IP with anti-myc antibody and probing with anti-HA antibody to monitor ubiquitination of DJ-1, or with anti-myc antibody to monitor the formation of DJ-1-ubiquitin conjugates (Fig.3A). 

Phrase: "This"

Phrase: "was"

Phrase: "followed by IP"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with anti-myc antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "probing with anti-HA antibody to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0419358:Probing, NOS [Diagnostic Procedure]

Phrase: "monitor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030695:monitor [Health Care Activity]
  1000   C0150369:monitor [Health Care Activity]
  1000   C0181904:Monitor [Medical Device]
  1000   C0596972:Monitor [Medical Device]
  1000   C1521743:Monitor [Professional or Occupational Group]
  1000   C1704646:Monitor [Manufactured Object]

Phrase: "ubiquitination of DJ-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1519751:Ubiquitination [Molecular Function]

Phrase: "or with anti-myc antibody to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "monitor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030695:monitor [Health Care Activity]
  1000   C0150369:monitor [Health Care Activity]
  1000   C0181904:Monitor [Medical Device]
  1000   C0596972:Monitor [Medical Device]
  1000   C1521743:Monitor [Professional or Occupational Group]
  1000   C1704646:Monitor [Manufactured Object]

Phrase: "the formation of DJ-1-ubiquitin conjugates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]

Phrase: "(Fig.3A"

Phrase: ")."
Processing 00000000.tx.124: In the absence of parkin, a small proportion of WT and M26I DJ-1 is mono-ubiquitinated, whereas mono-ubiquitination of L166P DJ-1 is not detected probably secondary to its reduced protein stability (Fig.3A). 

Phrase: "In the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of parkin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "a small proportion of WT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709707:Proportion [Quantitative Concept]

Phrase: "and"

Phrase: "M26I DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]

Phrase: "is"

Phrase: "mono-ubiquitinated,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041538:Ubiquitinated [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1551432:Mono [Population Group]
   861   C1551969:Mono [Language]

Phrase: "whereas"

Phrase: "mono-ubiquitination of L166P DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1519751:Ubiquitination [Molecular Function]
   753   C1551432:Mono [Population Group]
   753   C1551969:Mono [Language]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "probably secondary to its reduced protein stability"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0175668:Secondary to [Temporal Concept]
           Secondary
   748   C0027627:secondary [Neoplastic Process]
   748   C0205436:Secondary [Quantitative Concept]

Phrase: "(Fig.3A"

Phrase: ")."
Processing 00000000.tx.125: In the presence of parkin, we fail to observe enhanced ubiquitination of WT and mutant DJ-1 (Fig.3A). 

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of parkin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "we"

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "observe"

Phrase: "enhanced ubiquitination of WT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1519751:Ubiquitination [Molecular Function]

Phrase: "and"

Phrase: "mutant DJ-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]
   827   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(Fig.3A"

Phrase: ")."
Processing 00000000.tx.126: Moreover, with the exception of mono-ubiquitinated DJ-1, we fail to observe any HMW DJ-1-ubiquitin conjugates (Fig.3A), suggesting the absence of poly-ubiquitinated forms of DJ-1. 

Phrase: "Moreover,"

Phrase: "with the exception"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1554961:exception [Idea or Concept]
  1000   C1705847:Exception [Conceptual Entity]

Phrase: "of mono-ubiquitinated DJ-1,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1424222:DJ-1 [Gene or Genome]
   861   C3541418:DJ-1 [Gene or Genome]
   812   C0012836:DJ [Geographic Area]
   812   C0041538:Ubiquitinated [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1551432:Mono [Population Group]
   812   C1551969:Mono [Language]

Phrase: "we"

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "observe"

Phrase: "any HMW DJ-1-ubiquitin conjugates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0301869:conjugates [Immunologic Factor]

Phrase: "(Fig.3A"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the absence of"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "poly-ubiquitinated"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0041538:Ubiquitinated [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0747726:POLY [Conceptual Entity]

Phrase: "forms of DJ-1."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0348078:forms [Qualitative Concept]
   770   C0376315:Forms [Manufactured Object]
   737 E C1522492:Form [Functional Concept]
Processing 00000000.tx.127: To determine whether the failure to observe enhanced ubiquitination of DJ-1 by parkin was potentially due to the proteasomal degradation of poly-ubiquitinated forms of DJ-1, similar experiments were performed in the presence of the proteasome inhibitor MG132 (Fig.3B). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the failure to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0231174:Failure [Functional Concept]
   861   C0680095:failure [Individual Behavior]

Phrase: "observe"

Phrase: "enhanced ubiquitination of DJ-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1519751:Ubiquitination [Molecular Function]

Phrase: "by parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "potentially due to the proteasomal degradation of"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0678226:Due to [Functional Concept]
           due
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]
   748   C3146286:Due [Idea or Concept]

Phrase: "poly-ubiquitinated"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0041538:Ubiquitinated [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0747726:POLY [Conceptual Entity]

Phrase: "forms of DJ-1,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0348078:forms [Qualitative Concept]
   770   C0376315:Forms [Manufactured Object]
   737 E C1522492:Form [Functional Concept]

Phrase: "similar experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed in the presence of the proteasome inhibitor MG132"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   764   C1443643:Proteasome inhibitor [Pharmacologic Substance]
   764   C2266856:Proteasome Inhibitor [Molecular Function]
   764   C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   742   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0246694:MG132 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C0884358:Performed [Functional Concept]
   742   C1325620:proteasome [Cell Component]
   742   C1752727:Proteasome [Molecular Function]
   742   C1999216:Inhibitor [Qualitative Concept]
   708 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Fig.3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.128: Following proteasome inhibition, we fail to detect the formation of HMW DJ-1-ubiquitin conjugates but instead consistently detect mono-ubiquitinated DJ-1 species, including L166P DJ-1 (Fig.3B). 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "proteasome inhibition,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "we"

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the formation of HMW DJ-1-ubiquitin conjugates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0220781:formation [Biologic Function]
   739   C0439634:formation [Spatial Concept]
   739   C1522492:Formation [Functional Concept]

Phrase: "but"

Phrase: "instead consistently"

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "mono-ubiquitinated DJ-1 species,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1705920:Species [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "L166P DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]

Phrase: "(Fig.3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.129: However, we also observe a marked accumulation of full-length and truncated forms of L166P DJ-1 to near WT levels, further suggesting that this mutant is not subject to poly-ubiquitination. 

Phrase: "However,"

Phrase: "we also"

Phrase: "observe"

Phrase: "a marked accumulation of full-length"

Phrase: "and"

Phrase: "truncated forms of L166P DJ-1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   719 E C1522492:Form [Functional Concept]

Phrase: "to near WT levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "not subject to poly-ubiquitination."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0681850:Subject [Group]
   760   C0747726:POLY [Conceptual Entity]
   760   C1518422:Not [Functional Concept]
   760   C1519751:Ubiquitination [Molecular Function]
   760   C1550501:{Subject} [Idea or Concept]
   760   C1706203:Subject [Idea or Concept]
   760   C2349001:Subject [Human]
   760   C2697811:Subject [Functional Concept]
Processing 00000000.tx.130: Parkin overexpression does not influence the overall levels of mono-ubiquitinated DJ-1 following proteasome inhibition, but rather redistributes them from a detergent-soluble to an insoluble fraction (Fig.3B and D). 

Phrase: "Parkin overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514559:Overexpression [Genetic Function]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "influence"

Phrase: "the overall levels of mono-ubiquitinated DJ-1"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   750   C0456947:Level 1 [Intellectual Product]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "proteasome inhibition,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "but"

Phrase: "rather"

Phrase: "redistributes"

Phrase: "them from a detergent-soluble"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0011740:Detergent [Chemical Viewed Functionally]
   760   C1749467:soluble [Cell Component]
   760   C1948047:Soluble [Qualitative Concept]

Phrase: "to an insoluble fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "(Fig.3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.131: Taken together, these findings demonstrate that L166P and M26I mutant DJ-1 are not ubiquitinated by parkin despite their interaction, whereas DJ-1 can exist in a mono-ubiquitinated form independent of parkin overexpression. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "demonstrate"

Phrase: "that L166P"

Phrase: "and"

Phrase: "M26I mutant DJ-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1424222:DJ-1 [Gene or Genome]
   861   C3541418:DJ-1 [Gene or Genome]
   812   C0012836:DJ [Geographic Area]
   812   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "ubiquitinated by parkin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0041538:Ubiquitinated [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1418270:PARKIN [Gene or Genome]
   790   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "despite their interaction,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "whereas"

Phrase: "DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "can"

Phrase: "exist in a mono-ubiquitinated form"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0041538:Ubiquitinated [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]
   753   C1551432:Mono [Population Group]
   753   C1551969:Mono [Language]
   753   C2987476:Exist [Conceptual Entity]

Phrase: "independent of parkin overexpression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514559:Overexpression [Genetic Function]
Processing 00000000.tx.132: View larger version (81K): [in this window] [in a new window]  Figure3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(81K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure3."
Processing 00000000.tx.133: Parkin fails to ubiquitinate and enhance the degradation of DJ-1. 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "fails"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ubiquitinate"

Phrase: "and"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the degradation of DJ-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]
Processing 00000000.tx.134: (A and B) Parkin fails to ubiquitinate DJ-1. 

Phrase: "(A"

Phrase: "and"

Phrase: "B) Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "fails"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ubiquitinate"

Phrase: "DJ-1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]
Processing 00000000.tx.135: (A) SH-SY5Y cells were co-transfected with myc-tagged WT, L166P or M26I DJ-1 or control plasmid, together with HA-tagged ubiquitin, with or without FLAG-tagged parkin. 

Phrase: "(A) SH-SY5Y cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "co-transfected with myc-tagged WT, L166P"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C1883559:Wild Type [Organism Attribute]
   744   C0332307:Type [Qualitative Concept]
   744   C0445392:Wild [Intellectual Product]
   744   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   744   C1547052:*Type [Quantitative Concept]
   744   C1708632:Tagged [Qualitative Concept]
   711 E C0037293:Tag [Neoplastic Process]
   711 E C0181496:Tag [Manufactured Object]
   711 E C1710492:TAG [Gene or Genome]

Phrase: "or"

Phrase: "M26I DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]

Phrase: "or"

Phrase: "control plasmid,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "together with HA-tagged ubiquitin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with"

Phrase: "or without FLAG-tagged parkin."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C1418270:PARKIN [Gene or Genome]
   760   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   760   C1708067:Flag [Functional Concept]
   760   C1708632:Tagged [Qualitative Concept]
   760   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   726 E C0037293:Tag [Neoplastic Process]
   726 E C0181496:Tag [Manufactured Object]
   726 E C1710492:TAG [Gene or Genome]
Processing 00000000.tx.136: Equivalent soluble lysates were subjected to IP with anti-myc antibody, and IP and input lysates were analyzed by WB with anti-HA and anti-myc antibodies. 

Phrase: "Equivalent soluble lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "subjected to IP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with anti-myc antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "IP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "input lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "analyzed by WB"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with anti-HA"

Phrase: "and"

Phrase: "anti-myc antibodies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.137: (B) Similar ubiquitination experiments were performed using transfected cells treated with the proteasome inhibitor MG132 (5M) for 24h, as described earlier. 

Phrase: "(B) Similar ubiquitination experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "treated with the proteasome inhibitor MG132"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C1443643:Proteasome inhibitor [Pharmacologic Substance]
   790   C2266856:Proteasome Inhibitor [Molecular Function]
   790   C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   753   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0246694:MG132 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C1325620:proteasome [Cell Component]
   753   C1522326:Treated [Functional Concept]
   753   C1752727:Proteasome [Molecular Function]
   753   C1999216:Inhibitor [Qualitative Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "(5M"

Phrase: ")"

Phrase: "for 24h,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "earlier."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]
Processing 00000000.tx.138: (C and D) Effect of parkin on DJ-1 steady-state protein levels. 

Phrase: "(C"

Phrase: "and"

Phrase: "D)"

Phrase: "Effect of parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on DJ-1 steady-state protein levels."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   822   C0683927:state level [Spatial Concept]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0441889:Levels [Qualitative Concept]
   793   C0428479:Protein level [Laboratory or Test Result]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.139: (C) SH-SY5Y cells co-transfected as detailed earlier were fractionated into 1% Triton X-100-soluble or -insoluble fractions, and equivalent fractions analyzed by WB with anti-myc and anti-FLAG antibodies or with anti-actin antibody to demonstrate equal loading. 

Phrase: "(C) SH-SY5Y cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   886   C0229579:C-Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "co-transfected"

Phrase: "as"

Phrase: "detailed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522508:Detailed [Qualitative Concept]
   966 E C1561567:detail [Functional Concept]

Phrase: "earlier"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]

Phrase: "were"

Phrase: "fractionated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979893:Fractionated [Qualitative Concept]

Phrase: "into 1% Triton X-100-soluble or -insoluble fractions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   793   C1264633:Fractions [Quantitative Concept]
   760 E C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "equivalent fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "analyzed by WB"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with anti-myc"

Phrase: "and"

Phrase: "anti-FLAG antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "or with anti-actin antibody to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0369998:Anti-actin antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C1718641:Actin Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "demonstrate"

Phrase: "equal loading."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708715:Loading [Activity]
Processing 00000000.tx.140: (D) Similar steady-state experiments were performed using transfected cells treated with the proteasome inhibitor MG132 (5M) for 24h, as described earlier. 

Phrase: "("

Phrase: "D)"

Phrase: "Similar steady-state experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "treated with the proteasome inhibitor MG132"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C1443643:Proteasome inhibitor [Pharmacologic Substance]
   790   C2266856:Proteasome Inhibitor [Molecular Function]
   790   C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   753   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0246694:MG132 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C1325620:proteasome [Cell Component]
   753   C1522326:Treated [Functional Concept]
   753   C1752727:Proteasome [Molecular Function]
   753   C1999216:Inhibitor [Qualitative Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "(5M"

Phrase: ")"

Phrase: "for 24h,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "earlier."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]
Processing 00000000.tx.141: Full-length (FL), N-terminally truncated (N1 and N2) and mono-ubiquitinated (DJ-1-(Ub)1) myc-tagged DJ-1 species or HMW FLAG-tagged parkin species are indicated by arrows. 

Phrase: "Full-length"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0443225:Full [Qualitative Concept]
   861   C1444754:Length [Quantitative Concept]
   861   C1706316:LENGTH [Research Activity]
   789 E C0205166:Long [Qualitative Concept]
   789 E C1522425:Longest [Qualitative Concept]
   789 E C1706317:Long [Qualitative Concept]

Phrase: "(FL"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0443225:Full [Qualitative Concept]
   861   C1444754:Length [Quantitative Concept]
   861   C1706316:LENGTH [Research Activity]
   789 E C0205166:Long [Qualitative Concept]
   789 E C1522425:Longest [Qualitative Concept]
   789 E C1706317:Long [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "N-terminally"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "truncated"

Phrase: "(N1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441962:N1 [Finding]

Phrase: "and"

Phrase: "N2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441960:N2 [Finding]

Phrase: ")"

Phrase: "and"

Phrase: "mono-ubiquitinated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041538:Ubiquitinated [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1551432:Mono [Population Group]
   861   C1551969:Mono [Language]

Phrase: "(DJ-1-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "(Ub)1"

Phrase: ")"

Phrase: "myc-tagged DJ-1 species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1705920:Species [Conceptual Entity]

Phrase: "or"

Phrase: "HMW FLAG-tagged parkin species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C1705920:Species [Conceptual Entity]

Phrase: "are"

Phrase: "indicated by arrows."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0336721:arrows [Manufactured Object]
   790   C1444656:Indicated [Finding]
Processing 00000000.tx.142: Molecular weight markers are indicated in kDa. 

Phrase: "Molecular weight markers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0005516:molecular markers [Clinical Attribute]
           Marker
   734   C0026385:Molecular Weight [Quantitative Concept]

Phrase: "are"

Phrase: "indicated in kDa."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1444656:Indicated [Finding]
   790   C1532717:kDa [Quantitative Concept]
Processing 00000000.tx.143: All experiments were replicated at least three times with similar results.  

Phrase: "All experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "replicated at least three times"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0040223:times [Temporal Concept]
   760   C0205173:replicated [Functional Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C0205341:Replicate [Functional Concept]
   726 E C1883725:Replicate [Qualitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "with similar results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.144: The failure to observe ubiquitination of L166P and M26I mutant DJ-1 in the presence of parkin was surprising. 

Phrase: "The failure to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0231174:Failure [Functional Concept]
   861   C0680095:failure [Individual Behavior]

Phrase: "observe"

Phrase: "ubiquitination of L166P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1519751:Ubiquitination [Molecular Function]

Phrase: "and"

Phrase: "M26I mutant DJ-1 in the presence of parkin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C1424222:DJ-1 [Gene or Genome]
   764   C3541418:DJ-1 [Gene or Genome]
   742   C0012836:DJ [Geographic Area]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C0596988:Mutant [Cell or Molecular Dysfunction]
   742   C1418270:PARKIN [Gene or Genome]
   742   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "surprising."
Processing 00000000.tx.145: To explore whether the absence of HMW DJ-1-ubiquitin conjugates in the detergent-soluble fraction was secondary to these conjugates residing or being sequestered into the detergent-insoluble fraction, we examined and compared the 1% Triton X-100-soluble and -insoluble fractions from the earlier mentioned ubiquitination experiments (Fig.3C and D). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "explore"

Phrase: "whether"

Phrase: "the absence of HMW DJ-1-ubiquitin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0332197:absence [Quantitative Concept]
   742   C1689985:Absence [Anatomical Abnormality]

Phrase: "conjugates in the detergent-soluble fraction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0011740:Detergent [Chemical Viewed Functionally]
   753   C0301869:Conjugate [Immunologic Factor]
   753   C1264633:Fraction [Quantitative Concept]
   753   C1554103:Fraction [Idea or Concept]
   753   C1749467:soluble [Cell Component]
   753   C1948047:Soluble [Qualitative Concept]

Phrase: "was"

Phrase: "secondary to these conjugates"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0175668:Secondary to [Temporal Concept]
           Secondary
   770   C0027627:secondary [Neoplastic Process]
   770   C0205436:Secondary [Quantitative Concept]

Phrase: "residing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2982691:Reside [Activity]

Phrase: "or"

Phrase: "being"

Phrase: "sequestered into the detergent-insoluble fraction,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0011740:Detergent [Chemical Viewed Functionally]
   753   C0333312:Sequestered [Functional Concept]
   753   C1264633:Fraction [Quantitative Concept]
   753   C1554103:Fraction [Idea or Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "and"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "the 1% Triton X-100-soluble"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1749467:soluble [Cell Component]
   804   C1948047:Soluble [Qualitative Concept]
   717   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "and -"

Phrase: "insoluble fractions from the earlier mentioned ubiquitination experiments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1264633:Fractions [Quantitative Concept]
   711 E C1554103:Fraction [Idea or Concept]

Phrase: "(Fig.3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.146: Unexpectedly, parkin dramatically increases the amount of full-length L166P and M26I mutant DJ-1 in the detergent-insoluble fraction, and also has a smaller effect on WT DJ-1 (Fig.3C). 

Phrase: "Unexpectedly,"

Phrase: "parkin dramatically"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the amount of full-length L166P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "and"

Phrase: "M26I mutant DJ-1 in the detergent-insoluble fraction,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C1424222:DJ-1 [Gene or Genome]
   764   C3541418:DJ-1 [Gene or Genome]
   742   C0011740:Detergent [Chemical Viewed Functionally]
   742   C0012836:DJ [Geographic Area]
   742   C0596988:Mutant [Cell or Molecular Dysfunction]
   742   C1264633:Fraction [Quantitative Concept]
   742   C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "also"

Phrase: "has"

Phrase: "a smaller effect on WT DJ-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "(Fig.3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.147: In the detergent-soluble fraction, parkin also facilitates a small increase in the steady-state levels of WT, L166P and M26I DJ-1 (Fig.3C), suggesting that parkin may generally enhance the stability of DJ-1. 

Phrase: "In the detergent-soluble fraction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]

Phrase: "parkin also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "facilitates"

Phrase: "a small increase in the steady-state levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "of WT, L166P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "and"

Phrase: "M26I DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]

Phrase: "(Fig.3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "generally"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the stability of DJ-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205360:Stability [Qualitative Concept]
   760   C2347098:Stability [Qualitative Concept]
Processing 00000000.tx.148: Although full-length and HMW forms of parkin are present in the insoluble fraction, only full-length parkin is detected in the soluble fraction (Fig.3C). 

Phrase: "Although"

Phrase: "full-length"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0443225:Full [Qualitative Concept]
   861   C1444754:Length [Quantitative Concept]
   861   C1706316:LENGTH [Research Activity]
   789 E C0205166:Long [Qualitative Concept]
   789 E C1522425:Longest [Qualitative Concept]
   789 E C1706317:Long [Qualitative Concept]

Phrase: "and"

Phrase: "HMW"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C1979900:High molecular weight [Qualitative Concept]
   913   C0948775:high weight [Sign or Symptom]
   901   C0026385:Molecular Weight [Quantitative Concept]
   827   C0005910:weight [Organism Attribute]
   827   C0043100:Weight [Quantitative Concept]
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C1305866:weight [Diagnostic Procedure]
   827   C1521991:Molecular [Qualitative Concept]
   827   C1705104:Weight [Idea or Concept]
   827   C2700149:HIGH [Intellectual Product]
   755 E C0567416:Molecule [Substance]

Phrase: "forms of parkin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0348078:Form [Qualitative Concept]
   790   C0376315:Form [Manufactured Object]
   790   C1418270:PARKIN [Gene or Genome]
   790   C1522492:Form [Functional Concept]
   790   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "present in the insoluble fraction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "only full-length parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1418270:PARKIN [Gene or Genome]
   812   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "detected in the soluble fraction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0442726:Detected [Finding]
   760   C1264633:Fraction [Quantitative Concept]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1554103:Fraction [Idea or Concept]
   760   C1749467:soluble [Cell Component]
   760   C1948047:Soluble [Qualitative Concept]

Phrase: "(Fig.3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.149: In the detergent-insoluble fraction, the stabilizing effect of parkin on full-length L166P and M26I mutant DJ-1 steady-state levels is markedly enhanced following treatment with the proteasome inhibitor MG132, having only a small effect on WT DJ-1 (Fig.3D). 

Phrase: "In the detergent-insoluble fraction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]

Phrase: "the stabilizing effect of parkin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0184512:stabilizing [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on full-length L166P"

Phrase: "and"

Phrase: "M26I mutant DJ-1 steady-state levels"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   818   C0678587:steady state [Natural Phenomenon or Process]
   801   C0683927:state level [Spatial Concept]
   795   C0205361:Steady [Qualitative Concept]
   795   C0441889:Levels [Qualitative Concept]
   795   C1301808:State [Geographic Area]
   795   C1442792:State [Functional Concept]
   795   C3148680:State [Geographic Area]
   762 E C0456079:Level [Classification]
   762 E C1547707:Level [Geographic Area]
   762 E C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "treatment with the proteasome inhibitor MG132,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "having"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a small effect on WT DJ-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]

Phrase: "3D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450363:3D [Spatial Concept]
  1000   C2986797:3D [Functional Concept]

Phrase: ")."
Processing 00000000.tx.150: In addition, parkin also enhances the levels of N-terminally truncated forms of both WT L166P and M26I DJ-1 following proteasome inhibition (Fig.3D), and parkin also promotes the redistribution of mono-ubiquitinated DJ-1 from the soluble into the insoluble fraction (Fig.3B and D). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "parkin also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the levels of N-terminally truncated forms of both WT L166P"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   736   C0441889:Levels [Qualitative Concept]
   703 E C0456079:Level [Classification]
   703 E C1547707:Level [Geographic Area]
   703 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "M26I DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "proteasome inhibition"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]

Phrase: "3D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450363:3D [Spatial Concept]
  1000   C2986797:3D [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "parkin also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the redistribution of mono-ubiquitinated DJ-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332620:Redistribution [Functional Concept]

Phrase: "from the soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1749467:soluble [Cell Component]
  1000   C1948047:Soluble [Qualitative Concept]

Phrase: "into the insoluble fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "(Fig.3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.151: The enhanced levels of DJ-1 in the insoluble fraction following proteasome inhibition also correlate with the dramatic accumulation of full-length and HMW forms of parkin in this fraction (Fig.3D), whereas in the soluble fraction only full-length parkin is detected. 

Phrase: "The enhanced levels of DJ-1"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C0456947:Level 1 [Intellectual Product]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the insoluble fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "proteasome inhibition also"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
   827   C0021467:Inhibition [Mental Process]
   827   C0021469:Inhibition [Molecular Function]
   827   C1628982:% inhibition [Quantitative Concept]
   827   C3463820:Inhibition [Activity]
   755 E C0311403:Inhibited [Qualitative Concept]

Phrase: "correlate with the dramatic accumulation of full-length"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0443225:Full [Qualitative Concept]
   744   C1444754:Length [Quantitative Concept]
   744   C1706316:LENGTH [Research Activity]

Phrase: "and"

Phrase: "HMW"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C1979900:High molecular weight [Qualitative Concept]
   913   C0948775:high weight [Sign or Symptom]
   901   C0026385:Molecular Weight [Quantitative Concept]
   827   C0005910:weight [Organism Attribute]
   827   C0043100:Weight [Quantitative Concept]
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C1305866:weight [Diagnostic Procedure]
   827   C1521991:Molecular [Qualitative Concept]
   827   C1705104:Weight [Idea or Concept]
   827   C2700149:HIGH [Intellectual Product]
   755 E C0567416:Molecule [Substance]

Phrase: "forms of parkin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0348078:Form [Qualitative Concept]
   790   C0376315:Form [Manufactured Object]
   790   C1418270:PARKIN [Gene or Genome]
   790   C1522492:Form [Functional Concept]
   790   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in this fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1264633:Fraction [Quantitative Concept]
  1000   C1554103:Fraction [Idea or Concept]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]

Phrase: "3D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450363:3D [Spatial Concept]
  1000   C2986797:3D [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "whereas in the soluble fraction only full-length parkin"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   762   C1442089:Length Fraction [Quantitative Concept]
   742   C0205171:Only [Quantitative Concept]
   742   C0443225:Full [Qualitative Concept]
   742   C1264633:Fraction [Quantitative Concept]
   742   C1418270:PARKIN [Gene or Genome]
   742   C1444754:Length [Quantitative Concept]
   742   C1554103:Fraction [Idea or Concept]
   742   C1706316:LENGTH [Research Activity]
   742   C1720467:Only [Intellectual Product]
   742   C1749467:soluble [Cell Component]
   742   C1948047:Soluble [Qualitative Concept]
   742   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "detected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.152: These HMW forms of parkin likely represent poly-ubiquitinated species that accumulate following proteasome inhibition. 

Phrase: "These HMW"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C1979900:High molecular weight [Qualitative Concept]
   913   C0948775:high weight [Sign or Symptom]
   901   C0026385:Molecular Weight [Quantitative Concept]
   827   C0005910:weight [Organism Attribute]
   827   C0043100:Weight [Quantitative Concept]
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C1305866:weight [Diagnostic Procedure]
   827   C1521991:Molecular [Qualitative Concept]
   827   C1705104:Weight [Idea or Concept]
   827   C2700149:HIGH [Intellectual Product]
   755 E C0567416:Molecule [Substance]

Phrase: "forms of parkin likely"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0332148:Likely [Qualitative Concept]
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C0750492:Likely [Idea or Concept]
   770   C1418270:PARKIN [Gene or Genome]
   770   C1522492:Form [Functional Concept]
   770   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "poly-ubiquitinated"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0041538:Ubiquitinated [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0747726:POLY [Conceptual Entity]

Phrase: "species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705920:Species [Conceptual Entity]

Phrase: "that"

Phrase: "accumulate"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "proteasome inhibition."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]
Processing 00000000.tx.153: In the detergent-soluble fraction, the small stabilizing effect of parkin on DJ-1 levels is still observed following proteasome inhibition (Fig.3D). 

Phrase: "In the detergent-soluble fraction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]

Phrase: "the small stabilizing effect of parkin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0184512:stabilizing [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on DJ-1 levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   734   C1424222:DJ-1 [Gene or Genome]
   734   C3541418:DJ-1 [Gene or Genome]

Phrase: "is"

Phrase: "still"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "proteasome inhibition"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]

Phrase: "3D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450363:3D [Spatial Concept]
  1000   C2986797:3D [Functional Concept]

Phrase: ")."
Processing 00000000.tx.154: In these experiments, we fail to observe detergent-insoluble HMW DJ-1-ubiquitin conjugates in the absence or presence of parkin (Fig.3C and D), further suggesting that parkin does not poly-ubiquitinate mutant DJ-1. 

Phrase: "In these experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "we"

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "observe"

Phrase: "detergent-insoluble HMW DJ-1-ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "conjugates in the absence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0301869:Conjugate [Immunologic Factor]
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "presence of parkin"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0392148:Presence [Therapeutic or Preventive Procedure]
   718 E C0150312:Present [Quantitative Concept]
   718 E C0449450:Present [Idea or Concept]

Phrase: "(Fig.3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: "and"

Phrase: "D)"

Phrase: ","

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "poly-ubiquitinate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0032400:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0071360:poly [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0747726:POLY [Conceptual Entity]

Phrase: "mutant DJ-1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]
   827   C0596988:Mutant [Cell or Molecular Dysfunction]
Processing 00000000.tx.155: Collectively, these findings demonstrate that parkin can increase the steady-state levels of L166P and M26I mutant DJ-1, primarily of detergent-insoluble species, and this effect is enhanced by proteasome inhibition. 

Phrase: "Collectively,"

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "demonstrate"

Phrase: "that parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "can"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the steady-state levels of L166P"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C0678587:steady state [Natural Phenomenon or Process]
   773   C0683927:state level [Spatial Concept]
   753   C0205361:Steady [Qualitative Concept]
   753   C0441889:Levels [Qualitative Concept]
   753   C1301808:State [Geographic Area]
   753   C1442792:State [Functional Concept]
   753   C3148680:State [Geographic Area]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "M26I mutant DJ-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1424222:DJ-1 [Gene or Genome]
   861   C3541418:DJ-1 [Gene or Genome]
   812   C0012836:DJ [Geographic Area]
   812   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "primarily of detergent-insoluble species,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0011740:Detergent [Chemical Viewed Functionally]
   760   C1705920:Species [Conceptual Entity]

Phrase: "and"

Phrase: "this effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "enhanced by proteasome inhibition."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1325620:proteasome [Cell Component]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C1752727:Proteasome [Molecular Function]
   770   C2349975:Enhanced [Activity]
   770   C3463820:Inhibition [Activity]
Processing 00000000.tx.156: Taken together, these results indicate that although parkin interacts with L166P and M26I mutant DJ-1, parkin enhances neither their ubiquitination nor their degradation or turnover. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "although"

Phrase: "parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "interacts with L166P"

Phrase: "and"

Phrase: "M26I mutant DJ-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1424222:DJ-1 [Gene or Genome]
   861   C3541418:DJ-1 [Gene or Genome]
   812   C0012836:DJ [Geographic Area]
   812   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "neither their ubiquitination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519751:Ubiquitination [Molecular Function]

Phrase: "nor"

Phrase: "their degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "or"

Phrase: "turnover."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031227:turnover [Quantitative Concept]
  1000   C0243127:turnover [Functional Concept]
  1000   C0443331:Turnover [Health Care Activity]
Processing 00000000.tx.157: Instead, parkin may promote the stability of L166P and M26I mutant DJ-1. 

Phrase: "Instead,"

Phrase: "parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the stability of L166P"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205360:Stability [Qualitative Concept]
   770   C2347098:Stability [Qualitative Concept]

Phrase: "and"

Phrase: "M26I mutant DJ-1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1424222:DJ-1 [Gene or Genome]
   861   C3541418:DJ-1 [Gene or Genome]
   812   C0012836:DJ [Geographic Area]
   812   C0596988:Mutant [Cell or Molecular Dysfunction]
Processing 00000000.tx.158: This may suggest that the interaction of parkin with these mutants is either indirect or subserves an alternative as yet undetermined biological function. 

Phrase: "This"

Phrase: "may"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the interaction of parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "with these mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "either indirect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439852:Indirect [Qualitative Concept]

Phrase: "or"

Phrase: "subserves"

Phrase: "an alternative as yet undetermined biological function."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1523987:Alternative [Conceptual Entity]
Processing 00000000.tx.159: Oxidative stress promotes the association of parkin and DJ-1 As parkin interacts selectively with pathogenic DJ-1 mutants but not with WT protein, the possibility that parkin may only interact with DJ-1 under pathogenic or stressful conditions was explored. 

Phrase: "Oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the association of parkin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "DJ-1 As parkin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1424222:DJ-1 [Gene or Genome]
   833   C3541418:DJ-1 [Gene or Genome]
   770   C0012836:DJ [Geographic Area]
   770   C1418270:PARKIN [Gene or Genome]
   770   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "interacts"

Phrase: "selectively with pathogenic DJ-1 mutants"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1424222:DJ-1 [Gene or Genome]
   790   C3541418:DJ-1 [Gene or Genome]
   753   C0012836:DJ [Geographic Area]
   753   C0450254:Pathogenic [Organism]
   753   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "but"

Phrase: "not with WT protein,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1518422:Not [Functional Concept]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "the possibility"

Phrase: "that parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "interact with DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1424222:DJ-1 [Gene or Genome]
   833   C3541418:DJ-1 [Gene or Genome]
   770   C0012836:DJ [Geographic Area]

Phrase: "under pathogenic"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0450254:Pathogenic [Organism]
   928 E C0030657:pathogenicity [Qualitative Concept]
   928 E C1136169:Pathogenicity [Organism Attribute]

Phrase: "or"

Phrase: "stressful conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "was"

Phrase: "explored."
Processing 00000000.tx.160: To this end, the ability of WT DJ-1 and parkin to associate under conditions of oxidative stress was examined by co-immunoprecipitation experiments (Fig.4AC). 

Phrase: "To this end,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "the ability of WT DJ-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0085732:Ability [Organism Attribute]

Phrase: "and"

Phrase: "parkin to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "associate under conditions of oxidative stress"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   753   C0038435:Stress [Finding]
   753   C0311404:Oxidative [Functional Concept]
   753   C0750490:Associate [Idea or Concept]
   753   C1706221:Associate [Professional or Occupational Group]
   719   C0012634:condition [Disease or Syndrome]
   719   C0348080:Condition [Qualitative Concept]
   719   C1705253:Condition [Conceptual Entity]

Phrase: "was"

Phrase: "examined by co-immunoprecipitation experiments"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   760   C0021069:Immunoprecipitation [Laboratory Procedure]
   760   C0332128:Examined [Finding]
   760   C0681814:Experiments [Research Activity]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "(Fig.4AC"

Phrase: ")."
Processing 00000000.tx.161: First, the effects of hydrogen peroxide on the ability of parkin and WT DJ-1 to interact were monitored. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "the effects of hydrogen peroxide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on the ability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085732:Ability [Organism Attribute]
   928 E C1299581:Able [Finding]

Phrase: "of parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "WT DJ-1 to"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   853   C0441729:Type 1 [Classification]
   840   C1424222:DJ-1 [Gene or Genome]
   840   C1883559:Wild Type [Organism Attribute]
   840   C3541418:DJ-1 [Gene or Genome]
   804   C0012836:DJ [Geographic Area]
   804   C0332307:Type [Qualitative Concept]
   804   C0445392:Wild [Intellectual Product]
   804   C1547052:*Type [Quantitative Concept]

Phrase: "interact"

Phrase: "were"

Phrase: "monitored."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]
Processing 00000000.tx.162: Hydrogen peroxide oxidatively modifies cysteine residues in DJ-1, particularly Cys-106, resulting in an acidic shift in pI-value (44,45,58). 

Phrase: "Hydrogen peroxide oxidatively"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0020275:Hydrogen [Element, Ion, or Isotope]
   827   C0031180:Peroxide [Inorganic Chemical]
   827   C0523702:HYDROGEN [Laboratory Procedure]
   827   C0885426:hydrogen [Inorganic Chemical]

Phrase: "modifies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "cysteine residues in DJ-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "particularly Cys-106,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0010654:Cys [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "resulting in an acidic shift"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   806   C0332294:Resulting in [Functional Concept]
   760   C0001128:Acidic [Chemical]
   760   C0333051:Shift [Functional Concept]
   760   C0678226:resulting [Functional Concept]
   760   C2347509:Shift [Phenomenon or Process]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]

Phrase: "in pI-value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1522609:Value [Quantitative Concept]

Phrase: "(44,"

Phrase: "45,"

Phrase: "58"

Phrase: ")."
Processing 00000000.tx.163: SH-SY5Y cells were co-transfected with FLAG-tagged parkin and myc-tagged WT DJ-1, followed by treatment with hydrogen peroxide for 24h, and IP with anti-myc antibody. 

Phrase: "SH-SY5Y cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "co-transfected with FLAG-tagged parkin"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C1418270:PARKIN [Gene or Genome]
   753   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   753   C1708067:Flag [Functional Concept]
   753   C1708632:Tagged [Qualitative Concept]
   753   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   719 E C0037293:Tag [Neoplastic Process]
   719 E C0181496:Tag [Manufactured Object]
   719 E C1710492:TAG [Gene or Genome]

Phrase: "and"

Phrase: "myc-tagged WT DJ-1,"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   859   C1413560:TAG-1 [Gene or Genome]
   839   C0441729:Type 1 [Classification]
   827   C1424222:DJ-1 [Gene or Genome]
   827   C1883559:Wild Type [Organism Attribute]
   827   C3541418:DJ-1 [Gene or Genome]
   799   C0012836:DJ [Geographic Area]
   799   C0332307:Type [Qualitative Concept]
   799   C0445392:Wild [Intellectual Product]
   799   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   799   C1547052:*Type [Quantitative Concept]
   799   C1708632:Tagged [Qualitative Concept]
   766 E C0037293:Tag [Neoplastic Process]
   766 E C0181496:Tag [Manufactured Object]
   766 E C1710492:TAG [Gene or Genome]

Phrase: "followed by treatment"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with hydrogen peroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "for 24h,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "and"

Phrase: "IP with anti-myc antibody."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0021069:Immunoprecipitation [Laboratory Procedure]
Processing 00000000.tx.164: Hydrogen peroxide treatment results in a dose-dependent increase in the interaction of WT DJ-1 with parkin (Fig.4A). 

Phrase: "Hydrogen peroxide treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "results in a dose-dependent increase"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C1512045:Dose-dependent [Quantitative Concept]
   753   C0178602:Dose [Quantitative Concept]
   753   C0442805:Increase [Functional Concept]
   753   C0851827:Dependent [Qualitative Concept]
   753   C0869039:Dose [Quantitative Concept]
   753   C1114758:Dose # [Clinical Attribute]
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C2825142:Result [Finding]
   753   C3244310:dependent [Functional Concept]

Phrase: "in the interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "of WT DJ-1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   875   C0441729:Type 1 [Classification]
   861   C1424222:DJ-1 [Gene or Genome]
   861   C1883559:Wild Type [Organism Attribute]
   861   C3541418:DJ-1 [Gene or Genome]
   812   C0012836:DJ [Geographic Area]
   812   C0332307:Type [Qualitative Concept]
   812   C0445392:Wild [Intellectual Product]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "with parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Fig.4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.165: However, WT DJ-1 and parkin fail to interact under control conditions. 

Phrase: "However,"

Phrase: "WT DJ-1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   875   C0441729:Type 1 [Classification]
   861   C1424222:DJ-1 [Gene or Genome]
   861   C1883559:Wild Type [Organism Attribute]
   861   C3541418:DJ-1 [Gene or Genome]
   812   C0012836:DJ [Geographic Area]
   812   C0332307:Type [Qualitative Concept]
   812   C0445392:Wild [Intellectual Product]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact under control conditions."
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]
   715 E C0040607:Training [Educational Activity]
   715 E C0220931:Training [Educational Activity]
   715 E C0336809:Train [Manufactured Object]
   715 E C1552514:Train [Manufactured Object]
   715 E C2673163:training [Qualitative Concept]
Processing 00000000.tx.166: To determine whether parkin interacts with WT DJ-1 under other forms of oxidative stress, the effects of the mitochondrial complex-I inhibitor, 1-methyl-4-phenylpyridinium ion (MPP+), and the nitric oxide (NO) donor, S-nitroso-N-acetylpenicillamine (SNAP) were examined. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "interacts with WT DJ-1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1424222:DJ-1 [Gene or Genome]
   790   C1883559:Wild Type [Organism Attribute]
   790   C3541418:DJ-1 [Gene or Genome]
   783   C0441729:Type 1 [Classification]
   753   C0012836:DJ [Geographic Area]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "under other forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0348078:forms [Qualitative Concept]
  1000   C0376315:Forms [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "of oxidative stress,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "the effects of the mitochondrial complex-I inhibitor,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "1-methyl-4-phenylpyridinium ion (MPP+),"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0000098:1-Methyl-4-phenylpyridinium Ion [Hazardous or Poisonous Substance,Organic Chemical]
           1-Methyl-4-phenylpyridinium
   804   C0022023:Ion [Element, Ion, or Isotope]
   804   C1700702:ION [Functional Concept]

Phrase: "and"

Phrase: "the nitric oxide (NO) donor,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0600437:nitric oxide donor [Pharmacologic Substance]
   827   C0013018:Donor [Population Group]
   827   C0040288:Donor [Population Group]
   827   C1527169:Donor NOS [Finding]
   734   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]

Phrase: "S-nitroso-N-acetylpenicillamine (SNAP)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2603362:S' [Clinical Attribute]

Phrase: "were"

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.167: Treatment with both MPP+ and SNAP leads to a dose-dependent increase in the interaction of parkin with WT DJ-1 comparable with that observed with hydrogen peroxide (Fig.4B and C). 

Phrase: "Treatment with both MPP+"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "and SNAP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1515981:And [Idea or Concept]

Phrase: "leads to a dose-dependent increase"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   790   C1512045:Dose-dependent [Quantitative Concept]
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0178602:Dose [Quantitative Concept]
   753   C0181586:leads [Medical Device]
   753   C0442805:Increase [Functional Concept]
   753   C0851827:Dependent [Qualitative Concept]
   753   C0869039:Dose [Quantitative Concept]
   753   C1114758:Dose # [Clinical Attribute]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522538:Lead [Functional Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3244310:dependent [Functional Concept]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in the interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "of parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "with WT DJ-1 comparable"

Phrase: "with that"

Phrase: "observed with hydrogen peroxide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0020275:Hydrogen [Element, Ion, or Isotope]
   770   C0031180:Peroxide [Inorganic Chemical]
   770   C0523702:HYDROGEN [Laboratory Procedure]
   770   C0885426:hydrogen [Inorganic Chemical]
   770   C1441672:Observed [Functional Concept]

Phrase: "(Fig.4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: "and"

Phrase: "C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.168: Under all three oxidative conditions, a dose-dependent decrease in cell viability is observed (data not shown). 

Phrase: "Under all three oxidative conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "a dose-dependent decrease in cell viability"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0007620:Cell Viability [Cell Function]
   799   C0443348:viability [Qualitative Concept]

Phrase: "is"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.169: Taken together, these results suggest that parkin and DJ-1 can be linked together under conditions of oxidative stress. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "can"

Phrase: "be"

Phrase: "linked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "together under conditions of oxidative stress."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   753   C0038435:Stress [Finding]
   753   C0311404:Oxidative [Functional Concept]
   753   C1883357:Together [Qualitative Concept]
   719   C0012634:condition [Disease or Syndrome]
   719   C0348080:Condition [Qualitative Concept]
   719   C1705253:Condition [Conceptual Entity]
Processing 00000000.tx.170: View larger version (66K): [in this window] [in a new window]  Figure4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(66K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure4."
Processing 00000000.tx.171: Oxidative stress promotes the association of parkin and DJ-1. 

Phrase: "Oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the association of parkin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "DJ-1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]
Processing 00000000.tx.172: (A) Hydrogen peroxide treatment promotes the interaction of parkin and DJ-1. 

Phrase: "(A) Hydrogen peroxide treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0039798:treatment [Functional Concept]
   812   C0087111:Treatment [Therapeutic or Preventive Procedure]
   812   C1522326:Treatment [Functional Concept]
   812   C1533734:Treatment [Therapeutic or Preventive Procedure]
   812   C1705169:Treatment [Conceptual Entity]
   812   C3538994:TREATMENT [Research Activity]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the interaction of parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "DJ-1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]
Processing 00000000.tx.173: SH-SY5Y cells were co-transfected with myc-tagged WT DJ-1 or control plasmid, together with FLAG-tagged parkin, followed by treatment with increasing concentrations of hydrogen peroxide (H2O2) for 24h. 

Phrase: "SH-SY5Y cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "co-transfected with myc-tagged WT DJ-1"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   764   C1424222:DJ-1 [Gene or Genome]
   764   C1883559:Wild Type [Organism Attribute]
   764   C3541418:DJ-1 [Gene or Genome]
   762   C0441729:Type 1 [Classification]
   745   C1413560:TAG-1 [Gene or Genome]
   742   C0012836:DJ [Geographic Area]
   742   C0332307:Type [Qualitative Concept]
   742   C0445392:Wild [Intellectual Product]
   742   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   742   C1547052:*Type [Quantitative Concept]
   742   C1708632:Tagged [Qualitative Concept]
   708 E C0037293:Tag [Neoplastic Process]
   708 E C0181496:Tag [Manufactured Object]
   708 E C1710492:TAG [Gene or Genome]

Phrase: "or"

Phrase: "control plasmid,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "together with FLAG-tagged parkin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1418270:PARKIN [Gene or Genome]
   827   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "followed by treatment"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with increasing concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of hydrogen peroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "(H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: ")"

Phrase: "for 24h."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]
Processing 00000000.tx.174: Lysates were subjected to IP with anti-myc antibody, and IP and input lysates were analyzed by WB with anti-FLAG and anti-myc antibodies. 

Phrase: "Lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "subjected to IP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with anti-myc antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "IP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "input lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "analyzed by WB"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with anti-FLAG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708067:Flag [Functional Concept]

Phrase: "and"

Phrase: "anti-myc antibodies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.175: Similar experiments were performed using transfected cells treated with increasing concentrations of (B) MPP+ and (C) SNAP for 24h, as described earlier. 

Phrase: "Similar experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "treated with increasing concentrations of (B) MPP+"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   739   C0022023:Ion [Element, Ion, or Isotope]
   739   C0086045:Concentrations [Mental Process]
   739   C0442808:Increasing [Functional Concept]
   739   C1522326:Treated [Functional Concept]
   739   C1700702:ION [Functional Concept]
   706 E C1292734:TREAT [Functional Concept]
   706 E C1446561:Concentration [Quantitative Concept]

Phrase: "and ("

Phrase: "C) SNAP for 24h,"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "earlier."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]
Processing 00000000.tx.176: (D) Parkin fails to ubiquitinate DJ-1 following oxidative stress. 

Phrase: "("

Phrase: "D)"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "fails"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ubiquitinate"

Phrase: "DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "oxidative stress."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.177: SH-SY5Y cells were co-transfected with myc-tagged WT DJ-1 and HA-tagged ubiquitin, with or without FLAG-tagged parkin, followed by treatment with SNAP (500M), MPP+ (1mM) or H2O2 (500M) for 24h. 

Phrase: "SH-SY5Y cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "co-transfected with myc-tagged WT DJ-1"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   764   C1424222:DJ-1 [Gene or Genome]
   764   C1883559:Wild Type [Organism Attribute]
   764   C3541418:DJ-1 [Gene or Genome]
   762   C0441729:Type 1 [Classification]
   745   C1413560:TAG-1 [Gene or Genome]
   742   C0012836:DJ [Geographic Area]
   742   C0332307:Type [Qualitative Concept]
   742   C0445392:Wild [Intellectual Product]
   742   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   742   C1547052:*Type [Quantitative Concept]
   742   C1708632:Tagged [Qualitative Concept]
   708 E C0037293:Tag [Neoplastic Process]
   708 E C0181496:Tag [Manufactured Object]
   708 E C1710492:TAG [Gene or Genome]

Phrase: "and"

Phrase: "HA-tagged ubiquitin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with"

Phrase: "or without FLAG-tagged parkin,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C1418270:PARKIN [Gene or Genome]
   760   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   760   C1708067:Flag [Functional Concept]
   760   C1708632:Tagged [Qualitative Concept]
   760   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   726 E C0037293:Tag [Neoplastic Process]
   726 E C0181496:Tag [Manufactured Object]
   726 E C1710492:TAG [Gene or Genome]

Phrase: "followed by treatment"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with"

Phrase: "SNAP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2603362:S' [Clinical Attribute]

Phrase: "(500M"

Phrase: ")"

Phrase: ","

Phrase: "MPP+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0022023:Ion [Element, Ion, or Isotope]
   812   C1700702:ION [Functional Concept]

Phrase: "(1mM"

Phrase: ")"

Phrase: "or"

Phrase: "H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(500M"

Phrase: ")"

Phrase: "for 24h."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]
Processing 00000000.tx.178: Equivalent soluble lysates (2.5mg protein) were subjected to IP with anti-myc antibody, and IP and input lysates were analyzed by WB with anti-HA and anti-myc antibodies. 

Phrase: "Equivalent soluble lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1881488:Lysate [Physical Object]

Phrase: "(2.5mg protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "were"

Phrase: "subjected to IP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with anti-myc antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "IP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "input lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "analyzed by WB"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with anti-HA"

Phrase: "and"

Phrase: "anti-myc antibodies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.179: Full-length (FL) and mono-ubiquitinated [DJ-1-(Ub)1] myc-tagged DJ-1 species are indicated by arrows. 

Phrase: "Full-length"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0443225:Full [Qualitative Concept]
   861   C1444754:Length [Quantitative Concept]
   861   C1706316:LENGTH [Research Activity]
   789 E C0205166:Long [Qualitative Concept]
   789 E C1522425:Longest [Qualitative Concept]
   789 E C1706317:Long [Qualitative Concept]

Phrase: "(FL"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0443225:Full [Qualitative Concept]
   861   C1444754:Length [Quantitative Concept]
   861   C1706316:LENGTH [Research Activity]
   789 E C0205166:Long [Qualitative Concept]
   789 E C1522425:Longest [Qualitative Concept]
   789 E C1706317:Long [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "mono-ubiquitinated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041538:Ubiquitinated [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1551432:Mono [Population Group]
   861   C1551969:Mono [Language]

Phrase: "[DJ-1-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "(Ub)1"

Phrase: "] myc-tagged DJ-1 species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1705920:Species [Conceptual Entity]

Phrase: "are"

Phrase: "indicated by arrows."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0336721:arrows [Manufactured Object]
   790   C1444656:Indicated [Finding]
Processing 00000000.tx.180: (E) Effect of parkin on DJ-1 steady-state protein levels following oxidative stress. 

Phrase: "(E) Effect of parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on DJ-1 steady-state protein levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   822   C0683927:state level [Spatial Concept]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0441889:Levels [Qualitative Concept]
   793   C0428479:Protein level [Laboratory or Test Result]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "oxidative stress."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.181: SH-SY5Y cells co-transfected and treated as in (D) were fractionated into 1% Triton X-100-soluble or -insoluble fractions, and equivalent fractions analyzed by WB with anti-myc, anti-DJ-1 (C) and anti-FLAG antibodies or with anti-actin antibody to demonstrate equal loading. 

Phrase: "SH-SY5Y cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "co-transfected"

Phrase: "and"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "as"

Phrase: "in (D)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]

Phrase: "were"

Phrase: "fractionated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979893:Fractionated [Qualitative Concept]

Phrase: "into 1% Triton X-100-soluble or -insoluble fractions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   793   C1264633:Fractions [Quantitative Concept]
   760 E C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "equivalent fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "analyzed by WB"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with anti-myc,"

Phrase: "anti-DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "anti-FLAG antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "or with anti-actin antibody to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0369998:Anti-actin antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C1718641:Actin Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "demonstrate"

Phrase: "equal loading."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708715:Loading [Activity]
Processing 00000000.tx.182: Myc-tagged (Myc) or endogenous (endo) DJ-1 are indicated. 

Phrase: "Myc-tagged"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   861   C1708632:Tagged [Qualitative Concept]
   827 E C0037293:Tag [Neoplastic Process]
   827 E C0181496:Tag [Manufactured Object]
   827 E C1710492:TAG [Gene or Genome]

Phrase: "(Myc)"

Phrase: "or"

Phrase: "endogenous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205227:Endogenous [Functional Concept]

Phrase: "(endo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205227:Endogenous [Functional Concept]

Phrase: ")"

Phrase: "DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "are"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.183: Molecular weight markers are indicated in kDa. 

Phrase: "Molecular weight markers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0005516:molecular markers [Clinical Attribute]
           Marker
   734   C0026385:Molecular Weight [Quantitative Concept]

Phrase: "are"

Phrase: "indicated in kDa."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1444656:Indicated [Finding]
   790   C1532717:kDa [Quantitative Concept]
Processing 00000000.tx.184: All experiments were replicated at least three times with similar results.  

Phrase: "All experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "replicated at least three times"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0040223:times [Temporal Concept]
   760   C0205173:replicated [Functional Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C0205341:Replicate [Functional Concept]
   726 E C1883725:Replicate [Qualitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "with similar results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.185: To determine the consequences of the interaction of parkin and WT DJ-1 following oxidative stress, we examined the ability of parkin to ubiquitinate DJ-1, as well as the effect of parkin on DJ-1 steady-state levels, under oxidative conditions. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the consequences of the interaction of parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0686907:Consequence of [Functional Concept]
           consequences

Phrase: "and"

Phrase: "WT DJ-1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   875   C0441729:Type 1 [Classification]
   861   C1424222:DJ-1 [Gene or Genome]
   861   C1883559:Wild Type [Organism Attribute]
   861   C3541418:DJ-1 [Gene or Genome]
   812   C0012836:DJ [Geographic Area]
   812   C0332307:Type [Qualitative Concept]
   812   C0445392:Wild [Intellectual Product]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "oxidative stress,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the ability of parkin to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "ubiquitinate"

Phrase: "DJ-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "as well as"

Phrase: "the effect of parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on DJ-1 steady-state levels,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   840   C0678587:steady state [Natural Phenomenon or Process]
   823   C0683927:state level [Spatial Concept]
   804   C0205361:Steady [Qualitative Concept]
   804   C0441889:Levels [Qualitative Concept]
   804   C1301808:State [Geographic Area]
   804   C1442792:State [Functional Concept]
   804   C3148680:State [Geographic Area]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "under oxidative conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.186: First, ubiquitination experiments were performed as described earlier with myc-tagged WT DJ-1 and FLAG-tagged parkin under similar conditions of oxidative stress that promote the maximal interaction of both proteins (Fig.4D). 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "ubiquitination experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "earlier with myc-tagged WT DJ-1"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   770   C1424222:DJ-1 [Gene or Genome]
   770   C1883559:Wild Type [Organism Attribute]
   770   C3541418:DJ-1 [Gene or Genome]
   767   C0441729:Type 1 [Classification]
   750   C1413560:TAG-1 [Gene or Genome]
   744   C0012836:DJ [Geographic Area]
   744   C0332307:Type [Qualitative Concept]
   744   C0445392:Wild [Intellectual Product]
   744   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   744   C1547052:*Type [Quantitative Concept]
   744   C1708632:Tagged [Qualitative Concept]
   711 E C0037293:Tag [Neoplastic Process]
   711 E C0181496:Tag [Manufactured Object]
   711   C1279919:Early [Temporal Concept]
   711 E C1710492:TAG [Gene or Genome]

Phrase: "and"

Phrase: "FLAG-tagged parkin under similar conditions of oxidative stress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1418270:PARKIN [Gene or Genome]
   742   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the maximal interaction of both proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0872079:interaction protein [Molecular Function]
   753   C1704675:Interaction [Functional Concept]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]

Phrase: "4D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450377:4d [Intellectual Product]
  1000   C2986754:4D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.187: We fail to detect HMW DJ-1-ubiquitin conjugates in the absence or presence of parkin following oxidative stress, but we continue to consistently observe mono-ubiquitinated DJ-1 irrespective of the presence of parkin (Fig.4D). 

Phrase: "We"

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "HMW DJ-1-ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "conjugates in the absence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0301869:Conjugate [Immunologic Factor]
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "presence of parkin"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0392148:Presence [Therapeutic or Preventive Procedure]
   718 E C0150312:Present [Quantitative Concept]
   718 E C0449450:Present [Idea or Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "oxidative stress,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "but"

Phrase: "we"

Phrase: "continue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549178:Continue [Idea or Concept]

Phrase: "to consistently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "observe"

Phrase: "mono-ubiquitinated DJ-1 irrespective of the presence of parkin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C1424222:DJ-1 [Gene or Genome]
   760   C3541418:DJ-1 [Gene or Genome]
   739   C0012836:DJ [Geographic Area]
   739   C0041538:Ubiquitinated [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0392148:Presence [Therapeutic or Preventive Procedure]
   739   C1418270:PARKIN [Gene or Genome]
   739   C1551432:Mono [Population Group]
   739   C1551969:Mono [Language]
   739   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]

Phrase: "4D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450377:4d [Intellectual Product]
  1000   C2986754:4D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.188: Parkin does not modify the actual level of mono-ubiquitinated DJ-1 observed following oxidative stress, but instead marginally enhances the steady-state levels of soluble DJ-1 (Fig.4D and E), as demonstrated earlier (Fig.3C), thus leading to IP of greater quantities of full-length and mono-ubiquitinated DJ-1 in this experiment. 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "the actual level of mono-ubiquitinated DJ-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0456947:Level 1 [Intellectual Product]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "oxidative stress,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "but"

Phrase: "instead marginally"

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the steady-state levels of soluble DJ-1"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   770   C0678587:steady state [Natural Phenomenon or Process]
   754   C0683927:state level [Spatial Concept]
   750   C0456947:Level 1 [Intellectual Product]
   744   C0205361:Steady [Qualitative Concept]
   744   C0441889:Levels [Qualitative Concept]
   744   C1301808:State [Geographic Area]
   744   C1442792:State [Functional Concept]
   744   C3148680:State [Geographic Area]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]

Phrase: "4D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450377:4d [Intellectual Product]
  1000   C2986754:4D [Temporal Concept]

Phrase: "and"

Phrase: "E"

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "demonstrated"

Phrase: "earlier"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]

Phrase: "(Fig.3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "thus"

Phrase: "leading to IP of greater quantities of full-length"
Meta Candidates (Total=16; Excluded=7; Pruned=0; Remaining=9)
   742   C0021069:Immunoprecipitation [Laboratory Procedure]
   742   C0332152:Leading [Temporal Concept]
   742   C0443225:Full [Qualitative Concept]
   742   C0443228:greater [Quantitative Concept]
   742   C1265611:QUANTITIES [Quantitative Concept]
   742   C1444754:Length [Quantitative Concept]
   742   C1522538:Leading [Functional Concept]
   742   C1704243:Greater [Quantitative Concept]
   742   C1706316:LENGTH [Research Activity]
   708 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   708 E C0549177:Great [Quantitative Concept]
   708 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   708 E C1554108:Quantity [Intellectual Product]
   708 E C1561573:Quantity [Intellectual Product]
   708 E C2348269:Lead [Element, Ion, or Isotope]
   708 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "mono-ubiquitinated DJ-1 in this experiment."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C1424222:DJ-1 [Gene or Genome]
   778   C3541418:DJ-1 [Gene or Genome]
   748   C0012836:DJ [Geographic Area]
   748   C0041538:Ubiquitinated [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0681814:Experiment [Research Activity]
   748   C1551432:Mono [Population Group]
   748   C1551969:Mono [Language]
   748   C1706386:Experiment [Conceptual Entity]
Processing 00000000.tx.189: This is particularly apparent under control conditions (Fig.4D and E). 

Phrase: "This"

Phrase: "is"

Phrase: "particularly apparent under control conditions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0750489:apparent [Idea or Concept]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]

Phrase: "4D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450377:4d [Intellectual Product]
  1000   C2986754:4D [Temporal Concept]

Phrase: "and"

Phrase: "E"

Phrase: ")."
Processing 00000000.tx.190: It was not possible to perform this experiment in the presence of proteasome inhibitors secondary to excessive cell death (data not shown). 

Phrase: "It"

Phrase: "was"

Phrase: "not possible to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0332149:Possible [Qualitative Concept]
   827   C1518422:Not [Functional Concept]
   827   C1705910:Possible [Qualitative Concept]
   827   C2362652:Possible [Qualitative Concept]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "this experiment in the presence of proteasome inhibitors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0681814:Experiment [Research Activity]
   744   C1706386:Experiment [Conceptual Entity]

Phrase: "secondary to excessive cell death"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0175668:Secondary to [Temporal Concept]
           Secondary
   760   C0027627:secondary [Neoplastic Process]
   760   C0205436:Secondary [Quantitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.191: These results suggest that WT DJ-1 is not ubiquitinated by parkin under conditions of oxidative stress. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that WT DJ-1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   875   C0441729:Type 1 [Classification]
   861   C1424222:DJ-1 [Gene or Genome]
   861   C1883559:Wild Type [Organism Attribute]
   861   C3541418:DJ-1 [Gene or Genome]
   812   C0012836:DJ [Geographic Area]
   812   C0332307:Type [Qualitative Concept]
   812   C0445392:Wild [Intellectual Product]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "ubiquitinated by parkin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0041538:Ubiquitinated [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1418270:PARKIN [Gene or Genome]
   790   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "under conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "of oxidative stress."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.192: To determine the effects of parkin on the steady-state levels of WT DJ-1 following oxidative stress, we examined and compared the detergent-soluble and -insoluble fractions from the earlier mentioned ubiquitination experiment (Fig.4E). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the effects of parkin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on the steady-state levels"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   901   C0678587:steady state [Natural Phenomenon or Process]
   884   C0683927:state level [Spatial Concept]
   827   C0205361:Steady [Qualitative Concept]
   827   C0441889:Levels [Qualitative Concept]
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "of WT DJ-1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   875   C0441729:Type 1 [Classification]
   861   C1424222:DJ-1 [Gene or Genome]
   861   C1883559:Wild Type [Organism Attribute]
   861   C3541418:DJ-1 [Gene or Genome]
   812   C0012836:DJ [Geographic Area]
   812   C0332307:Type [Qualitative Concept]
   812   C0445392:Wild [Intellectual Product]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "oxidative stress,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "and"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "the detergent-soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1749467:soluble [Cell Component]
   861   C1948047:Soluble [Qualitative Concept]

Phrase: "and -"

Phrase: "insoluble fractions from the earlier mentioned ubiquitination experiment"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1264633:Fractions [Quantitative Concept]
   711 E C1554103:Fraction [Idea or Concept]

Phrase: "(Fig.4E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450378:4e [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.193: Under control conditions, parkin marginally enhances the levels of WT DJ-1 in both the soluble and insoluble fractions (Fig.4E), as observed earlier (Fig.3C). 

Phrase: "Under control conditions,"
Meta Candidates (Total=17; Excluded=9; Pruned=0; Remaining=8)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   805 E C0040607:Training [Educational Activity]
   805 E C0220931:Training [Educational Activity]
   805 E C0336809:Train [Manufactured Object]
   805 E C1552514:Train [Manufactured Object]
   805 E C2673163:training [Qualitative Concept]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "parkin marginally"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the levels of WT DJ-1"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0456947:Level 1 [Intellectual Product]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "in both"

Phrase: "the soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1749467:soluble [Cell Component]
  1000   C1948047:Soluble [Qualitative Concept]

Phrase: "and"

Phrase: "insoluble fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "(Fig.4E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450378:4e [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "earlier"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]

Phrase: "(Fig.3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.194: This stabilizing effect of parkin on WT DJ-1 is abrogated under oxidative conditions (Fig.4E). 

Phrase: "This stabilizing effect of parkin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0184512:stabilizing [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on WT DJ-1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   875   C0441729:Type 1 [Classification]
   861   C1424222:DJ-1 [Gene or Genome]
   861   C1883559:Wild Type [Organism Attribute]
   861   C3541418:DJ-1 [Gene or Genome]
   812   C0012836:DJ [Geographic Area]
   812   C0332307:Type [Qualitative Concept]
   812   C0445392:Wild [Intellectual Product]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "is"

Phrase: "abrogated under oxidative conditions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0311404:Oxidative [Functional Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "(Fig.4E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450378:4e [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.195: Furthermore, these oxidative conditions lead to a marked reduction in the steady-state levels of WT DJ-1 in the detergent-insoluble fraction irrespective of parkin overexpression, with no obvious changes in the soluble fraction. 

Phrase: "Furthermore,"

Phrase: "these oxidative conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "lead to a marked reduction"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]
   760   C0522501:Marked [Qualitative Concept]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C1706089:Marked [Qualitative Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in the steady-state levels"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   901   C0678587:steady state [Natural Phenomenon or Process]
   884   C0683927:state level [Spatial Concept]
   827   C0205361:Steady [Qualitative Concept]
   827   C0441889:Levels [Qualitative Concept]
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "of WT DJ-1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   875   C0441729:Type 1 [Classification]
   861   C1424222:DJ-1 [Gene or Genome]
   861   C1883559:Wild Type [Organism Attribute]
   861   C3541418:DJ-1 [Gene or Genome]
   812   C0012836:DJ [Geographic Area]
   812   C0332307:Type [Qualitative Concept]
   812   C0445392:Wild [Intellectual Product]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "in the detergent-insoluble fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]

Phrase: "irrespective of parkin overexpression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514559:Overexpression [Genetic Function]

Phrase: "with no obvious changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "in the soluble fraction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.196: Oxidative stress also has a similar effect on the steady-state levels of detergent-insoluble endogenous DJ-1 in these cells (Fig.4E). 

Phrase: "Oxidative stress also"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   827   C0038435:Stress [Finding]
   827   C0311404:Oxidative [Functional Concept]
   755 E C0231297:Stressful [Functional Concept]

Phrase: "has"

Phrase: "a similar effect on the steady-state levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "of detergent-insoluble endogenous DJ-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C1424222:DJ-1 [Gene or Genome]
   840   C3541418:DJ-1 [Gene or Genome]
   804   C0011740:Detergent [Chemical Viewed Functionally]
   804   C0012836:DJ [Geographic Area]
   804   C0205227:Endogenous [Functional Concept]

Phrase: "in these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig.4E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450378:4e [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.197: These results suggest that oxidative stress may reduce the stability of detergent-insoluble forms of DJ-1. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "may"

Phrase: "reduce"

Phrase: "the stability of detergent-insoluble forms of DJ-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205360:Stability [Qualitative Concept]
   742   C2347098:Stability [Qualitative Concept]
Processing 00000000.tx.198: In contrast, treatment with MPP+, and to a lesser extent SNAP, results in a marked redistribution of full-length parkin from the detergent-soluble to the insoluble fraction (Fig.4E). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "treatment with MPP+,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "and to a lesser extent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439792:Extent [Spatial Concept]
   760   C0547044:Lesser [Qualitative Concept]
   760   C1515981:And [Idea or Concept]

Phrase: "SNAP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2603362:S' [Clinical Attribute]

Phrase: "results in a marked redistribution of full-length parkin"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   762   C1548201:Full results [Idea or Concept]
   742   C0332620:Redistribution [Functional Concept]
   742   C0443225:Full [Qualitative Concept]
   742   C0522501:Marked [Qualitative Concept]
   742   C1274040:Result [Functional Concept]
   742   C1418270:PARKIN [Gene or Genome]
   742   C1444754:Length [Quantitative Concept]
   742   C1546471:Result [Idea or Concept]
   742   C1706089:Marked [Qualitative Concept]
   742   C1706316:LENGTH [Research Activity]
   742   C2825142:Result [Finding]
   742   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "from the detergent-soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1749467:soluble [Cell Component]
   861   C1948047:Soluble [Qualitative Concept]

Phrase: "to the insoluble fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "(Fig.4E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450378:4e [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.199: This redistribution may reflect movement of parkin between different cellular compartments or organelles, or a change in the biochemical properties of parkin. 

Phrase: "This redistribution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332620:Redistribution [Functional Concept]

Phrase: "may"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "movement of parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0026649:Movement [Organism Function]

Phrase: "between different cellular compartments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1185625:Compartments [Body Space or Junction]
   827   C1382196:Compartments [Natural Phenomenon or Process]
   793 E C2986730:Compartment [Spatial Concept]

Phrase: "or"

Phrase: "organelles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029219:Organelles [Cell Component]

Phrase: "or"

Phrase: "a change in the biochemical properties of parkin."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0392747:Change [Functional Concept]
   744   C0443172:change [Quantitative Concept]
   744   C1705241:Change [Quantitative Concept]
Processing 00000000.tx.200: Additional experiments using quantitative DSS cross-linking show that oxidative stress has no effect on homo-dimer formation of detergent-soluble WT DJ-1 (data not shown). 

Phrase: "Additional experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "quantitative DSS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0058479:disuccinimidyl suberate [Organic Chemical,Pharmacologic Substance]
   827   C0947344:Suberate [Organic Chemical]

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "has"

Phrase: "no effect on homo-dimer formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1301751:No effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "of detergent-soluble WT DJ-1"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   839   C0441729:Type 1 [Classification]
   827   C1424222:DJ-1 [Gene or Genome]
   827   C1883559:Wild Type [Organism Attribute]
   827   C3541418:DJ-1 [Gene or Genome]
   799   C0011740:Detergent [Chemical Viewed Functionally]
   799   C0012836:DJ [Geographic Area]
   799   C0332307:Type [Qualitative Concept]
   799   C0445392:Wild [Intellectual Product]
   799   C1547052:*Type [Quantitative Concept]
   799   C1749467:soluble [Cell Component]
   799   C1948047:Soluble [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.201: Collectively, these results indicate that although parkin interacts with WT DJ-1 under oxidative stress, this does not promote the parkin-mediated ubiquitination or degradation of DJ-1. 

Phrase: "Collectively,"

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "although"

Phrase: "parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "interacts with WT DJ-1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1424222:DJ-1 [Gene or Genome]
   790   C1883559:Wild Type [Organism Attribute]
   790   C3541418:DJ-1 [Gene or Genome]
   783   C0441729:Type 1 [Classification]
   753   C0012836:DJ [Geographic Area]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "under oxidative stress,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "this"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the parkin-mediated ubiquitination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1519751:Ubiquitination [Molecular Function]

Phrase: "or"

Phrase: "degradation of DJ-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]
Processing 00000000.tx.202: Instead, the small stabilizing effect of parkin on WT DJ-1 may be impaired by oxidative stress. 

Phrase: "Instead,"

Phrase: "the small stabilizing effect of parkin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0184512:stabilizing [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on WT DJ-1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   875   C0441729:Type 1 [Classification]
   861   C1424222:DJ-1 [Gene or Genome]
   861   C1883559:Wild Type [Organism Attribute]
   861   C3541418:DJ-1 [Gene or Genome]
   812   C0012836:DJ [Geographic Area]
   812   C0332307:Type [Qualitative Concept]
   812   C0445392:Wild [Intellectual Product]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "impaired by oxidative stress."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   770   C0038435:Stress [Finding]
   770   C0221099:Impaired [Functional Concept]
   770   C0311404:Oxidative [Functional Concept]
   770   C0684336:Impaired [Pathologic Function]
Processing 00000000.tx.203: Intriguingly, oxidative stress can reduce the stability of insoluble DJ-1, as well as reducing the solubility of parkin. 

Phrase: "Intriguingly,"

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "can"

Phrase: "reduce"

Phrase: "the stability of insoluble DJ-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205360:Stability [Qualitative Concept]
   753   C2347098:Stability [Qualitative Concept]

Phrase: "as well as"

Phrase: "reducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reducing [Qualitative Concept]

Phrase: "the solubility of parkin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0037628:Solubility [Qualitative Concept]
Processing 00000000.tx.204: Our findings support the idea that the interaction of DJ-1 and parkin under oxidative stress may be an indirect association or may serve an alternative biological role. 

Phrase: "Our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the idea"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1512612:Ideal [Qualitative Concept]

Phrase: "that"

Phrase: "the interaction of DJ-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "parkin under oxidative stress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1418270:PARKIN [Gene or Genome]
   770   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "be"

Phrase: "an indirect association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "or"

Phrase: "may"

Phrase: "serve"

Phrase: "an alternative biological role."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035820:Role [Social Behavior]
   827   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.205: L166P mutant DJ-1 associates with parkin, CHIP and Hsp70 Parkin exists in a macromolecular protein complex with CHIP and Hsp70, where this complex participates in the ubiquitination and degradation of parkin substrates such as Pael-R (27). 

Phrase: "L166P mutant DJ-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1424222:DJ-1 [Gene or Genome]
   861   C3541418:DJ-1 [Gene or Genome]
   812   C0012836:DJ [Geographic Area]
   812   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "associates with parkin,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0750490:Associate [Idea or Concept]
   790   C1418270:PARKIN [Gene or Genome]
   790   C1706221:Associate [Professional or Occupational Group]
   790   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "CHIP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600596:Chip [Research Device]

Phrase: "and"

Phrase: "Hsp70 Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "exists in a macromolecular protein complex"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1523872:protein complex [Cell Component]
   783   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   783   C2246374:macromolecular complex [Cell Component]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439855:Complex [Qualitative Concept]
   753   C1704241:Complex [Chemical Viewed Structurally]
   753   C2987476:Exist [Conceptual Entity]

Phrase: "with CHIP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600596:Chip [Research Device]

Phrase: "and"

Phrase: "Hsp70,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243043:HSP 70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415760:HSP70 [Gene or Genome]
  1000   C1527149:HSP70 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "where"

Phrase: "this complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "participates in the ubiquitination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1519751:Ubiquitination [Molecular Function]

Phrase: "and"

Phrase: "degradation of parkin substrates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "such as Pael-R (27"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.206: To ascertain whether DJ-1 mutants could additionally interact with components of this parkin complex, co-immunoprecipitation experiments were performed (Fig.5). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ascertain"

Phrase: "whether"

Phrase: "DJ-1 mutants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0596988:mutants [Cell or Molecular Dysfunction]
   734   C1424222:DJ-1 [Gene or Genome]
   734   C3541418:DJ-1 [Gene or Genome]

Phrase: "could"

Phrase: "additionally"

Phrase: "interact with components of this parkin complex,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0439855:Complex [Qualitative Concept]
   748   C0449432:Components [Manufactured Object]
   748   C1418270:PARKIN [Gene or Genome]
   748   C1704241:Complex [Chemical Viewed Structurally]
   748   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   714 E C1705248:Component [Conceptual Entity]

Phrase: "co-immunoprecipitation experiments"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C1449705:Co-Immunoprecipitation [Laboratory Procedure]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Fig.5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.207: We chose to study only L166P DJ-1 in these experiments because this mutant displays the most robust interaction with parkin. 

Phrase: "We"

Phrase: "chose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Choose [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "only L166P DJ-1 in these experiments"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C1424222:DJ-1 [Gene or Genome]
   778   C3541418:DJ-1 [Gene or Genome]
   748   C0012836:DJ [Geographic Area]
   748   C0205171:Only [Quantitative Concept]
   748   C0681814:Experiments [Research Activity]
   748   C1720467:Only [Intellectual Product]
   714 E C1706386:Experiment [Conceptual Entity]

Phrase: "because"

Phrase: "this mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "the most robust interaction with parkin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.208: SH-SY5Y cells were co-transfected with myc-tagged DJ-1 (WT or L166P) together with HA-tagged CHIP, FLAG-tagged parkin or both proteins, followed by treatment with the proteasome inhibitor MG132 for 24h to restore L166P DJ-1 levels to those of WT, and IP with anti-myc antibody. 

Phrase: "SH-SY5Y cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "co-transfected with myc-tagged DJ-1"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   778   C1424222:DJ-1 [Gene or Genome]
   778   C3541418:DJ-1 [Gene or Genome]
   757   C1413560:TAG-1 [Gene or Genome]
   748   C0012836:DJ [Geographic Area]
   748   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   748   C1708632:Tagged [Qualitative Concept]
   714 E C0037293:Tag [Neoplastic Process]
   714 E C0181496:Tag [Manufactured Object]
   714 E C1710492:TAG [Gene or Genome]

Phrase: "(WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "L166P"

Phrase: ")"

Phrase: "together with HA-tagged CHIP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0600596:Chip [Research Device]

Phrase: "FLAG-tagged parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1418270:PARKIN [Gene or Genome]
   827   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "both proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "followed by treatment"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with the proteasome inhibitor MG132"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0246694:MG132 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   734   C1443643:Proteasome inhibitor [Pharmacologic Substance]
   734   C2266856:Proteasome Inhibitor [Molecular Function]
   734   C3537238:Proteasome Inhibitor [Pharmacologic Substance]

Phrase: "for 24h to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456696:/24h [Temporal Concept]
   861   C1442770:24H [Temporal Concept]

Phrase: "restore"

Phrase: "L166P DJ-1 levels to those of WT,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   745   C0456947:Level 1 [Intellectual Product]
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "IP with anti-myc antibody."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0021069:Immunoprecipitation [Laboratory Procedure]
Processing 00000000.tx.209: L166P DJ-1 specifically interacts with CHIP in the presence or absence of parkin, whereas WT DJ-1 fails to interact with CHIP (Fig.5A). 

Phrase: "L166P DJ-1 specifically"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1424222:DJ-1 [Gene or Genome]
   861   C3541418:DJ-1 [Gene or Genome]
   812   C0012836:DJ [Geographic Area]

Phrase: "interacts with CHIP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0600596:Chip [Research Device]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of parkin,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "whereas"

Phrase: "WT DJ-1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   875   C0441729:Type 1 [Classification]
   861   C1424222:DJ-1 [Gene or Genome]
   861   C1883559:Wild Type [Organism Attribute]
   861   C3541418:DJ-1 [Gene or Genome]
   812   C0012836:DJ [Geographic Area]
   812   C0332307:Type [Qualitative Concept]
   812   C0445392:Wild [Intellectual Product]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "fails"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with CHIP (Fig.5A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0349966:Fig [Food]
   760   C0600596:Chip [Research Device]
   760   C1337208:FIG [Food]
   760   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.210: Parkin fails to appreciably alter the interaction of CHIP with L166P DJ-1. 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "fails"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to appreciably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the interaction of CHIP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "with L166P DJ-1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]
Processing 00000000.tx.211: In a similar manner, CHIP fails to alter the interaction of parkin with L166P DJ-1, suggesting that parkin and CHIP may interact with L166P DJ-1 independently of each other. 

Phrase: "In a similar manner,"

Phrase: "CHIP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600596:Chip [Research Device]

Phrase: "fails"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the interaction of parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "with L166P DJ-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "CHIP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600596:Chip [Research Device]

Phrase: "may"

Phrase: "interact with L166P DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1424222:DJ-1 [Gene or Genome]
   806   C3541418:DJ-1 [Gene or Genome]
   760   C0012836:DJ [Geographic Area]

Phrase: "independently of each other."
Processing 00000000.tx.212: In similar co-immunoprecipitation experiments, we also monitored the ability of L166P DJ-1 to interact with Hsp70. 

Phrase: "In similar co-immunoprecipitation experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "we also"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "the ability of L166P DJ-1 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0085732:Ability [Organism Attribute]

Phrase: "interact with Hsp70."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0243043:HSP 70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1415760:HSP70 [Gene or Genome]
   790   C1527149:HSP70 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.213: SH-SY5Y cells were co-transfected with myc-tagged DJ-1 (WT or L166P) together with V5-tagged Hsp70 or control plasmid, followed by treatment with or without MG132 for 24h, and IP with anti-V5 antibody. 

Phrase: "SH-SY5Y cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "co-transfected with myc-tagged DJ-1"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   778   C1424222:DJ-1 [Gene or Genome]
   778   C3541418:DJ-1 [Gene or Genome]
   757   C1413560:TAG-1 [Gene or Genome]
   748   C0012836:DJ [Geographic Area]
   748   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   748   C1708632:Tagged [Qualitative Concept]
   714 E C0037293:Tag [Neoplastic Process]
   714 E C0181496:Tag [Manufactured Object]
   714 E C1710492:TAG [Gene or Genome]

Phrase: "(WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "L166P"

Phrase: ")"

Phrase: "together with V5-tagged Hsp70"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243043:HSP 70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1415760:HSP70 [Gene or Genome]
   827   C1527149:HSP70 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "or"

Phrase: "control plasmid,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "followed by treatment"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with"

Phrase: "or without MG132"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0246694:MG132 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "for 24h,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "and"

Phrase: "IP with anti-V5 antibody."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0021069:Immunoprecipitation [Laboratory Procedure]
Processing 00000000.tx.214: We find that only full-length L166P DJ-1 interacts with Hsp70, on the other hand, Hsp70 also interacts with N-terminally truncated forms of WT and L166P DJ-1 (Fig.5B). 

Phrase: "We"

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "that only full-length L166P DJ-1"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   827   C1424222:DJ-1 [Gene or Genome]
   827   C3541418:DJ-1 [Gene or Genome]
   799   C0012836:DJ [Geographic Area]
   799   C0205171:Only [Quantitative Concept]
   799   C0443225:Full [Qualitative Concept]
   799   C1444754:Length [Quantitative Concept]
   799   C1706316:LENGTH [Research Activity]
   799   C1720467:Only [Intellectual Product]
   727 E C0205166:Long [Qualitative Concept]
   727 E C1522425:Longest [Qualitative Concept]
   727 E C1706317:Long [Qualitative Concept]

Phrase: "interacts with Hsp70,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0243043:HSP 70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1415760:HSP70 [Gene or Genome]
   790   C1527149:HSP70 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "on the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "Hsp70 also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243043:HSP 70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1415760:HSP70 [Gene or Genome]
   861   C1527149:HSP70 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "interacts with N-terminally truncated forms of WT"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C3463805:Type of Form [Intellectual Product]
           form type
   764   C1883559:Wild Type [Organism Attribute]
   742   C0332307:Type [Qualitative Concept]
   742   C0348078:forms [Qualitative Concept]
   742   C0376315:Forms [Manufactured Object]
   742   C0445392:Wild [Intellectual Product]
   742   C1547052:*Type [Quantitative Concept]
   708 E C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "L166P DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]

Phrase: "(Fig.5B"

Phrase: ")."
Processing 00000000.tx.215: In the presence of the proteasome inhibitor MG132 to restore L166P DJ-1 levels, the interaction of Hsp70 with full-length and truncated forms of L166P DJ-1 is enhanced and we additionally observe a weak interaction of full-length WT DJ-1 with Hsp70 (Fig.5B). 

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of the proteasome inhibitor MG132 to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0246694:MG132 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "restore"

Phrase: "L166P DJ-1 levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "the interaction of Hsp70"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "with full-length"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0443225:Full [Qualitative Concept]
   861   C1444754:Length [Quantitative Concept]
   861   C1706316:LENGTH [Research Activity]
   789 E C0205166:Long [Qualitative Concept]
   789 E C1522425:Longest [Qualitative Concept]
   789 E C1706317:Long [Qualitative Concept]

Phrase: "and"

Phrase: "truncated forms of L166P DJ-1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   719 E C1522492:Form [Functional Concept]

Phrase: "is"

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "and"

Phrase: "we additionally"

Phrase: "observe"

Phrase: "a weak interaction of full-length WT DJ-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1704675:Interaction [Functional Concept]

Phrase: "with Hsp70 (Fig.5B"

Phrase: ")."
Processing 00000000.tx.216: The interaction of full-length WT DJ-1 with Hsp70 following proteasome inhibition may relate to the putative chaperone function of DJ-1. 

Phrase: "The interaction of full-length WT DJ-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1704675:Interaction [Functional Concept]

Phrase: "with Hsp70"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243043:HSP 70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415760:HSP70 [Gene or Genome]
  1000   C1527149:HSP70 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "proteasome inhibition"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "may"

Phrase: "relate to the putative chaperone function of DJ-1."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C1424222:DJ-1 [Gene or Genome]
   764   C3541418:DJ-1 [Gene or Genome]
   742   C0012836:DJ [Geographic Area]
   742   C0031843:function [Physiologic Function]
   742   C0163712:Relate [Organic Chemical]
   742   C0243041:Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0542341:Function [Functional Concept]
   742   C0700205:FUNCTION [Classification]
   742   C1705273:Function [Intellectual Product]
Processing 00000000.tx.217: To determine whether Hsp70 can promote the stability of L166P DJ-1, similar to the effect of parkin (Fig.3D), we examined the steady-state levels of WT or L166P DJ-1 in the detergent-insoluble fraction in the absence or presence of Hsp70 following proteasome inhibition (Fig.5C). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "Hsp70"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243043:HSP 70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415760:HSP70 [Gene or Genome]
  1000   C1527149:HSP70 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "can"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the stability of L166P DJ-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205360:Stability [Qualitative Concept]
   753   C2347098:Stability [Qualitative Concept]

Phrase: "similar to the effect of parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]

Phrase: "3D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450363:3D [Spatial Concept]
  1000   C2986797:3D [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the steady-state levels of WT"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   778   C0678587:steady state [Natural Phenomenon or Process]
   762   C0683927:state level [Spatial Concept]
   748   C0205361:Steady [Qualitative Concept]
   748   C0441889:Levels [Qualitative Concept]
   748   C1301808:State [Geographic Area]
   748   C1442792:State [Functional Concept]
   748   C3148680:State [Geographic Area]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "or"

Phrase: "L166P DJ-1 in the detergent-insoluble fraction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1424222:DJ-1 [Gene or Genome]
   770   C3541418:DJ-1 [Gene or Genome]
   744   C0011740:Detergent [Chemical Viewed Functionally]
   744   C0012836:DJ [Geographic Area]
   744   C1264633:Fraction [Quantitative Concept]
   744   C1554103:Fraction [Idea or Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of Hsp70"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0392148:Presence [Therapeutic or Preventive Procedure]
   718 E C0150312:Present [Quantitative Concept]
   718 E C0449450:Present [Idea or Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "proteasome inhibition"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "(Fig.5C"

Phrase: ")."
Processing 00000000.tx.218: Hsp70 markedly enhances the level of full-length L166P DJ-1, as well as N-terminally truncated forms of WT and L166P DJ-1, with smaller effects on full-length WT DJ-1 (Fig.5C). 

Phrase: "Hsp70 markedly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243043:HSP 70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1415760:HSP70 [Gene or Genome]
   861   C1527149:HSP70 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the level of full-length L166P DJ-1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0456947:Level 1 [Intellectual Product]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "as well as"

Phrase: "N-terminally truncated forms of WT"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   789   C3463805:Type of Form [Intellectual Product]
           form type
   748   C0348078:forms [Qualitative Concept]
   748   C0376315:Forms [Manufactured Object]
   714 E C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "L166P DJ-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]

Phrase: "with smaller effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "on full-length WT DJ-1"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   839   C0441729:Type 1 [Classification]
   827   C1424222:DJ-1 [Gene or Genome]
   827   C1883559:Wild Type [Organism Attribute]
   827   C3541418:DJ-1 [Gene or Genome]
   799   C0012836:DJ [Geographic Area]
   799   C0332307:Type [Qualitative Concept]
   799   C0443225:Full [Qualitative Concept]
   799   C0445392:Wild [Intellectual Product]
   799   C1444754:Length [Quantitative Concept]
   799   C1547052:*Type [Quantitative Concept]
   799   C1706316:LENGTH [Research Activity]
   727 E C0205166:Long [Qualitative Concept]
   727 E C1522425:Longest [Qualitative Concept]
   727 E C1706317:Long [Qualitative Concept]

Phrase: "(Fig.5C"

Phrase: ")."
Processing 00000000.tx.219: This finding suggests that Hsp70 can promote the stability of detergent-insoluble DJ-1, primarily L166P DJ-1. 

Phrase: "This finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that Hsp70"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243043:HSP 70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415760:HSP70 [Gene or Genome]
  1000   C1527149:HSP70 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "can"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the stability of detergent-insoluble DJ-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205360:Stability [Qualitative Concept]
   748   C2347098:Stability [Qualitative Concept]

Phrase: "primarily L166P DJ-1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1424222:DJ-1 [Gene or Genome]
   861   C3541418:DJ-1 [Gene or Genome]
   812   C0012836:DJ [Geographic Area]
Processing 00000000.tx.220: This stabilizing effect reflects the interaction profile of Hsp70 with WT and L166P DJ-1 (Fig.5B). 

Phrase: "This stabilizing effect"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0184512:stabilizing [Qualitative Concept]
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the interaction profile of Hsp70"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1979963:Profile [Laboratory Procedure]
   760   C2003903:Profile [Functional Concept]

Phrase: "with WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "L166P DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]

Phrase: "(Fig.5B"

Phrase: ")."
Processing 00000000.tx.221: Taken together, these results indicate that both CHIP and Hsp70 are able to interact with L166P DJ-1, and suggest that parkin may associate with L166P DJ-1, and possibly other DJ-1 mutants, as part of a larger protein complex containing CHIP and Hsp70. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "both CHIP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600596:Chip [Research Device]

Phrase: "and"

Phrase: "Hsp70"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243043:HSP 70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415760:HSP70 [Gene or Genome]
  1000   C1527149:HSP70 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "are"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "interact with L166P DJ-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1424222:DJ-1 [Gene or Genome]
   806   C3541418:DJ-1 [Gene or Genome]
   760   C0012836:DJ [Geographic Area]

Phrase: "and"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "associate with L166P DJ-1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1424222:DJ-1 [Gene or Genome]
   806   C3541418:DJ-1 [Gene or Genome]
   760   C0012836:DJ [Geographic Area]
   760   C0750490:Associate [Idea or Concept]
   760   C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "other DJ-1 mutants,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0596988:mutants [Cell or Molecular Dysfunction]
   734   C1424222:DJ-1 [Gene or Genome]
   734   C3541418:DJ-1 [Gene or Genome]

Phrase: "as"

Phrase: "part of a larger protein complex containing CHIP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1292711:Part of [Spatial Concept]
   744   C0449719:Part [Spatial Concept]
   744   C1709471:Part [Quantitative Concept]

Phrase: "and"

Phrase: "Hsp70."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243043:HSP 70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415760:HSP70 [Gene or Genome]
  1000   C1527149:HSP70 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.222: This observation may explain the failure of parkin to directly ubiquitinate L166P and M26I mutant DJ-1 (Fig.3A and B). 

Phrase: "This observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "may"

Phrase: "explain"

Phrase: "the failure of parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0231174:Failure [Functional Concept]
   770   C0680095:failure [Individual Behavior]

Phrase: "to directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "ubiquitinate"

Phrase: "L166P"

Phrase: "and"

Phrase: "M26I mutant DJ-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1424222:DJ-1 [Gene or Genome]
   861   C3541418:DJ-1 [Gene or Genome]
   812   C0012836:DJ [Geographic Area]
   812   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(Fig.3A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.223: View larger version (36K): [in this window] [in a new window]  Figure5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(36K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure5."
Processing 00000000.tx.224: Association of L166P DJ-1 with parkin, CHIP and Hsp70. 

Phrase: "Association of L166P DJ-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "with parkin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "CHIP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600596:Chip [Research Device]

Phrase: "and"

Phrase: "Hsp70."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243043:HSP 70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415760:HSP70 [Gene or Genome]
  1000   C1527149:HSP70 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.225: (A) Interaction of L166P DJ-1 with CHIP and parkin. 

Phrase: "(A) Interaction of L166P DJ-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704675:Interaction [Functional Concept]

Phrase: "with CHIP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600596:Chip [Research Device]

Phrase: "and"

Phrase: "parkin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.226: SH-SY5Y cells were co-transfected with myc-tagged WT or L166P DJ-1, together with HA-tagged CHIP, FLAG-tagged parkin or both proteins, followed by treatment with the proteasome inhibitor MG132 (5M) for 24h. 

Phrase: "SH-SY5Y cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "co-transfected with myc-tagged WT"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   778   C1883559:Wild Type [Organism Attribute]
   748   C0332307:Type [Qualitative Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   748   C1547052:*Type [Quantitative Concept]
   748   C1708632:Tagged [Qualitative Concept]
   714 E C0037293:Tag [Neoplastic Process]
   714 E C0181496:Tag [Manufactured Object]
   714 E C1710492:TAG [Gene or Genome]

Phrase: "or"

Phrase: "L166P DJ-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]

Phrase: "together with HA-tagged CHIP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0600596:Chip [Research Device]

Phrase: "FLAG-tagged parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1418270:PARKIN [Gene or Genome]
   827   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "both proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "followed by treatment"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with the proteasome inhibitor MG132"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0246694:MG132 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   734   C1443643:Proteasome inhibitor [Pharmacologic Substance]
   734   C2266856:Proteasome Inhibitor [Molecular Function]
   734   C3537238:Proteasome Inhibitor [Pharmacologic Substance]

Phrase: "(5M"

Phrase: ")"

Phrase: "for 24h."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]
Processing 00000000.tx.227: Lysates were subjected to IP with anti-myc antibody, and IP and input lysates were analyzed by WB with anti-HA, anti-FLAG and anti-myc antibodies. 

Phrase: "Lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "subjected to IP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with anti-myc antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "IP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "input lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "analyzed by WB"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with anti-HA,"

Phrase: "anti-FLAG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708067:Flag [Functional Concept]

Phrase: "and"

Phrase: "anti-myc antibodies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.228: (B) Interaction of L166P DJ-1 with Hsp70. 

Phrase: "(B) Interaction of L166P DJ-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704675:Interaction [Functional Concept]

Phrase: "with Hsp70."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243043:HSP 70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415760:HSP70 [Gene or Genome]
  1000   C1527149:HSP70 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.229: SH-SY5Y cells were co-transfected with myc-tagged WT or L166P DJ-1, together with V5-tagged Hsp70 or control plasmid, followed by treatment with or without the proteasome inhibitor MG132 (5M) for 24h. 

Phrase: "SH-SY5Y cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "co-transfected with myc-tagged WT"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   778   C1883559:Wild Type [Organism Attribute]
   748   C0332307:Type [Qualitative Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   748   C1547052:*Type [Quantitative Concept]
   748   C1708632:Tagged [Qualitative Concept]
   714 E C0037293:Tag [Neoplastic Process]
   714 E C0181496:Tag [Manufactured Object]
   714 E C1710492:TAG [Gene or Genome]

Phrase: "or"

Phrase: "L166P DJ-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]

Phrase: "together with V5-tagged Hsp70"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243043:HSP 70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1415760:HSP70 [Gene or Genome]
   827   C1527149:HSP70 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "or"

Phrase: "control plasmid,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "followed by treatment"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with"

Phrase: "or without the proteasome inhibitor MG132"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1443643:Proteasome inhibitor [Pharmacologic Substance]
   790   C2266856:Proteasome Inhibitor [Molecular Function]
   790   C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   753   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0246694:MG132 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C1325620:proteasome [Cell Component]
   753   C1752727:Proteasome [Molecular Function]
   753   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(5M"

Phrase: ")"

Phrase: "for 24h."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]
Processing 00000000.tx.230: Lysates were subjected to IP with anti-V5 antibody, and IP and input lysates were analyzed by WB with anti-myc and anti-V5 antibodies. 

Phrase: "Lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "subjected to IP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with anti-V5 antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "IP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "input lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "analyzed by WB"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with anti-myc"

Phrase: "and"

Phrase: "anti-V5 antibodies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.231: (C) Effect of Hsp70 on DJ-1 steady-state protein levels. 

Phrase: "(C) Effect of Hsp70"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on DJ-1 steady-state protein levels."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   822   C0683927:state level [Spatial Concept]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0441889:Levels [Qualitative Concept]
   793   C0428479:Protein level [Laboratory or Test Result]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.232: The 1% Triton X-100-insoluble fraction from cells co-transfected with myc-tagged WT or L166P DJ-1 with or without V5-tagged Hsp70, followed by treatment with MG132 (5M) for 24h, was analyzed by WB with anti-myc and anti-actin antibodies. 

Phrase: "The 1% Triton X-100-insoluble fraction from cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   745   C0805525:Cell Fraction [Cell Component]
   742   C1264633:Fraction [Quantitative Concept]
   742   C1554103:Fraction [Idea or Concept]

Phrase: "co-transfected with myc-tagged WT"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   778   C1883559:Wild Type [Organism Attribute]
   748   C0332307:Type [Qualitative Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   748   C1547052:*Type [Quantitative Concept]
   748   C1708632:Tagged [Qualitative Concept]
   714 E C0037293:Tag [Neoplastic Process]
   714 E C0181496:Tag [Manufactured Object]
   714 E C1710492:TAG [Gene or Genome]

Phrase: "or"

Phrase: "L166P DJ-1 with"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1424222:DJ-1 [Gene or Genome]
   833   C3541418:DJ-1 [Gene or Genome]
   770   C0012836:DJ [Geographic Area]

Phrase: "or without V5-tagged Hsp70,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0243043:HSP 70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1415760:HSP70 [Gene or Genome]
   760   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   760   C1527149:HSP70 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   760   C1708632:Tagged [Qualitative Concept]
   760   C2349105:V5+ [Element, Ion, or Isotope]
   726 E C0037293:Tag [Neoplastic Process]
   726 E C0181496:Tag [Manufactured Object]
   726 E C1710492:TAG [Gene or Genome]

Phrase: "followed by treatment"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with MG132"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0246694:MG132 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(5M"

Phrase: ")"

Phrase: "for 24h,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "was"

Phrase: "analyzed by WB"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with anti-myc"

Phrase: "and"

Phrase: "anti-actin antibodies."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   988   C0369998:Anti-actin antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   884   C1718641:Actin Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   755 E C0439681:Actinic [Qualitative Concept]
Processing 00000000.tx.233: Full-length (FL) and N-terminally truncated (N1 and N2) myc-tagged DJ-1 species are indicated by arrows. 

Phrase: "Full-length"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0443225:Full [Qualitative Concept]
   861   C1444754:Length [Quantitative Concept]
   861   C1706316:LENGTH [Research Activity]
   789 E C0205166:Long [Qualitative Concept]
   789 E C1522425:Longest [Qualitative Concept]
   789 E C1706317:Long [Qualitative Concept]

Phrase: "(FL"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0443225:Full [Qualitative Concept]
   861   C1444754:Length [Quantitative Concept]
   861   C1706316:LENGTH [Research Activity]
   789 E C0205166:Long [Qualitative Concept]
   789 E C1522425:Longest [Qualitative Concept]
   789 E C1706317:Long [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "N-terminally"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "truncated"

Phrase: "(N1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441962:N1 [Finding]

Phrase: "and"

Phrase: "N2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441960:N2 [Finding]

Phrase: ")"

Phrase: "myc-tagged DJ-1 species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1705920:Species [Conceptual Entity]

Phrase: "are"

Phrase: "indicated by arrows."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0336721:arrows [Manufactured Object]
   790   C1444656:Indicated [Finding]
Processing 00000000.tx.234: Molecular weight markers are indicated in kDa. 

Phrase: "Molecular weight markers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0005516:molecular markers [Clinical Attribute]
           Marker
   734   C0026385:Molecular Weight [Quantitative Concept]

Phrase: "are"

Phrase: "indicated in kDa."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1444656:Indicated [Finding]
   790   C1532717:kDa [Quantitative Concept]
Processing 00000000.tx.235: All experiments were replicated with similar results.  

Phrase: "All experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "replicated with similar results."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0205173:replicated [Functional Concept]
   770   C2348205:Similar [Qualitative Concept]
   737 E C0205341:Replicate [Functional Concept]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737 E C1883725:Replicate [Qualitative Concept]
   737   C2825142:Result [Finding]
Processing 00000000.tx.236: Alterations of DJ-1 protein levels in Parkinson's disease brains Parkin enhances the steady-state levels of DJ-1 primarily in the detergent-insoluble fraction in cultured cells, and this may relate to increased protein stability. 

Phrase: "Alterations of DJ-1 protein levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1515926:Alteration [Idea or Concept]

Phrase: "in Parkinson's disease brains Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1418270:PARKIN [Gene or Genome]
   812   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the steady-state levels of DJ-1 primarily"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   770   C0678587:steady state [Natural Phenomenon or Process]
   754   C0683927:state level [Spatial Concept]
   750   C0456947:Level 1 [Intellectual Product]
   744   C0205361:Steady [Qualitative Concept]
   744   C0441889:Levels [Qualitative Concept]
   744   C1301808:State [Geographic Area]
   744   C1442792:State [Functional Concept]
   744   C3148680:State [Geographic Area]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the detergent-insoluble fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]

Phrase: "in cultured cells,"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0007600:cultured cells [Cell]
  1000   C0007635:Cultured Cells [Cell]
  1000   C3282338:Cells, Cultured [Cell]
   966 E C0007585:culture cell [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "this"

Phrase: "may"

Phrase: "relate to increased protein stability."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C2350440:Protein Stability [Qualitative Concept]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0163712:Relate [Organic Chemical]
   760   C0205217:Increased [Quantitative Concept]
   760   C0205360:Stability [Qualitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C2347098:Stability [Qualitative Concept]
Processing 00000000.tx.237: To explore whether this finding has potential pathophysiological relevance, we monitored the levels and detergent solubility of DJ-1 in human post-mortem cingulate cortex tissue from aged-matched normal control, Alzheimer's disease (AD) and PD/dementia with Lewy bodies (DLB) patients (Table1; Fig.6). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "explore"

Phrase: "whether"

Phrase: "this finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "has"

Phrase: "potential pathophysiological relevance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347946:Relevance [Qualitative Concept]

Phrase: "we"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "the levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "detergent solubility of DJ-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0037628:Solubility [Qualitative Concept]

Phrase: "in human post-mortem cingulate cortex tissue"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   895   C0440744:Human tissue [Tissue]
   885   C0444184:Postmortem tissue [Tissue]
   799   C0040300:Tissue [Tissue]
   799   C1547928:Tissue [Intellectual Product]

Phrase: "from aged-matched normal control,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C2705716:normal control [Qualitative Concept]
   812   C0205307:Normal [Qualitative Concept]
   812   C0243148:control [Qualitative Concept]
   812   C0439166:% normal [Quantitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2347086:% Normal [Quantitative Concept]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD)"

Phrase: "and"

Phrase: "PD/dementia with Lewy bodies (DLB) patients"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   804 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   753   C0011265:dementia [Mental or Behavioral Dysfunction]
   753   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "(Table1"

Phrase: "; Fig.6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.238: Although the relative amount of DJ-1 does not change in the detergent-soluble fraction of all cases, a dramatic increase of DJ-1 levels in the detergent-insoluble fraction is observed in PD/DLB cases when compared with control or AD cases (Fig.6A). 

Phrase: "Although"

Phrase: "the relative amount of DJ-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "change in the detergent-soluble fraction of all cases,"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   764   C1264633:Fraction of [Quantitative Concept]
           Fraction
   742   C0011740:Detergent [Chemical Viewed Functionally]
   742   C0392747:Change [Functional Concept]
   742   C0443172:change [Quantitative Concept]
   742   C0868928:Cases [Functional Concept]
   742   C1533148:Cases [Quantitative Concept]
   742   C1554103:Fraction [Idea or Concept]
   742   C1705241:Change [Quantitative Concept]
   742   C1749467:soluble [Cell Component]
   742   C1948047:Soluble [Qualitative Concept]
   708 E C1706255:CASE [Medical Device]
   708 E C1706256:Case [Conceptual Entity]

Phrase: "a dramatic increase of DJ-1 levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "in the detergent-insoluble fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]

Phrase: "is"

Phrase: "observed in PD/DLB cases"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   833   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   776 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0085200:Lewy Bodies [Cell Component]
   744   C0011265:dementia [Mental or Behavioral Dysfunction]
   744   C0242821:bodies [Human]
   744   C0497327:Dementia [Mental or Behavioral Dysfunction]
   744   C0868928:Cases [Functional Concept]
   744   C1441672:Observed [Functional Concept]
   744   C1533148:Cases [Quantitative Concept]
   744   C1995017:Bodies [Cell Component]
   711 E C0460148:Body [Anatomical Structure]
   711 E C1268086:Body [Anatomical Structure]
   711 E C1706255:CASE [Medical Device]
   711 E C1706256:Case [Conceptual Entity]

Phrase: "when"

Phrase: "compared with control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1707455:Compared [Activity]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: "or"

Phrase: "AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "(Fig.6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.239: Quantification and normalization of DJ-1 protein levels reveals a >5-fold increase of DJ-1 in the insoluble fraction of PD/DLB cases when compared with combined control and AD cases, whereas there is no apparent difference in the soluble fraction (Fig.6A). 

Phrase: "Quantification"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantification [Quantitative Concept]

Phrase: "and"

Phrase: "normalization of DJ-1 protein levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1882115:Normalization [Research Activity]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "a >5-fold increase of DJ-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "in the insoluble fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "of PD/DLB cases"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   877   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   818   C0085200:Lewy Bodies [Cell Component]
   795   C0011265:dementia [Mental or Behavioral Dysfunction]
   795   C0242821:bodies [Human]
   795   C0332285:Of [Spatial Concept]
   795   C0497327:Dementia [Mental or Behavioral Dysfunction]
   795   C0868928:Cases [Functional Concept]
   795   C1533148:Cases [Quantitative Concept]
   795   C1995017:Bodies [Cell Component]
   762 E C0460148:Body [Anatomical Structure]
   762 E C1268086:Body [Anatomical Structure]
   762 E C1706255:CASE [Medical Device]
   762 E C1706256:Case [Conceptual Entity]

Phrase: "when"

Phrase: "compared with combined control"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0205195:Combined [Qualitative Concept]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0336789:Combine [Manufactured Object]

Phrase: "and"

Phrase: "AD cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "whereas"

Phrase: "there"

Phrase: "is"

Phrase: "no apparent difference in the soluble fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "(Fig.6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.240: Parkin resides only in the detergent-insoluble fraction in the aged human brain, but we fail to observe any difference in parkin levels in PD/DLB cases compared with control or AD cases (Fig.6A). 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "resides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2982691:Reside [Activity]

Phrase: "only in the detergent-insoluble fraction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0011740:Detergent [Chemical Viewed Functionally]
   753   C0205171:Only [Quantitative Concept]
   753   C1264633:Fraction [Quantitative Concept]
   753   C1554103:Fraction [Idea or Concept]
   753   C1720467:Only [Intellectual Product]

Phrase: "in the aged human brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "but"

Phrase: "we"

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "observe"

Phrase: "any difference in parkin levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "in PD/DLB cases"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   877   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   818   C0085200:Lewy Bodies [Cell Component]
   795   C0011265:dementia [Mental or Behavioral Dysfunction]
   795   C0150312:In [Quantitative Concept]
   795   C0242821:bodies [Human]
   795   C0332285:In [Spatial Concept]
   795   C0497327:Dementia [Mental or Behavioral Dysfunction]
   795   C0868928:Cases [Functional Concept]
   795   C1533148:Cases [Quantitative Concept]
   795   C1995017:Bodies [Cell Component]
   762 E C0460148:Body [Anatomical Structure]
   762 E C1268086:Body [Anatomical Structure]
   762 E C1706255:CASE [Medical Device]
   762 E C1706256:Case [Conceptual Entity]

Phrase: "compared with control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1707455:Compared [Activity]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: "or"

Phrase: "AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "(Fig.6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.241: To determine whether this observation is specifically related to pathologically affected regions of PD/DLB brains, we examined DJ-1 levels in similar protein fractions derived from cerebellum tissue, a region not affected by the pathogenesis of PD/DLB. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "this observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "is"

Phrase: "specifically"

Phrase: "related"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439849:Related [Qualitative Concept]
  1000   C0445223:Related [Finding]
   966 E C0163712:Relate [Organic Chemical]

Phrase: "to pathologically affected regions of PD/DLB brains,"
Meta Candidates (Total=21; Excluded=6; Pruned=0; Remaining=15)
   797   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   756   C0085200:Lewy Bodies [Cell Component]
   755 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   738   C0006104:Brains [Body Part, Organ, or Organ Component]
   738   C0011265:dementia [Mental or Behavioral Dysfunction]
   738   C0242821:bodies [Human]
   738   C0392760:Affected [Functional Concept]
   738   C0497327:Dementia [Mental or Behavioral Dysfunction]
   738   C1314939:Affected [Functional Concept]
   738   C1883351:To [Qualitative Concept]
   738   C1995017:Bodies [Cell Component]
   737   C0005898:Body Regions [Body Location or Region]
   737   C1273723:brain regions [Body Location or Region]
   721 E C0229962:Body region [Body Part, Organ, or Organ Component]
   721 E C1280064:Body region [Body Location or Region]
   704   C0017446:Region [Geographic Area]
   704   C0205147:Region [Spatial Concept]
   704 E C0460148:Body [Anatomical Structure]
   704 E C1268086:Body [Anatomical Structure]
   704 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "DJ-1 levels in similar protein fractions"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   757   C0428479:Protein level [Laboratory or Test Result]
   757   C0456947:Level 1 [Intellectual Product]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "derived from cerebellum tissue,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
   770   C0040300:Tissue [Tissue]
   770   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
   770   C1441547:Derived [Qualitative Concept]
   770   C1547928:Tissue [Intellectual Product]
   770   C1707522:Cerebellum [Tissue]
   770   C3245521:derived [Idea or Concept]

Phrase: "a region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by the pathogenesis of PD/DLB."
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   806   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   761 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   760   C0085200:Lewy Bodies [Cell Component]
   739   C0011265:dementia [Mental or Behavioral Dysfunction]
   739   C0242821:bodies [Human]
   739   C0392760:Affected [Functional Concept]
   739   C0497327:Dementia [Mental or Behavioral Dysfunction]
   739   C0543483:pathogenesis [Functional Concept]
   739   C0699748:Pathogenesis [Pathologic Function]
   739   C1314939:Affected [Functional Concept]
   739   C1995017:Bodies [Cell Component]
   706 E C0001721:Affect [Mental Process]
   706 E C0460148:Body [Anatomical Structure]
   706 E C1268086:Body [Anatomical Structure]
Processing 00000000.tx.242: We observe no apparent differences of DJ-1 levels in the detergent-soluble or insoluble fractions of PD/DLB cases compared with control or AD cases (Fig.6B), suggesting that increased DJ-1 levels observed in PD/DLB cingulate cortex are directly related to the pathogenesis of PD/DLB. 

Phrase: "We"

Phrase: "observe"

Phrase: "no apparent differences of DJ-1 levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]

Phrase: "in the detergent-soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1749467:soluble [Cell Component]
   861   C1948047:Soluble [Qualitative Concept]

Phrase: "or"

Phrase: "insoluble fractions of PD/DLB cases"
Meta Candidates (Total=17; Excluded=6; Pruned=0; Remaining=11)
   818   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   767 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   764   C0085200:Lewy Bodies [Cell Component]
   748   C1264633:Fraction of [Quantitative Concept]
           Fractions
   742   C0011265:dementia [Mental or Behavioral Dysfunction]
   742   C0242821:bodies [Human]
   742   C0497327:Dementia [Mental or Behavioral Dysfunction]
   742   C0868928:Cases [Functional Concept]
   742   C1533148:Cases [Quantitative Concept]
   742   C1995017:Bodies [Cell Component]
   708 E C0460148:Body [Anatomical Structure]
   708 E C1268086:Body [Anatomical Structure]
   708 E C1554103:Fraction [Idea or Concept]
   708 E C1706255:CASE [Medical Device]
   708 E C1706256:Case [Conceptual Entity]

Phrase: "compared with control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1707455:Compared [Activity]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: "or"

Phrase: "AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "(Fig.6B"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that increased DJ-1 levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "observed in PD/DLB cingulate cortex"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   818   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   767 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   764   C0085200:Lewy Bodies [Cell Component]
   764   C0598179:Cingulate Cortex [Body Part, Organ, or Organ Component]
   742   C0007776:Cortex [Body Part, Organ, or Organ Component]
   742   C0011265:dementia [Mental or Behavioral Dysfunction]
   742   C0242821:bodies [Human]
   742   C0497327:Dementia [Mental or Behavioral Dysfunction]
   742   C1176472:Cortex [Body Part, Organ, or Organ Component]
   742   C1441672:Observed [Functional Concept]
   742   C1995017:Bodies [Cell Component]
   742   C2700441:Cortex [Plant]
   708 E C0460148:Body [Anatomical Structure]
   708 E C1268086:Body [Anatomical Structure]

Phrase: "are"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "related to the pathogenesis of PD/DLB."
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   806   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   761 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   760   C0085200:Lewy Bodies [Cell Component]
   739   C0011265:dementia [Mental or Behavioral Dysfunction]
   739   C0242821:bodies [Human]
   739   C0439849:Related [Qualitative Concept]
   739   C0445223:Related [Finding]
   739   C0497327:Dementia [Mental or Behavioral Dysfunction]
   739   C0543483:pathogenesis [Functional Concept]
   739   C0699748:Pathogenesis [Pathologic Function]
   739   C1995017:Bodies [Cell Component]
   706 E C0163712:Relate [Organic Chemical]
   706 E C0460148:Body [Anatomical Structure]
   706 E C1268086:Body [Anatomical Structure]
Processing 00000000.tx.243: View this table: [in this window] [in a new window]  Table1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table1."
Processing 00000000.tx.244: Clinical details of human subject's tissue used for western blotting  View larger version (52K): [in this window] [in a new window]  Figure6. 

Phrase: "Clinical details of human subject's tissue"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1522508:Details [Qualitative Concept]
   719 E C1561567:detail [Functional Concept]

Phrase: "used for western blotting  View larger version"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   778   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   774   C0808391:Version used [Finding]
   762 E C0949466:Western Blot [Laboratory Procedure]
   748   C0333052:Version [Functional Concept]
   748   C0443228:larger [Quantitative Concept]
   748   C0449911:View [Spatial Concept]
   748   C0549177:Larger [Quantitative Concept]
   748   C1273517:used [Finding]
   748   C1704243:Larger [Quantitative Concept]
   748   C1705493:Western [Spatial Concept]
   748   C2607870:Version [Spatial Concept]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]

Phrase: "(52K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure6."
Processing 00000000.tx.245: Alterations in DJ-1 protein levels in sporadic and parkin-linked PD brain. 

Phrase: "Alterations in DJ-1 protein levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1515926:Alteration [Idea or Concept]

Phrase: "in sporadic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205422:Sporadic [Temporal Concept]

Phrase: "and"

Phrase: "parkin-linked PD brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.246: (A) Increased levels of insoluble DJ-1 in PD/dementia with Lewy bodies (DLB) brains. 

Phrase: "(A) Increased levels of insoluble DJ-1"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0456947:Level 1 [Intellectual Product]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "in PD/dementia with Lewy bodies"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   901   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   827   C0085200:Lewy Bodies [Cell Component]
   799   C0011265:dementia [Mental or Behavioral Dysfunction]
   799   C0150312:In [Quantitative Concept]
   799   C0242821:bodies [Human]
   799   C0332285:In [Spatial Concept]
   799   C0497327:Dementia [Mental or Behavioral Dysfunction]
   799   C1995017:Bodies [Cell Component]
   766 E C0460148:Body [Anatomical Structure]
   766 E C1268086:Body [Anatomical Structure]

Phrase: "(DLB"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   865 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: ")"

Phrase: "brains."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.247: Equivalent detergent-soluble and -insoluble fractions extracted from cingulate cortex tissue of control (Con), AD and PD/DLB brains were analyzed by WB with anti-DJ-1 (N), anti-parkin, anti-SOD1 or anti--tubulin antibodies, as indicated. 

Phrase: "Equivalent detergent-soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1749467:soluble [Cell Component]
   827   C1948047:Soluble [Qualitative Concept]

Phrase: "and -"

Phrase: "insoluble fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "extracted from cingulate cortex tissue of control (Con),"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   778   C0598179:Cingulate Cortex [Body Part, Organ, or Organ Component]
   748   C0007776:Cortex [Body Part, Organ, or Organ Component]
   748   C0040300:Tissue [Tissue]
   748   C0185115:Extracted [Therapeutic or Preventive Procedure]
   748   C0243148:control [Qualitative Concept]
   748   C1176472:Cortex [Body Part, Organ, or Organ Component]
   748   C1547928:Tissue [Intellectual Product]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C2700441:Cortex [Plant]
   748   C3274648:Control [Qualitative Concept]
   748   C3541890:EXTRACTED [Finding]
   714 E C2828366:Extract [Substance]

Phrase: "AD"

Phrase: "and"

Phrase: "PD/DLB brains"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   804 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   753   C0011265:dementia [Mental or Behavioral Dysfunction]
   753   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "were"

Phrase: "analyzed by WB"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with anti-DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]

Phrase: "(N), anti-parkin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1418270:PARKIN [Gene or Genome]
   827   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "anti-SOD1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1151619:SOD-1 [Molecular Function]
   861   C1420306:SOD1 [Gene or Genome]

Phrase: "or"

Phrase: "anti--tubulin antibodies,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.248: DJ-1 protein levels were quantified and normalized in the detergent-soluble and -insoluble fraction of control (control+AD; n=4) and PD/DLB (n=5) brains. 

Phrase: "DJ-1 protein levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0428479:Protein level [Laboratory or Test Result]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "quantified"

Phrase: "and"

Phrase: "normalized in the detergent-soluble"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0011740:Detergent [Chemical Viewed Functionally]
   760   C1749467:soluble [Cell Component]
   760   C1882115:Normalized [Research Activity]
   760   C1948047:Soluble [Qualitative Concept]

Phrase: "and -"

Phrase: "insoluble fraction of control"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1264633:Fraction of [Quantitative Concept]
           Fraction
   770   C1554103:Fraction [Idea or Concept]

Phrase: "(control+AD"

Phrase: "; n=4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "PD/DLB"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   926   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   827 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   760   C0011265:dementia [Mental or Behavioral Dysfunction]
   760   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "(n=5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "brains."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.249: Data are expressed as a percentage (%) of control levels as the ratio of DJ-1 to SOD1 (soluble fraction) or -tubulin (insoluble fraction), and bars represent the meanSE. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as a percentage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439165:Percentage [Quantitative Concept]
   770   C1549488:Percentage [Idea or Concept]
   770   C1561533:Percentage [Idea or Concept]

Phrase: "(%"

Phrase: ")"

Phrase: "of control levels"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   861   C0243148:control [Qualitative Concept]
   861   C0441889:Levels [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "as the ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456603:Ratio [Quantitative Concept]
  1000   C1547037:Ratio [Intellectual Product]

Phrase: "of DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "to SOD1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1151619:SOD-1 [Molecular Function]
  1000   C1420306:SOD1 [Gene or Genome]

Phrase: "(soluble fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: "or -tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2937342:tubulin [Cell Component]

Phrase: "(insoluble fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the meanSE."
Processing 00000000.tx.250: (B) Similar experiments were performed on detergent-soluble and -insoluble fractions extracted from cerebellum tissue of control, AD and PD/DLB brains. 

Phrase: "(B) Similar experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed on detergent-soluble"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0011740:Detergent [Chemical Viewed Functionally]
   770   C0884358:Performed [Functional Concept]
   770   C1749467:soluble [Cell Component]
   770   C1948047:Soluble [Qualitative Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and -"

Phrase: "insoluble fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "extracted from cerebellum tissue of control,"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   820   C1268981:Tissue of cerebellum [Body Part, Organ, or Organ Component]
           Cerebellum
   753   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
   753   C0040300:Tissue [Tissue]
   753   C0185115:Extracted [Therapeutic or Preventive Procedure]
   753   C0243148:control [Qualitative Concept]
   753   C1547928:Tissue [Intellectual Product]
   753   C1550141:Control [Substance]
   753   C1707522:Cerebellum [Tissue]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   753   C3541890:EXTRACTED [Finding]
   719 E C2828366:Extract [Substance]

Phrase: "AD"

Phrase: "and"

Phrase: "PD/DLB brains."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   804 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   753   C0011265:dementia [Mental or Behavioral Dysfunction]
   753   C0497327:Dementia [Mental or Behavioral Dysfunction]
Processing 00000000.tx.251: (C) Reduced levels of insoluble DJ-1 in parkin-linked AR-JP brains. 

Phrase: "(C) Reduced levels of insoluble DJ-1"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0456947:Level 1 [Intellectual Product]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "in parkin-linked AR-JP brains."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   793   C0006104:Brains [Body Part, Organ, or Organ Component]
   760 E C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.252: Detergent-soluble and -insoluble fractions extracted from frontal cortex tissue of control and parkin-deficient AR-JP brains were analyzed by WB with anti-DJ-1 (N), anti-actin or anti-parkin antibodies, as indicated. 

Phrase: "Detergent-soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1749467:soluble [Cell Component]
   861   C1948047:Soluble [Qualitative Concept]

Phrase: "and -"

Phrase: "insoluble fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "extracted from frontal cortex tissue of control"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   778   C0016733:Frontal cortex [Body Part, Organ, or Organ Component]
   748   C0007776:Cortex [Body Part, Organ, or Organ Component]
   748   C0040300:Tissue [Tissue]
   748   C0185115:Extracted [Therapeutic or Preventive Procedure]
   748   C0205123:Frontal [Spatial Concept]
   748   C0243148:control [Qualitative Concept]
   748   C1176472:Cortex [Body Part, Organ, or Organ Component]
   748   C1547928:Tissue [Intellectual Product]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C2700441:Cortex [Plant]
   748   C3274648:Control [Qualitative Concept]
   748   C3541890:EXTRACTED [Finding]
   714 E C2828366:Extract [Substance]

Phrase: "and"

Phrase: "parkin-deficient AR-JP brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   793   C0006104:Brains [Body Part, Organ, or Organ Component]
   760 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "analyzed by WB"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with anti-DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]

Phrase: "(N), anti-actin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   913   C1317971:N-Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   755 E C0439681:Actinic [Qualitative Concept]

Phrase: "or"

Phrase: "anti-parkin antibodies,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.253: DJ-1 protein levels were quantified and normalized in the detergent-soluble and -insoluble fraction of control and AR-JP brains. 

Phrase: "DJ-1 protein levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0428479:Protein level [Laboratory or Test Result]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "quantified"

Phrase: "and"

Phrase: "normalized in the detergent-soluble"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0011740:Detergent [Chemical Viewed Functionally]
   760   C1749467:soluble [Cell Component]
   760   C1882115:Normalized [Research Activity]
   760   C1948047:Soluble [Qualitative Concept]

Phrase: "and -"

Phrase: "insoluble fraction of control"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1264633:Fraction of [Quantitative Concept]
           Fraction
   770   C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "AR-JP brains."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0006104:Brains [Body Part, Organ, or Organ Component]
   766 E C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.254: Data from individual cases are expressed in arbitrary units as the ratio of DJ-1 to actin. 

Phrase: "Data from individual cases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed in arbitrary units"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   799   C0439183:Arbitrary unit [Quantitative Concept]
   770   C0439148:Units [Quantitative Concept]
   770   C1264693:*Arbitrary [Quantitative Concept]
   770   C1519795:Units [Quantitative Concept]
   737 E C1704753:Unit [Manufactured Object]
   737 E C1880519:Unit [Quantitative Concept]

Phrase: "as the ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456603:Ratio [Quantitative Concept]
  1000   C1547037:Ratio [Intellectual Product]

Phrase: "of DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "to actin."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]
Processing 00000000.tx.255: All experiments were replicated with similar results.  

Phrase: "All experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "replicated with similar results."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0205173:replicated [Functional Concept]
   770   C2348205:Similar [Qualitative Concept]
   737 E C0205341:Replicate [Functional Concept]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737 E C1883725:Replicate [Qualitative Concept]
   737   C2825142:Result [Finding]
Processing 00000000.tx.256: To determine whether the absence of parkin influences the levels of DJ-1 protein in vivo, we examined brain tissue from the frontal cortex of patients with parkin-linked AR-JP (due to parkin exonic deletions) and aged-matched normal controls (Fig.6C). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the absence of parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "influences"

Phrase: "the levels of DJ-1 protein"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   767   C0428479:Protein level [Laboratory or Test Result]
   767   C0456947:Level 1 [Intellectual Product]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "brain tissue from the frontal cortex of patients"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0440746:Brain tissue [Tissue]
   770   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   744   C0006104:Brain [Body Part, Organ, or Organ Component]
   744   C0040300:Tissue [Tissue]
   744   C1269537:Brain [Body Part, Organ, or Organ Component]
   744   C1547928:Tissue [Intellectual Product]

Phrase: "with parkin-linked AR-JP ("
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   878   C0332162:With onset [Qualitative Concept]
           Onset
   812   C0441748:Autosomal recessive [Intellectual Product]
   812   C3149653:Juvenile onset [Finding]
   793   C0332287:With [Qualitative Concept]
   793   C0596142:autosomal [Cell Component]
   793   C1418270:PARKIN [Gene or Genome]
   793   C1705690:With [Intellectual Product]
   793   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   793   C3146221:Juvenile [Age Group]
   760   C1517892:Link [Intellectual Product]
   760   C1704666:Link [Intellectual Product]

Phrase: "due to parkin exonic deletions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1880274:Deletions [Activity]
   793 E C1442161:Deletion [Cell or Molecular Dysfunction]
   793 E C1511760:Deletion [Genetic Function]

Phrase: ")"

Phrase: "and"

Phrase: "aged-matched normal controls"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   827   C2705716:normal control [Qualitative Concept]
   812   C0205307:Normal [Qualitative Concept]
   812   C0439166:% normal [Quantitative Concept]
   812   C2347086:% Normal [Quantitative Concept]
   779   C0243148:control [Qualitative Concept]
   779   C1550141:Control [Substance]
   779   C1882979:Control [Conceptual Entity]
   779   C2587213:Control [Functional Concept]
   779   C3274648:Control [Qualitative Concept]

Phrase: "(Fig.6C"

Phrase: ")."
Processing 00000000.tx.257: We find that the absence of parkin in the frontal cortex of AR-JP brains leads to a marked reduction of DJ-1 in the detergent-insoluble fraction in three out of four AR-JP cases (cases 1, 3 and 4) when compared with control cases (Fig.6C), as revealed by densitometry. 

Phrase: "We"

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "that"

Phrase: "the absence of parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "in the frontal cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0016733:Frontal cortex [Body Part, Organ, or Organ Component]
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C0205123:Frontal [Spatial Concept]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "of AR-JP brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0006104:Brains [Body Part, Organ, or Organ Component]
   766 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "leads to a marked reduction of DJ-1"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   770   C1424222:DJ-1 [Gene or Genome]
   770   C3541418:DJ-1 [Gene or Genome]
   744   C0012836:DJ [Geographic Area]
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0181586:leads [Medical Device]
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]
   744   C0522501:Marked [Qualitative Concept]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1522538:Lead [Functional Concept]
   744   C1706089:Marked [Qualitative Concept]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in the detergent-insoluble fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]

Phrase: "in three"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "out of four AR-JP cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   795   C0868928:Cases [Functional Concept]
   795   C1533148:Cases [Quantitative Concept]
   762 E C1706255:CASE [Medical Device]
   762 E C1706256:Case [Conceptual Entity]

Phrase: "(cases 1,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "4"

Phrase: ")"

Phrase: "when"

Phrase: "compared with control cases"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   802   C0872128:case control [Health Care Activity]
   770   C0243148:control [Qualitative Concept]
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "(Fig.6C"

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "revealed by densitometry."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011321:Densitometry [Laboratory Procedure]
   790   C0443289:Revealed [Qualitative Concept]
Processing 00000000.tx.258: We observe no consistent change of DJ-1 levels in the detergent-soluble fraction of control and AR-JP cases, although two out of four AR-JP cases (cases 3 and 4) display noticeably reduced levels of DJ-1 when compared with all control cases (Fig.6C). 

Phrase: "We"

Phrase: "observe"

Phrase: "no consistent change of DJ-1 levels"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0442739:No change [Finding]
   774   C1548568:No change [Intellectual Product]
   748   C0392747:Change [Functional Concept]
   748   C0443172:change [Quantitative Concept]
   748   C1705241:Change [Quantitative Concept]

Phrase: "in the detergent-soluble fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]

Phrase: "of control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "AR-JP cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   799   C0868928:Cases [Functional Concept]
   799   C1533148:Cases [Quantitative Concept]
   766 E C1706255:CASE [Medical Device]
   766 E C1706256:Case [Conceptual Entity]

Phrase: "although"

Phrase: "two out of four AR-JP cases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0205448:Two [Quantitative Concept]

Phrase: "(cases 3"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "4"

Phrase: ")"

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "noticeably reduced levels of DJ-1"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C0456947:Level 1 [Intellectual Product]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "when"

Phrase: "compared with all control cases"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   781   C0872128:case control [Health Care Activity]
   760   C0243148:control [Qualitative Concept]
   760   C0868928:Cases [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   760   C1550141:Control [Substance]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]

Phrase: "(Fig.6C"

Phrase: ")."
Processing 00000000.tx.259: As expected, parkin is detected in the detergent-insoluble fraction of control brains, but is absent from AR-JP brains, as previously described (19,59). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "detected in the detergent-insoluble fraction of control brains,"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   764   C1264633:Fraction of [Quantitative Concept]
           Fraction
   762   C0596948:brains control [Mental Process]
   742   C0006104:Brains [Body Part, Organ, or Organ Component]
   742   C0011740:Detergent [Chemical Viewed Functionally]
   742   C0243148:control [Qualitative Concept]
   742   C0442726:Detected [Finding]
   742   C1511790:Detected [Therapeutic or Preventive Procedure]
   742   C1550141:Control [Substance]
   742   C1554103:Fraction [Idea or Concept]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C3274648:Control [Qualitative Concept]
   708 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "but"

Phrase: "is"

Phrase: "absent from AR-JP brains,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332197:Absent [Quantitative Concept]
   744   C2699517:ABSENT [Finding]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(19,"

Phrase: "59"

Phrase: ")."
Processing 00000000.tx.260: Consistent with the stabilizing effect of parkin on DJ-1 in cultured cells, these data might suggest that parkin is able to influence the stability of DJ-1 in vivo; 

Phrase: "Consistent with the stabilizing effect of parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "on DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "in cultured cells,"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0007600:cultured cells [Cell]
  1000   C0007635:Cultured Cells [Cell]
  1000   C3282338:Cells, Cultured [Cell]
   966 E C0007585:culture cell [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "might"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "influence"

Phrase: "the stability of DJ-1 in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205360:Stability [Qualitative Concept]
   748   C2347098:Stability [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.261: in particular, the absence of parkin leads to a reduction of DJ-1 primarily in the detergent-insoluble fraction.  

Phrase: "in particular,"

Phrase: "the absence of parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "leads to a reduction of DJ-1 primarily"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C1424222:DJ-1 [Gene or Genome]
   770   C3541418:DJ-1 [Gene or Genome]
   744   C0012836:DJ [Geographic Area]
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0181586:leads [Medical Device]
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1522538:Lead [Functional Concept]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in the detergent-insoluble fraction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.262: DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  The major findings of this study are that parkin selectively but differentially interacts with pathogenic mutant forms of DJ-1. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The major findings of this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   783   C0683954:study findings [Finding]
   753   C2607943:findings [Functional Concept]
   753   C2926606:Findings [Clinical Attribute]
   753   C3539655:Findings [Intellectual Product]
   719 E C0037088:Finding [Sign or Symptom]
   719 E C0243095:Finding [Finding]
   719 E C2825141:Finding [Finding]

Phrase: "are"

Phrase: "that parkin selectively"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "but"

Phrase: "differentially"

Phrase: "interacts with pathogenic mutant forms of DJ-1."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C1424222:DJ-1 [Gene or Genome]
   770   C3541418:DJ-1 [Gene or Genome]
   744   C0012836:DJ [Geographic Area]
   744   C0348078:forms [Qualitative Concept]
   744   C0376315:Forms [Manufactured Object]
   744   C0450254:Pathogenic [Organism]
   744   C0596988:Mutant [Cell or Molecular Dysfunction]
   711 E C1522492:Form [Functional Concept]
Processing 00000000.tx.263: Pathogenic DJ-1 mutants exhibit impairments in homo-dimer formation. 

Phrase: "Pathogenic DJ-1 mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "impairments in homo-dimer formation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0684336:Impairments [Pathologic Function]
   760   C2598156:Impairments [Clinical Attribute]
Processing 00000000.tx.264: Parkin fails to ubiquitinate and enhance the degradation of L166P and M26I mutant DJ-1, but instead promotes their stability. 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "fails"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ubiquitinate"

Phrase: "and"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the degradation of L166P"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "M26I mutant DJ-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1424222:DJ-1 [Gene or Genome]
   861   C3541418:DJ-1 [Gene or Genome]
   812   C0012836:DJ [Geographic Area]
   812   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "but"

Phrase: "instead"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "their stability."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0205360:Stability [Qualitative Concept]
  1000   C2347098:Stability [Qualitative Concept]
   928 E C1547311:Stable [Intellectual Product]
Processing 00000000.tx.265: Furthermore, L166P DJ-1 may be capable of forming a protein complex with parkin, CHIP and Hsp70. 

Phrase: "Furthermore,"

Phrase: "L166P DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]

Phrase: "may"

Phrase: "be"

Phrase: "capable of forming"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C2698977:Capability [Qualitative Concept]

Phrase: "a protein complex with parkin,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0038164:a protein [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   806   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1523872:protein complex [Cell Component]
   797   C0673396:parkin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0439855:Complex [Qualitative Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "CHIP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600596:Chip [Research Device]

Phrase: "and"

Phrase: "Hsp70."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243043:HSP 70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415760:HSP70 [Gene or Genome]
  1000   C1527149:HSP70 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.266: Oxidative stress promotes an interaction between parkin and WT DJ-1, although this does not lead to the ubiquitination or degradation of DJ-1. 

Phrase: "Oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "an interaction between parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "WT DJ-1,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   875   C0441729:Type 1 [Classification]
   861   C1424222:DJ-1 [Gene or Genome]
   861   C1883559:Wild Type [Organism Attribute]
   861   C3541418:DJ-1 [Gene or Genome]
   812   C0012836:DJ [Geographic Area]
   812   C0332307:Type [Qualitative Concept]
   812   C0445392:Wild [Intellectual Product]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "although"

Phrase: "this"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "lead to the ubiquitination"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1519751:Ubiquitination [Molecular Function]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "degradation of DJ-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]
Processing 00000000.tx.267: Parkin-mediated alterations in DJ-1 stability may be pathogenically relevant as DJ-1 levels are dramatically increased in the detergent-insoluble fraction from sporadic PD/DLB brains, but are reduced in the insoluble fraction from parkin-linked AR-JP brains. 

Phrase: "Parkin-mediated alterations in DJ-1 stability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1515926:Alteration [Idea or Concept]

Phrase: "may"

Phrase: "be"

Phrase: "pathogenically relevant as DJ-1 levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2347946:Relevant [Qualitative Concept]

Phrase: "are"

Phrase: "dramatically"

Phrase: "increased in the detergent-insoluble fraction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0011740:Detergent [Chemical Viewed Functionally]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C1264633:Fraction [Quantitative Concept]
   753   C1554103:Fraction [Idea or Concept]

Phrase: "from sporadic PD/DLB brains,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   861   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   812   C0085200:Lewy Bodies [Cell Component]
   793   C0006104:Brains [Body Part, Organ, or Organ Component]
   793   C0011265:dementia [Mental or Behavioral Dysfunction]
   793   C0205422:Sporadic [Temporal Concept]
   793   C0242821:bodies [Human]
   793   C0497327:Dementia [Mental or Behavioral Dysfunction]
   793   C1517320:From [Qualitative Concept]
   793   C1995017:Bodies [Cell Component]
   760 E C0460148:Body [Anatomical Structure]
   760 E C1268086:Body [Anatomical Structure]
   760 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "but"

Phrase: "are"

Phrase: "reduced in the insoluble fraction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0392756:Reduced [Qualitative Concept]
   760   C1264633:Fraction [Quantitative Concept]
   760   C1554103:Fraction [Idea or Concept]

Phrase: "from parkin-linked AR-JP brains."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   793   C0006104:Brains [Body Part, Organ, or Organ Component]
   760 E C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.268: This study links together, at multiple levels, two gene products associated with familial forms of PD that may have important implications for understanding the molecular pathogenesis of this disease. 

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "links"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "at multiple levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "two gene products"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   867   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   867   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0017337:Gene [Gene or Genome]
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]

Phrase: "associated with familial forms of PD"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   773   C1832428:Familial form [Finding]
   753   C0015576:familial [Family Group]
   753   C0241888:Familial [Functional Concept]
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1522492:Form [Functional Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "that"

Phrase: "may"

Phrase: "have"

Phrase: "important implications for understanding"

Phrase: "the molecular pathogenesis of this disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0543483:pathogenesis [Functional Concept]
   753   C0699748:Pathogenesis [Pathologic Function]
Processing 00000000.tx.269: The selective association of parkin with pathogenic mutant forms of DJ-1 suggests that these mutants might share common properties. 

Phrase: "The selective association of parkin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "with pathogenic mutant forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0348078:forms [Qualitative Concept]
   827   C0376315:Forms [Manufactured Object]
   793 E C1522492:Form [Functional Concept]

Phrase: "of DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "these mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "might"

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "common properties."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]
Processing 00000000.tx.270: However, the L166P mutant clearly differs from other DJ-1 mutants in that it interacts with parkin most robustly. 

Phrase: "However,"

Phrase: "the L166P mutant clearly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "differs from other DJ-1 mutants"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1424222:DJ-1 [Gene or Genome]
   790   C3541418:DJ-1 [Gene or Genome]
   753   C0012836:DJ [Geographic Area]
   753   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "in"

Phrase: "that"

Phrase: "it"

Phrase: "interacts with parkin most robustly."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1418270:PARKIN [Gene or Genome]
   760   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.271: L166P DJ-1 is a highly unstable, unfolded protein that fails to dimerize and is rapidly degraded by the 20/26S proteasome (3335). 

Phrase: "L166P DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]

Phrase: "is"

Phrase: "a highly unstable, unfolded protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "fails"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "dimerize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376525:Dimerize [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "is"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "degraded by the 20/26S proteasome"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0286330:26S proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1166804:26S proteasome [Cell Component]
   753   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1325620:proteasome [Cell Component]
   753   C1552140:26s [Body Part, Organ, or Organ Component]
   753   C1752727:Proteasome [Molecular Function]
   753   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "(3335"

Phrase: ")."
Processing 00000000.tx.272: Unfolding of the L166P mutant might conceivably promote its association with a variety of proteins or protein complexes, including components of the UPS or chaperone systems. 

Phrase: "Unfolding of the L166P mutant"

Phrase: "might"

Phrase: "conceivably"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "its association with a variety of proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "or"

Phrase: "protein complexes,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   966   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966   C1523872:protein complex [Cell Component]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1704241:Complexes [Chemical Viewed Structurally]
   827 E C0439855:Complex [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "components of the UPS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0449432:Components [Manufactured Object]
   719 E C1705248:Component [Conceptual Entity]

Phrase: "or"

Phrase: "chaperone systems."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   777 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.273: Furthermore, L166P DJ-1 may be incorporated into higher-order protein complexes in cultured cells (35). 

Phrase: "Furthermore,"

Phrase: "L166P DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]

Phrase: "may"

Phrase: "be"

Phrase: "incorporated into higher-order protein complexes"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   767   C1180347:complex protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756 E C1523872:protein complex [Cell Component]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1704241:Complexes [Chemical Viewed Structurally]
   753   C1705175:Order [Intellectual Product]
   753   C1705176:Order [Qualitative Concept]
   753   C1705177:Order [Classification]
   753   C1705178:Order [Activity]
   753   C1882348:Order [Qualitative Concept]
   719   C0205250:High [Qualitative Concept]
   719 E C0439855:Complex [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "in cultured cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0007600:cultured cells [Cell]
  1000   C0007635:Cultured Cells [Cell]
  1000   C3282338:Cells, Cultured [Cell]
   966 E C0007585:culture cell [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.274: Parkin or a parkin-associated complex does not appear to be involved in the ubiquitination or degradation of L166P DJ-1. 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "a parkin-associated complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "involved in the ubiquitination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1314939:Involved [Functional Concept]
   770   C1519751:Ubiquitination [Molecular Function]

Phrase: "or"

Phrase: "degradation of L166P DJ-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]
Processing 00000000.tx.275: Instead, parkin can stabilize L166P or M26I mutant DJ-1, particularly detergent-insoluble forms, through a mechanism that does not involve ubiquitination, thus arguing in favour of a protective or stabilizing role for parkin. 

Phrase: "Instead,"

Phrase: "parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "can"

Phrase: "stabilize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184512:stabilize [Qualitative Concept]

Phrase: "L166P"

Phrase: "or"

Phrase: "M26I mutant DJ-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1424222:DJ-1 [Gene or Genome]
   861   C3541418:DJ-1 [Gene or Genome]
   812   C0012836:DJ [Geographic Area]
   812   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "particularly detergent-insoluble forms,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0348078:forms [Qualitative Concept]
   812   C0376315:Forms [Manufactured Object]
   779 E C1522492:Form [Functional Concept]

Phrase: "through a mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "that"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "involve"

Phrase: "ubiquitination,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519751:Ubiquitination [Molecular Function]

Phrase: "thus"

Phrase: "arguing in favour of a protective"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "or"

Phrase: "stabilizing role for parkin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.276: The mechanism of parkin's unexpected stabilizing effect is unclear, but might result from delaying or reducing the normal turnover of exogenous DJ-1. 

Phrase: "The mechanism of parkin's unexpected stabilizing effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "unclear,"

Phrase: "but"

Phrase: "might"

Phrase: "result from delaying"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C2825142:Result [Finding]
   756   C0205421:Delay [Temporal Concept]

Phrase: "or"

Phrase: "reducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reducing [Qualitative Concept]

Phrase: "the normal turnover of exogenous DJ-1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0031227:turnover [Quantitative Concept]
   748   C0243127:turnover [Functional Concept]
   748   C0443331:Turnover [Health Care Activity]
Processing 00000000.tx.277: Although it is possible that parkin or Hsp70 might stabilize DJ-1 by sequestration or redistribution into distinct inclusion bodies or cellular organelles, this is perhaps doubtful given that this stabilizing effect is observed in both detergent-soluble and insoluble fractions. 

Phrase: "Although"

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "Hsp70"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243043:HSP 70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415760:HSP70 [Gene or Genome]
  1000   C1527149:HSP70 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "might"

Phrase: "stabilize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184512:stabilize [Qualitative Concept]

Phrase: "DJ-1 by sequestration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1424222:DJ-1 [Gene or Genome]
   833   C3541418:DJ-1 [Gene or Genome]
   770   C0012836:DJ [Geographic Area]
   770   C0443301:Sequestration [Functional Concept]

Phrase: "or"

Phrase: "redistribution into distinct inclusion bodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332620:Redistribution [Functional Concept]

Phrase: "or"

Phrase: "cellular organelles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029219:Organelles [Cell Component]

Phrase: "this"

Phrase: "is"

Phrase: "perhaps doubtful"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0750558:Doubtful [Conceptual Entity]
   789 E C0870444:doubt [Mental Process]

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "that"

Phrase: "this stabilizing effect"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0184512:stabilizing [Qualitative Concept]
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "observed in both detergent-soluble"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0011740:Detergent [Chemical Viewed Functionally]
   760   C1441672:Observed [Functional Concept]
   760   C1749467:soluble [Cell Component]
   760   C1948047:Soluble [Qualitative Concept]

Phrase: "and"

Phrase: "insoluble fractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.278: Such soluble and insoluble fractions are unlikely to simultaneously contain either inclusion bodies or organelles due to their intrinsic solubility in detergent. 

Phrase: "Such soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1749467:soluble [Cell Component]
  1000   C1948047:Soluble [Qualitative Concept]

Phrase: "and"

Phrase: "insoluble fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "are"

Phrase: "unlikely to simultaneously"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0521115:simultaneously [Temporal Concept]
   827   C0750558:Unlikely [Conceptual Entity]
   827   C1710571:Unlikely [Qualitative Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "either inclusion bodies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0007637:Inclusion Bodies [Cell Component]
   827   C0242821:bodies [Human]
   827   C1512693:Inclusion [Qualitative Concept]
   827   C1995017:Bodies [Cell Component]
   793 E C0460148:Body [Anatomical Structure]
   793 E C1268086:Body [Anatomical Structure]

Phrase: "or"

Phrase: "organelles due to their intrinsic solubility"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0029219:Organelles [Cell Component]

Phrase: "in detergent."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011740:Detergent [Chemical Viewed Functionally]
Processing 00000000.tx.279: Thus, parkin's stabilizing effect is likely related to a more generalized effect, such that parkin binding might reduce the availability of DJ-1 for degradation. 

Phrase: "Thus,"

Phrase: "parkin's stabilizing effect"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0184512:stabilizing [Qualitative Concept]
   827   C1280500:Effect [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "related to a more generalized effect,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0205246:Generalized [Spatial Concept]
   753   C0439849:Related [Qualitative Concept]
   753   C0445223:Related [Finding]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
   719 E C0163712:Relate [Organic Chemical]

Phrase: "such"

Phrase: "that parkin binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "might"

Phrase: "reduce"

Phrase: "the availability of DJ-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0470187:Availability of [Functional Concept]
           Availability

Phrase: "for degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]
Processing 00000000.tx.280: It will be of interest to determine whether parkin's stabilizing effect extends to DJ-1 harboring other pathogenic mutations, such as A104T and D149A, or the recently identified homozygous E64D mutation (60). 

Phrase: "It"

Phrase: "will"

Phrase: "be of interest to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0543488:Interest [Mental Process]
   770   C2987476:Be [Conceptual Entity]

Phrase: "determine"

Phrase: "whether"

Phrase: "parkin's stabilizing effect"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0184512:stabilizing [Qualitative Concept]
   827   C1280500:Effect [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]

Phrase: "extends to DJ-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1424222:DJ-1 [Gene or Genome]
   833   C3541418:DJ-1 [Gene or Genome]
   770   C0012836:DJ [Geographic Area]
   770   C0231448:Extend [Functional Concept]
   770   C0439792:extend [Spatial Concept]

Phrase: "harboring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475311:Harbor [Manufactured Object]

Phrase: "other pathogenic mutations,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "such as A104T"

Phrase: "and"

Phrase: "D149A,"

Phrase: "or"

Phrase: "the recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "homozygous E64D mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026882:Mutation [Genetic Function]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(60"

Phrase: ")."
Processing 00000000.tx.281: As L166P DJ-1 exists entirely in a non-dimeric form, a large proportion of which is monomeric (37), this might suggest that parkin selectively associates with DJ-1 monomers. 

Phrase: "As L166P DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]

Phrase: "exists"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]

Phrase: "entirely in a non-dimeric form,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1518422:Non [Functional Concept]
   753   C1522492:Form [Functional Concept]

Phrase: "a large proportion of which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709707:Proportion [Quantitative Concept]

Phrase: "is"

Phrase: "monomeric"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "(37"

Phrase: ")"

Phrase: ","

Phrase: "this"

Phrase: "might"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that parkin selectively"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "associates with DJ-1 monomers."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1424222:DJ-1 [Gene or Genome]
   806   C3541418:DJ-1 [Gene or Genome]
   760   C0012836:DJ [Geographic Area]
   760   C0596973:monomers [Chemical Viewed Structurally]
   760   C0750490:Associate [Idea or Concept]
   760   C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.282: Other pathogenic DJ-1 mutants demonstrate impairments in homo-dimer formation, yet still retain the capacity to form a significant population of dimers, which may lead to the availability of much smaller levels of monomeric DJ-1. 

Phrase: "Other pathogenic DJ-1 mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "demonstrate"

Phrase: "impairments in homo-dimer formation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0684336:Impairments [Pathologic Function]
   760   C2598156:Impairments [Clinical Attribute]

Phrase: "yet still"

Phrase: "retain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "the capacity to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516240:Capacity [Quantitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a significant population of dimers,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0032659:Population [Quantitative Concept]
   760   C1257890:Population [Population Group]

Phrase: "which"

Phrase: "may"

Phrase: "lead to the availability of much smaller levels of monomeric DJ-1."
Meta Candidates (Total=19; Excluded=4; Pruned=0; Remaining=15)
   753   C0470187:Availability of [Functional Concept]
           Availability
   753   C1424222:DJ-1 [Gene or Genome]
   753   C3541418:DJ-1 [Gene or Genome]
   751   C0428255:lead levels [Laboratory or Test Result]
   736   C0012836:DJ [Geographic Area]
   736   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   736   C0441889:Levels [Qualitative Concept]
   736   C0547044:Smaller [Qualitative Concept]
   736   C0700321:Smaller [Quantitative Concept]
   736   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   736   C1522538:Lead [Functional Concept]
   736   C2348269:Lead [Element, Ion, or Isotope]
   736   C3275067:LEAD [Therapeutic or Preventive Procedure]
   734   C0456947:Level 1 [Intellectual Product]
   734 E C0524167:Lead level [Laboratory Procedure]
   703 E C0456079:Level [Classification]
   703 E C1547707:Level [Geographic Area]
   703 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.283: This may explain the relatively weaker interaction of these DJ-1 mutants with parkin compared with the non-dimeric L166P mutant. 

Phrase: "This"

Phrase: "may"

Phrase: "explain"

Phrase: "the relatively weaker interaction of these DJ-1 mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1704675:Interaction [Functional Concept]

Phrase: "with parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "compared with the non-dimeric L166P mutant."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0596988:Mutant [Cell or Molecular Dysfunction]
   748   C1518422:Non [Functional Concept]
   748   C1707455:Compared [Activity]
Processing 00000000.tx.284: The association of parkin with DJ-1 mutants may not be directly relevant to the pathogenesis of PD as not all cases of DJ-1-linked PD result from missense mutations. 

Phrase: "The association of parkin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "with DJ-1 mutants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0596988:mutants [Cell or Molecular Dysfunction]
   734   C1424222:DJ-1 [Gene or Genome]
   734   C3541418:DJ-1 [Gene or Genome]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "directly relevant to the pathogenesis of PD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2347946:Relevant [Qualitative Concept]

Phrase: "as"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "all cases of DJ-1-linked PD result"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   744   C0868928:Cases [Functional Concept]
   744   C1533148:Cases [Quantitative Concept]
   711 E C1706255:CASE [Medical Device]
   711 E C1706256:Case [Conceptual Entity]

Phrase: "from missense mutations."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0599155:Mutations, Missense [Genetic Function]
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.285: Indeed, exonic deletions appear to be a prominent cause of DJ-1-linked PD, some of which result in a complete loss of DJ-1 protein (61). 

Phrase: "Indeed,"

Phrase: "exonic deletions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1880274:Deletions [Activity]
   827 E C1442161:Deletion [Cell or Molecular Dysfunction]
   827 E C1511760:Deletion [Genetic Function]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a prominent cause of DJ-1-linked PD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0015127:cause [Functional Concept]
   744   C1524003:Cause [Conceptual Entity]

Phrase: "some of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205392:Some [Quantitative Concept]
   790   C3540770:Some [Intellectual Product]

Phrase: "result in a complete loss of DJ-1 protein"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   784   C3538910:Protein DJ-1 [Amino Acid, Peptide, or Protein]
   764   C1424222:DJ-1 [Gene or Genome]
   764   C3541418:DJ-1 [Gene or Genome]
   762   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   742   C0012836:DJ [Geographic Area]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205197:Complete [Qualitative Concept]
   742   C0725685:COMPLEAT [Food]
   742   C1274040:Result [Functional Concept]
   742   C1517945:Loss [Quantitative Concept]
   742   C1546471:Result [Idea or Concept]
   742   C2825142:Result [Finding]

Phrase: "(61"

Phrase: ")."
Processing 00000000.tx.286: Therefore, the interaction of parkin and DJ-1 may instead link both proteins in a common molecular pathway but only under selective conditions, including pathogenic mutations or oxidative stress. 

Phrase: "Therefore,"

Phrase: "the interaction of parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "may"

Phrase: "instead"

Phrase: "link"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "both proteins in a common molecular pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "but"

Phrase: "only under selective conditions,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205171:Only [Quantitative Concept]
   770   C1720467:Only [Intellectual Product]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "pathogenic mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "or"

Phrase: "oxidative stress."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.287: The failure of parkin to ubiquitinate or to enhance the degradation of L166P or M26I mutant DJ-1 is suggestive of an indirect interaction, perhaps as part of a larger protein complex that contains CHIP and Hsp70 together with other proteins. 

Phrase: "The failure of parkin to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0231174:Failure [Functional Concept]
   760   C0680095:failure [Individual Behavior]

Phrase: "ubiquitinate"

Phrase: "or"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the degradation of L166P"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "or"

Phrase: "M26I mutant DJ-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1424222:DJ-1 [Gene or Genome]
   861   C3541418:DJ-1 [Gene or Genome]
   812   C0012836:DJ [Geographic Area]
   812   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "suggestive of an indirect interaction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332299:Suggestive of [Functional Concept]
           suggestive

Phrase: "perhaps"

Phrase: "as"

Phrase: "part of a larger protein complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1292711:Part of [Spatial Concept]
   753   C0449719:Part [Spatial Concept]
   753   C1709471:Part [Quantitative Concept]

Phrase: "that"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "CHIP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600596:Chip [Research Device]

Phrase: "and"

Phrase: "Hsp70 together with other proteins."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243043:HSP 70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1415760:HSP70 [Gene or Genome]
   760   C1527149:HSP70 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.288: The function of such a protein complex is unclear. 

Phrase: "The function of such"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "a protein complex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1523872:protein complex [Cell Component]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "is"

Phrase: "unclear."
Processing 00000000.tx.289: Lack of a direct parkin-mediated effect on L166P DJ-1 highlights the distinct possibility that parkin may serve subsidiary roles other than ubiquitination that might include protein stabilization or refolding. 

Phrase: "Lack of a direct parkin-mediated effect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332268:lack [Qualitative Concept]

Phrase: "on L166P DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]

Phrase: "highlights"

Phrase: "the distinct possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0332149:Possible [Qualitative Concept]
   789   C1705910:Possible [Qualitative Concept]
   789   C2362652:Possible [Qualitative Concept]

Phrase: "that parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "serve"

Phrase: "subsidiary roles other than ubiquitination"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0035820:Roles [Social Behavior]
   726 E C1705810:Role [Conceptual Entity]

Phrase: "that"

Phrase: "might"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "protein stabilization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1327386:protein stabilization [Molecular Function]
   861   C1293130:Stabilisation [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "refolding."
Processing 00000000.tx.290: We find no evidence for poly-ubiquitination of L166P DJ-1 in our study, suggesting that ubiquitination does not play a major role in the proteasomal degradation of L166P DJ-1. 

Phrase: "We"

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "no evidence for poly-ubiquitination of L166P DJ-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in our study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that ubiquitination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519751:Ubiquitination [Molecular Function]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a major role in the proteasomal degradation of L166P DJ-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0035820:Role [Social Behavior]
   738   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.291: Previous studies have similarly failed to demonstrate the formation of HMW L166P DJ-1-ubiquitin conjugates, but have instead observed the accumulation of full-length and truncated L166P DJ-1 following proteasome inhibition (33,34,36,37). 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "similarly"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "the formation of HMW L166P DJ-1-ubiquitin conjugates,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0220781:formation [Biologic Function]
   738   C0439634:formation [Spatial Concept]
   738   C1522492:Formation [Functional Concept]

Phrase: "but"

Phrase: "have"

Phrase: "instead"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "the accumulation of full-length"

Phrase: "and"

Phrase: "truncated L166P DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1424222:DJ-1 [Gene or Genome]
   861   C3541418:DJ-1 [Gene or Genome]
   812   C0012836:DJ [Geographic Area]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "proteasome inhibition"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "(33,"

Phrase: "34,"

Phrase: "36,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.292: The unfolded nature of L166P DJ-1 may therefore be sufficient for degradation in an ubiquitin-independent manner by the 20/26S proteasomal complex, similar to other natively unfolded proteins including -synuclein and tau (62,63). 

Phrase: "The unfolded nature of L166P DJ-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0349590:Nature [Idea or Concept]
   748   C1262865:Nature [Functional Concept]

Phrase: "may"

Phrase: "therefore"

Phrase: "be"

Phrase: "sufficient for degradation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205410:Sufficient [Qualitative Concept]

Phrase: "in an ubiquitin-independent manner"

Phrase: "by the 20/26S proteasomal complex,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "similar to other natively unfolded proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "including -"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "(62,"

Phrase: "63"

Phrase: ")."
Processing 00000000.tx.293: Intriguingly, a small proportion of DJ-1 can be mono-ubiquitinated independent of parkin overexpression, raising the possibility that DJ-1 function may be regulated, in part, by non-degradative mono-ubiquitination. 

Phrase: "Intriguingly,"

Phrase: "a small proportion of DJ-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709707:Proportion [Quantitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "mono-ubiquitinated independent of parkin overexpression,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0041538:Ubiquitinated [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1551432:Mono [Population Group]
   753   C1551969:Mono [Language]

Phrase: "raising"

Phrase: "the possibility"

Phrase: "that DJ-1 function"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]
   734   C1424222:DJ-1 [Gene or Genome]
   734   C3541418:DJ-1 [Gene or Genome]

Phrase: "may"

Phrase: "be"

Phrase: "regulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: ","

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "by non-degradative mono-ubiquitination."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1519751:Ubiquitination [Molecular Function]
   812   C1551432:Mono [Population Group]
   812   C1551969:Mono [Language]
Processing 00000000.tx.294: The oxidative stress-induced interaction of parkin and DJ-1 failed to result in the ubiquitination or enhanced degradation of DJ-1, perhaps suggestive of an indirect interaction and/or that this association may serve an alternative biological function. 

Phrase: "The oxidative stress-induced interaction of parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "result in the ubiquitination"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1274040:Result [Functional Concept]
   770   C1519751:Ubiquitination [Molecular Function]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "or"

Phrase: "enhanced degradation of DJ-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "perhaps suggestive of an indirect interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332299:Suggestive of [Functional Concept]
           suggestive

Phrase: "and/or"

Phrase: "that"

Phrase: "this association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "may"

Phrase: "serve"

Phrase: "an alternative biological function."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0031845:Biological function, NOS [Physiologic Function]
   827   C0005532:Biological [Biomedical Occupation or Discipline]
   827   C0031843:function [Physiologic Function]
   827   C0205460:biological [Qualitative Concept]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.295: Current evidence suggests that DJ-1 may function as an anti-oxidant protein and/or as a sensor of oxidative stress (4448). 

Phrase: "Current evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "may"

Phrase: "function as an anti-oxidant protein"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C0815043:function protein [Amino Acid, Peptide, or Protein]
   783   C1527118:Protein Function [Molecular Function]
   753   C0031843:function [Physiologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0085403:oxidant [Chemical Viewed Functionally]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "and/or as a sensor of oxidative stress"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   770   C1706528:And/Or [Conceptual Entity]
   744   C0038435:Stress [Finding]
   744   C0183210:Sensor [Medical Device]
   744   C0311404:Oxidative [Functional Concept]
   744   C1515981:And [Idea or Concept]
   744   C1705193:Sensor [Manufactured Object]

Phrase: "(4448"

Phrase: ")."
Processing 00000000.tx.296: Furthermore, DJ-1 may be functional under oxidative conditions because its reported chaperone and protease activities are not apparently sensitive to hydrogen peroxide treatment (37,42). 

Phrase: "Furthermore,"

Phrase: "DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "may"

Phrase: "be"

Phrase: "functional under oxidative conditions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205245:Functional [Functional Concept]
   770   C0542341:Functional [Functional Concept]
   770   C2700217:Functional [Conceptual Entity]

Phrase: "because"

Phrase: "its reported chaperone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0243041:Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "protease activities"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   983   C1150095:protease activity [Molecular Function]
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "are"

Phrase: "not apparently sensitive to hydrogen peroxide treatment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0332324:Sensitive to [Functional Concept]
           Sensitive
   748   C1550474:sensitive [Idea or Concept]

Phrase: "(37,"

Phrase: "42"

Phrase: ")."
Processing 00000000.tx.297: As oxidative conditions do not apparently impair DJ-1, the oxidative stress-induced association of parkin and DJ-1 is unlikely the result of damaged DJ-1 protein, in contrast to the effects of pathogenic mutations, but instead may serve an alternative role. 

Phrase: "As oxidative conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "do"

Phrase: "not apparently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0750541:apparently [Idea or Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "impair"

Phrase: "DJ-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "the oxidative stress-induced association of parkin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "is"

Phrase: "unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "the result of damaged DJ-1 protein,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]

Phrase: "in contrast to the effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "of pathogenic mutations,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "but"

Phrase: "instead"

Phrase: "may"

Phrase: "serve"

Phrase: "an alternative role."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035820:Role [Social Behavior]
   861   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.298: One possibility is that parkin and DJ-1 might converge in a common molecular pathway in response to oxidative stress. 

Phrase: "One possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0332149:Possible [Qualitative Concept]
   789   C1705910:Possible [Qualitative Concept]
   789   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "that parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "might"

Phrase: "converge in a common molecular pathway"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1704259:molecular pathway [Molecular Function]
           Pathway
   753   C0205214:Common [Quantitative Concept]
   753   C1521991:Molecular [Qualitative Concept]
   753   C1522138:Common [Functional Concept]
   753   C1705987:Pathway [Conceptual Entity]
   753   C2700387:Converge [Activity]
   753   C3245511:common [Intellectual Product]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to oxidative stress."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.299: At present, however, the significance of the oxidative stress-induced association of parkin and DJ-1 and its relevance to the pathogenesis of PD is not understood but clearly warrants further attention. 

Phrase: "At present,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "however,"

Phrase: "the significance of the oxidative stress-induced association of parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0237881:Significance [Quantitative Concept]
   739   C0750502:Significance [Idea or Concept]

Phrase: "and"

Phrase: "DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "and"

Phrase: "its relevance to the pathogenesis of PD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2347946:Relevance [Qualitative Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "understood"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]

Phrase: "but"

Phrase: "clearly"

Phrase: "warrants"

Phrase: "further attention."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004268:Attention [Mental Process]
Processing 00000000.tx.300: DJ-1 levels are dramatically increased in the insoluble fraction from sporadic PD/DLB brains. 

Phrase: "DJ-1 levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   734   C1424222:DJ-1 [Gene or Genome]
   734   C3541418:DJ-1 [Gene or Genome]

Phrase: "are"

Phrase: "dramatically"

Phrase: "increased in the insoluble fraction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1264633:Fraction [Quantitative Concept]
   760   C1554103:Fraction [Idea or Concept]

Phrase: "from sporadic PD/DLB brains."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   861   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   812   C0085200:Lewy Bodies [Cell Component]
   793   C0006104:Brains [Body Part, Organ, or Organ Component]
   793   C0011265:dementia [Mental or Behavioral Dysfunction]
   793   C0205422:Sporadic [Temporal Concept]
   793   C0242821:bodies [Human]
   793   C0497327:Dementia [Mental or Behavioral Dysfunction]
   793   C1517320:From [Qualitative Concept]
   793   C1995017:Bodies [Cell Component]
   760 E C0460148:Body [Anatomical Structure]
   760 E C1268086:Body [Anatomical Structure]
   760 E C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.301: The significance of this finding is not understood but might relate to increased stability of the DJ-1 protein and/or up-regulation of DJ-1 mRNA as a consequence of disease pathogenesis. 

Phrase: "The significance of this finding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237881:Significance [Quantitative Concept]
   760   C0750502:Significance [Idea or Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "understood"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]

Phrase: "but"

Phrase: "might"

Phrase: "relate to increased stability of the DJ-1 protein"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   784   C3538910:Protein DJ-1 [Amino Acid, Peptide, or Protein]
   764   C1424222:DJ-1 [Gene or Genome]
   764   C3541418:DJ-1 [Gene or Genome]
   762   C2350440:Protein Stability [Qualitative Concept]
   742   C0012836:DJ [Geographic Area]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0163712:Relate [Organic Chemical]
   742   C0205217:Increased [Quantitative Concept]
   742   C0205360:Stability [Qualitative Concept]
   742   C0442805:Increased [Functional Concept]
   742   C2347098:Stability [Qualitative Concept]

Phrase: "and/or"

Phrase: "up-regulation of DJ-1 mRNA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0041904:Up-Regulation [Cell Function,Molecular Function]
   790   C0162493:Up-Regulation [Genetic Function]
   753   C0547043:Up [Spatial Concept]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1282911:Up [Spatial Concept]
   753   C1327622:Regulation [Biologic Function]

Phrase: "as a consequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0686907:Consequence [Functional Concept]

Phrase: "of disease pathogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0543483:pathogenesis [Functional Concept]
   861   C0699748:Pathogenesis [Pathologic Function]
Processing 00000000.tx.302: Oxidative stress is one obvious candidate for enhancing DJ-1 protein levels. 

Phrase: "Oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "is"

Phrase: "one obvious candidate for enhancing DJ-1 protein levels."
Processing 00000000.tx.303: Parkin is primarily detergent-insoluble in the aged human brain (64). 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "primarily detergent-insoluble in the aged human brain"

Phrase: "(64"

Phrase: ")."
Processing 00000000.tx.304: Increased levels of oxidative stress that are commonly observed in the brains of sporadic PD patients (49,50) may promote the association of parkin and DJ-1, subsequently leading to stabilization of DJ-1 exclusively in the insoluble fraction. 

Phrase: "Increased levels of oxidative stress"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C1319127:Level of stress [Finding]
           levels stress
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "that"

Phrase: "are"

Phrase: "commonly"

Phrase: "observed in the brains of sporadic PD patients"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   744   C0006104:Brains [Body Part, Organ, or Organ Component]
   744   C0030705:Patients [Patient or Disabled Group]
   744   C0205422:Sporadic [Temporal Concept]
   744   C1441672:Observed [Functional Concept]
   711 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(49,"

Phrase: "50"

Phrase: ")"

Phrase: "may"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the association of parkin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "DJ-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "subsequently"

Phrase: "leading to stabilization of DJ-1 exclusively"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   778   C1424222:DJ-1 [Gene or Genome]
   778   C3541418:DJ-1 [Gene or Genome]
   748   C0012836:DJ [Geographic Area]
   748   C0332152:Leading [Temporal Concept]
   748   C1293130:Stabilisation [Therapeutic or Preventive Procedure]
   748   C1522538:Leading [Functional Concept]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in the insoluble fraction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.305: Although this might provide an attractive putative mechanism, it is difficult to reconcile this notion with the observation that oxidative stress may actually reduce the stability of insoluble DJ-1, at least in human SH-SY5Y cells. 

Phrase: "Although"

Phrase: "this"

Phrase: "might"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "an attractive putative mechanism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]

Phrase: "it"

Phrase: "is"

Phrase: "difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "reconcile"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1960278:RECONCILE [Organic Chemical,Pharmacologic Substance]

Phrase: "this notion with the observation"

Phrase: "that oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "may"

Phrase: "actually"

Phrase: "reduce"

Phrase: "the stability of insoluble DJ-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205360:Stability [Qualitative Concept]
   753   C2347098:Stability [Qualitative Concept]

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in human SH-SY5Y cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   902   C0427861:Human cells [Laboratory or Test Result]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.306: The generally reduced levels of DJ-1 in the insoluble fraction from parkin-deficient AR-JP brains might suggest that loss of insoluble parkin may primarily destabilize DJ-1 in this fraction, consistent with the stabilizing effect of parkin in cultured cells. 

Phrase: "The generally reduced levels of DJ-1"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0456947:Level 1 [Intellectual Product]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the insoluble fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "from parkin-deficient AR-JP brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   793   C0006104:Brains [Body Part, Organ, or Organ Component]
   760 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "might"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that loss of insoluble parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "may"

Phrase: "primarily"

Phrase: "destabilize"

Phrase: "DJ-1 in this fraction,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1424222:DJ-1 [Gene or Genome]
   806   C3541418:DJ-1 [Gene or Genome]
   760   C0012836:DJ [Geographic Area]
   760   C1264633:Fraction [Quantitative Concept]
   760   C1554103:Fraction [Idea or Concept]

Phrase: "consistent with the stabilizing effect of parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "in cultured cells."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0007600:cultured cells [Cell]
  1000   C0007635:Cultured Cells [Cell]
  1000   C3282338:Cells, Cultured [Cell]
   966 E C0007585:culture cell [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.307: However, more cases need to be examined to determine whether the reduction in DJ-1 levels is a consistent feature of parkin-linked AR-JP brains. 

Phrase: "However,"

Phrase: "more cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the reduction in DJ-1 levels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "a consistent feature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1521970:Feature [Qualitative Concept]
   861   C1706388:Feature [Conceptual Entity]
   861   C2346469:Feature [Qualitative Concept]
   861   C2348519:Feature [Qualitative Concept]

Phrase: "of parkin-linked AR-JP brains."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   793   C0006104:Brains [Body Part, Organ, or Organ Component]
   760 E C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.308: Increased DJ-1 levels in PD/DLB brains might alternatively be related to the presence of Lewy bodies or insoluble forms of -synuclein. 

Phrase: "Increased DJ-1 levels in PD/DLB brains"
Meta Candidates (Total=22; Excluded=7; Pruned=0; Remaining=15)
   797   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   756   C0085200:Lewy Bodies [Cell Component]
   756   C1424222:DJ-1 [Gene or Genome]
   756   C3541418:DJ-1 [Gene or Genome]
   755 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   738   C0006104:Brains [Body Part, Organ, or Organ Component]
   738   C0011265:dementia [Mental or Behavioral Dysfunction]
   738   C0012836:DJ [Geographic Area]
   738   C0205217:Increased [Quantitative Concept]
   738   C0242821:bodies [Human]
   738   C0441889:Levels [Qualitative Concept]
   738   C0442805:Increased [Functional Concept]
   738   C0497327:Dementia [Mental or Behavioral Dysfunction]
   738   C1995017:Bodies [Cell Component]
   737   C0456947:Level 1 [Intellectual Product]
   704 E C0456079:Level [Classification]
   704 E C0460148:Body [Anatomical Structure]
   704 E C1268086:Body [Anatomical Structure]
   704 E C1269537:Brain [Body Part, Organ, or Organ Component]
   704 E C1547707:Level [Geographic Area]
   704 E C2946261:Level [Pharmacologic Substance]

Phrase: "might"

Phrase: "alternatively"

Phrase: "be"

Phrase: "related to the presence of Lewy bodies"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   778   C0085200:Lewy Bodies [Cell Component]
   748   C0242821:bodies [Human]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0439849:Related [Qualitative Concept]
   748   C0445223:Related [Finding]
   748   C1995017:Bodies [Cell Component]
   714 E C0163712:Relate [Organic Chemical]
   714 E C0460148:Body [Anatomical Structure]
   714 E C1268086:Body [Anatomical Structure]

Phrase: "or"

Phrase: "insoluble forms of -synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.309: However, this appears unlikely given that DJ-1 fails to interact with -synuclein and does not localize to Lewy bodies or other inclusions in sporadic PD (35,65,66). 

Phrase: "However,"

Phrase: "this"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "that DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "fails"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "localize to Lewy bodies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0085200:Lewy Bodies [Cell Component]
   770   C0242821:bodies [Human]
   770   C0392752:localize [Spatial Concept]
   770   C1995017:Bodies [Cell Component]
   737 E C0460148:Body [Anatomical Structure]
   737 E C1268086:Body [Anatomical Structure]

Phrase: "or"

Phrase: "other inclusions in sporadic PD (35,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1512693:Inclusion [Qualitative Concept]

Phrase: "65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "66"

Phrase: ")."
Processing 00000000.tx.310: Increased levels of detergent-insoluble DJ-1 appear to be a common feature of many neurodegenerative diseases (65,66). 

Phrase: "Increased levels of detergent-insoluble DJ-1"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0456947:Level 1 [Intellectual Product]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a common feature of many neurodegenerative diseases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1521970:Feature [Qualitative Concept]
   748   C1706388:Feature [Conceptual Entity]
   748   C2346469:Feature [Qualitative Concept]
   748   C2348519:Feature [Qualitative Concept]

Phrase: "(65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "66"

Phrase: ")."
Processing 00000000.tx.311: The tendency of DJ-1 to co-localize with hallmark neuronal and glial tau inclusions in a number of neurodegenerative tauopathies likely accounts for these increased levels of insoluble DJ-1. 

Phrase: "The tendency of DJ-1"

Phrase: "to"

Phrase: "co-localize with hallmark"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392752:localize [Spatial Concept]

Phrase: "neuronal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521390:Neuronal [Immunologic Factor]
   928 E C0027882:Neuron [Cell]

Phrase: "and"

Phrase: "glial tau inclusions in a number of neurodegenerative tauopathies likely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   706   C1512693:Inclusion [Qualitative Concept]

Phrase: "accounts for these increased levels of insoluble DJ-1."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   764   C1424222:DJ-1 [Gene or Genome]
   764   C3541418:DJ-1 [Gene or Genome]
   745   C0456947:Level 1 [Intellectual Product]
   742   C0012836:DJ [Geographic Area]
   742   C0205217:Increased [Quantitative Concept]
   742   C0441889:Levels [Qualitative Concept]
   742   C0442805:Increased [Functional Concept]
   742   C1551359:account [Idea or Concept]
   742   C2741673:Account # [Clinical Attribute]
   742   C2981730:Account [Classification]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.312: As DJ-1 is absent from Lewy bodies in PD and DLB brains (65,66), the increased levels of insoluble DJ-1 observed in PD/DLB brains may represent a distinct pathological species with altered biochemical properties that specifically results from disease pathogenesis. 

Phrase: "As DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "is"

Phrase: "absent from Lewy bodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:Absent [Quantitative Concept]
   770   C2699517:ABSENT [Finding]

Phrase: "in PD"

Phrase: "and"

Phrase: "DLB brains"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   926   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   827 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   760   C0011265:dementia [Mental or Behavioral Dysfunction]
   760   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "(65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "66"

Phrase: ")"

Phrase: ","

Phrase: "the increased levels of insoluble DJ-1"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0456947:Level 1 [Intellectual Product]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "observed in PD/DLB brains"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   833   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   776 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0085200:Lewy Bodies [Cell Component]
   744   C0006104:Brains [Body Part, Organ, or Organ Component]
   744   C0011265:dementia [Mental or Behavioral Dysfunction]
   744   C0242821:bodies [Human]
   744   C0497327:Dementia [Mental or Behavioral Dysfunction]
   744   C1441672:Observed [Functional Concept]
   744   C1995017:Bodies [Cell Component]
   711 E C0460148:Body [Anatomical Structure]
   711 E C1268086:Body [Anatomical Structure]
   711 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a distinct pathological species with altered biochemical properties"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1705920:Species [Conceptual Entity]

Phrase: "that specifically"

Phrase: "results from disease pathogenesis."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0012634:Disease [Disease or Syndrome]
   770   C0543483:pathogenesis [Functional Concept]
   770   C0699748:Pathogenesis [Pathologic Function]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.313: In conclusion, we report an association between the PD-linked gene products parkin and DJ-1 mediated by pathogenic DJ-1 mutations and oxidative stress. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "we"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "an association between the PD-linked gene products parkin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0004083:Association [Mental Process]
   742   C0439849:Association [Qualitative Concept]
   742   C0596306:Association [Phenomenon or Process]
   742   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "mediated by pathogenic DJ-1 mutations"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C1424222:DJ-1 [Gene or Genome]
   790   C3541418:DJ-1 [Gene or Genome]
   753   C0012836:DJ [Geographic Area]
   753   C0026882:Mutations [Genetic Function]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0450254:Pathogenic [Organism]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "oxidative stress."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.314: Pathogenic mutations in DJ-1 tend to impair homo-dimer formation, and parkin might be involved in stabilizing these mutants rather than targeting them for proteasomal degradation. 

Phrase: "Pathogenic mutations in DJ-1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "tend"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "impair"

Phrase: "homo-dimer formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "might"

Phrase: "be"

Phrase: "involved in stabilizing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0184512:stabilizing [Qualitative Concept]
   790   C1314939:Involved [Functional Concept]

Phrase: "these mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "rather than"

Phrase: "targeting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeting [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "them for proteasomal degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]
Processing 00000000.tx.315: In contrast, the oxidative stress-induced association of parkin and DJ-1 may link both proteins in a common pathway related to cellular stress. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the oxidative stress-induced association of parkin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "may"

Phrase: "link"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "both proteins in a common pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "related to cellular stress."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C1516373:Cellular Stress [Cell or Molecular Dysfunction]
   770   C0007634:Cellular [Cell]
   770   C0038435:Stress [Finding]
   770   C0178539:Cellular [Functional Concept]
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   737 E C0163712:Relate [Organic Chemical]
Processing 00000000.tx.316: The stabilizing effect of parkin on DJ-1 appears to be one functional outcome from the association of both proteins, which may be relevant both in cultured cells and in vivo in PD. 

Phrase: "The stabilizing effect of parkin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0184512:stabilizing [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "one functional outcome from the association of both proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1274040:Outcome [Functional Concept]

Phrase: "which"

Phrase: "may"

Phrase: "be"

Phrase: "relevant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347946:Relevant [Qualitative Concept]

Phrase: "both in cultured cells"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   833   C0007600:cultured cells [Cell]
   833   C0007635:Cultured Cells [Cell]
   833   C3282338:Cells, Cultured [Cell]
   802 E C0007585:cells culture [Laboratory Procedure]
   770   C0007634:Cells [Cell]
   770   C0238767:Both [Spatial Concept]
   770   C1706086:Both [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "in vivo in PD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.317: The association of parkin and DJ-1 at multiple levels may potentially link both proteins in a common molecular pathway, and this may have important implications for understanding the pathogenesis of PD.  

Phrase: "The association of parkin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "DJ-1 at multiple levels"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C1424222:DJ-1 [Gene or Genome]
   806   C3541418:DJ-1 [Gene or Genome]
   781   C0456947:Level 1 [Intellectual Product]
   760   C0012836:DJ [Geographic Area]
   760   C0439064:Multiple [Quantitative Concept]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "may"

Phrase: "potentially"

Phrase: "link"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "both proteins in a common molecular pathway,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "this"

Phrase: "may"

Phrase: "have"

Phrase: "important implications for understanding"

Phrase: "the pathogenesis of PD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0543483:pathogenesis [Functional Concept]
   770   C0699748:Pathogenesis [Pathologic Function]
Processing 00000000.tx.318: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Expression plasmids, cell culture and antibodies Full-length human DJ-1 cDNA was cloned into the mammalian expression plasmid pcDNA3.1-Myc-His (Invitrogen), and point mutations were introduced by PCR-mediated site-directed mutagenesis using the QuickChange kit (Stratagene). 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Expression plasmids,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "cell culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "antibodies Full-length human DJ-1 cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "cloned into the mammalian expression plasmid pcDNA3.1-Myc-"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   742   C0009013:cloned [Cell]
   742   C0024660:Mammalian [Mammal]
   742   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   708 E C1522642:Clone [Tissue]

Phrase: "His"

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "point mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0162735:Point Mutations [Cell or Molecular Dysfunction]
   861   C0026882:Mutations [Genetic Function]
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "introduced by PCR-mediated site-directed mutagenesis"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   814   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   748   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0079866:Mutagenesis [Molecular Function]
   748   C0086597:mediated [Social Behavior]
   748   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   748   C0205145:Site [Spatial Concept]
   748   C0677874:pCR [Finding]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]
   748   C3146302:Mutagenesis [Laboratory Procedure]
   714   C0439851:Direct [Qualitative Concept]
   714   C1292748:introduce [Functional Concept]
   714   C1947931:Direct [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the QuickChange kit (Stratagene"

Phrase: ")."
Processing 00000000.tx.319: Human -synuclein and ubiquitin cDNAs were cloned into pRK5-HA vector as described previously (20). 

Phrase: "Human -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "ubiquitin cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "cloned into pRK5-HA vector"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0009013:cloned [Cell]
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]
   726 E C1522642:Clone [Tissue]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.320: Expression plasmids for FLAG-tagged human parkin and V5-tagged human Hsp70 were kindly provided by R. 

Phrase: "Expression plasmids for FLAG-tagged human parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "V5-tagged human Hsp70"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0243043:HSP 70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1415760:HSP70 [Gene or Genome]
   812   C1527149:HSP70 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "were"

Phrase: "kindly"

Phrase: "provided by R."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205090:R- [Spatial Concept]
   790   C0684010:R. [Professional or Occupational Group]
   790   C1999230:Provided [Activity]
   790   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.321: Takahashi (RIKEN Brain Science Institute, Japan), HA-tagged mouse CHIP was kindly provided by S. 

Phrase: "Takahashi"

Phrase: "(RIKEN Brain Science Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0021622:institute [Organization]
   812   C1272753:Institute [Idea or Concept]

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "HA-tagged mouse CHIP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0600596:Chip [Research Device]

Phrase: "was"

Phrase: "kindly"

Phrase: "provided by S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1999230:Provided [Activity]
Processing 00000000.tx.322: Hatakeyama (Kyushu University, Japan) and FLAG-tagged human DJ-1 was kindly provided by H. 

Phrase: "Hatakeyama"

Phrase: "(Kyushu University,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041740:University [Manufactured Object,Organization]
   861   C0454747:Kyushu [Geographic Area]

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "FLAG-tagged human DJ-1"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   858   C1413560:TAG-1 [Gene or Genome]
   840   C1424222:DJ-1 [Gene or Genome]
   840   C3541418:DJ-1 [Gene or Genome]
   804   C0012836:DJ [Geographic Area]
   804   C0086418:Human [Human]
   804   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   804   C1708067:Flag [Functional Concept]
   804   C1708632:Tagged [Qualitative Concept]
   771 E C0037293:Tag [Neoplastic Process]
   771 E C0181496:Tag [Manufactured Object]
   771 E C1710492:TAG [Gene or Genome]

Phrase: "was"

Phrase: "kindly"

Phrase: "provided by H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0033727:H+ [Element, Ion, or Isotope]
   790   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0441932:H+ [Classification]
   790   C0564385:/h [Quantitative Concept]
   790   C1999230:Provided [Activity]
Processing 00000000.tx.323: Ariga (Hokkaido University, Japan). 

Phrase: "Ariga"

Phrase: "(Hokkaido University,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041740:University [Manufactured Object,Organization]
   861   C0454745:Hokkaido [Geographic Area]

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")."
Processing 00000000.tx.324: A plasmid containing -galactosidase cDNA was used as a control in all experiments. 

Phrase: "A plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "containing -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "galactosidase cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "used as a control"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1273517:used [Finding]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "in all experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.325: The integrity of all constructs was confirmed by sequencing. 

Phrase: "The integrity of all constructs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205266:integrity [Qualitative Concept]
   760   C0872403:integrity [Individual Behavior]
   760   C1947912:Integrity [Qualitative Concept]

Phrase: "was"

Phrase: "confirmed by sequencing."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0750484:Confirmed [Idea or Concept]
   790   C1553778:Sequencing [Intellectual Product]
   790   C1561491:Sequencing [Functional Concept]
   756 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.326: Human SH-SY5Y neuroblastoma cells were maintained in DMEM supplemented with 10% FBS and penicillin/streptomycin at 37C in a 5% CO2 atmosphere. 

Phrase: "Human SH-SY5Y neuroblastoma cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   897   C0427861:Human cells [Laboratory or Test Result]
   823   C0815000:neuroblastoma cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "maintained in DMEM"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1314677:Maintained [Functional Concept]
   756 E C0024501:Maintain [Activity]

Phrase: "supplemented with 10% FBS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0242295:Supplement [Food]
   737   C1947943:Supplement [Intellectual Product]
   737   C2348609:Supplement [Functional Concept]

Phrase: "and"

Phrase: "penicillin/streptomycin at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "in a 5% CO2 atmosphere."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0004178:Atmosphere [Natural Phenomenon or Process]
   827   C0678214:atmosphere [Quantitative Concept]
Processing 00000000.tx.327: Cells were transfected with plasmids using Lipofectamine Plus reagent (Invitrogen) according to the manufacturers recommendations. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Lipofectamine Plus reagent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "according to the manufacturers recommendations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034866:recommendations [Idea or Concept]
Processing 00000000.tx.328: Affinity-purified rabbit polyclonal anti-DJ-1 antibodies, DJ-1 (N) and DJ-1 (C), raised to N- and C-terminal epitopes, respectively, have been described previously (33); 

Phrase: "Affinity-purified rabbit polyclonal anti-DJ-1 antibodies,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   847   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   836   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   834   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   820 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   793   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "(N)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "(C),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "raised to N-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0442818:Raised [Quantitative Concept]

Phrase: "and"

Phrase: "C-terminal epitopes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003316:Epitopes [Immunologic Factor]
   734   C1707271:C-Terminal [Amino Acid Sequence]

Phrase: "respectively,"

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(33"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.329: mouse monoclonal anti-Myc (clone 9E10), anti-Myc-HRP and anti-HA-HRP antibodies were obtained from Roche; 

Phrase: "mouse monoclonal anti-Myc (clone 9E10"

Phrase: ")"

Phrase: ","

Phrase: "anti-Myc-HRP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019941:HRP [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "anti-HA-HRP antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   902   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   886 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "obtained from Roche"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0331965:Roche [Health Care Related Organization]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.330: mouse monoclonal anti-FLAG (M2), anti-FLAG-HRP, anti--tubulin and rabbit polyclonal anti-actin antibodies were obtained from Sigma; 

Phrase: "mouse monoclonal anti-FLAG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1708067:Flag [Functional Concept]

Phrase: "(M2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0457242:m2 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "anti-FLAG-HRP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019941:HRP [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]

Phrase: "anti--tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2937342:tubulin [Cell Component]

Phrase: "and"

Phrase: "rabbit polyclonal anti-actin antibodies"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   881   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   873   C0369998:Anti-actin antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   853   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   836 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   823   C1718641:Actin Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   771 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   733 E C0439681:Actinic [Qualitative Concept]

Phrase: "were"

Phrase: "obtained from Sigma"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1301820:Obtained [Functional Concept]
   790   C1719918:Sigma [Intellectual Product]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.331: mouse monoclonal anti-V5 and anti-V5-HRP antibodies were obtained from Invitrogen; 

Phrase: "mouse monoclonal anti-V5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2349105:V5+ [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "anti-V5-HRP antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   902   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   886 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "obtained from Invitrogen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.332: mouse monoclonal anti-parkin (clone PRK8) antibody has been described elsewhere (64); 

Phrase: "mouse monoclonal anti-parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1418270:PARKIN [Gene or Genome]
   812   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(clone PRK8"

Phrase: ")"

Phrase: "antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "elsewhere"

Phrase: "(64"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.333: rabbit polyclonal anti-SOD1 antibody was kindly provided by D. 

Phrase: "rabbit polyclonal anti-SOD1 antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   897   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   853   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "kindly"

Phrase: "provided by D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1999230:Provided [Activity]
Processing 00000000.tx.334: Borchelt (Johns Hopkins University); 

Phrase: "Borchelt"

Phrase: "(Johns Hopkins University"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.335: HRP-coupled anti-mouse and anti-rabbit antibodies were obtained from Pierce. 

Phrase: "HRP-coupled anti-mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mouse [Mammal]
   812   C0025929:mouse [Mammal]
   812   C0026809:Mouse [Mammal]

Phrase: "and"

Phrase: "anti-rabbit antibodies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   884   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0034493:Rabbit [Mammal]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "obtained from Pierce."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.336: Co-immunoprecipitation and western blotting For co-immunoprecipitation from cell cultures, SH-SY5Y cells were transfected with 2g of each plasmid. 

Phrase: "Co-immunoprecipitation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   861   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "western blotting For co-immunoprecipitation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   790 E C0949466:Western Blot [Laboratory Procedure]
   760   C1705493:Western [Spatial Concept]

Phrase: "from cell cultures,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0007585:Cell Cultures [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Cultures [Idea or Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "SH-SY5Y cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with 2g of each plasmid."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.337: After 48h, cells were washed with cold PBS and harvested in IP buffer [0.5% Triton X-100, 1x Complete mini protease inhibitor cocktail (Roche), in PBS] Lysates were then rotated at 4C for 1h followed by centrifugation at 17500g for 15min. 

Phrase: "After 48h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed with cold PBS"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0009264:Cold [Natural Phenomenon or Process]
   770   C0009443:Cold [Disease or Syndrome]
   770   C0234192:Cold [Physiologic Function]
   770   C1548982:Washed [Idea or Concept]
   770   C1720830:PBS [Disease or Syndrome]
   770   C1823521:PBS [Gene or Genome]
   737 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "harvested in IP buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0021069:Immunoprecipitation [Laboratory Procedure]
   737   C1512335:Harvest [Health Care Activity]

Phrase: "[0.5% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: "1x Complete mini protease inhibitor cocktail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0678420:Cocktail [Food]

Phrase: "(Roche"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331965:Roche [Health Care Related Organization]

Phrase: ")"

Phrase: ","

Phrase: "in PBS] Lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "rotated at 4C"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0231458:Rotated [Spatial Concept]
   790   C0450376:4c [Intellectual Product]
   718 E C0040480:Twisting [Physiologic Function]
   718 E C0231467:Twisted [Spatial Concept]
   718 E C1265748:Twisting [Pathologic Function]
   718 E C1881716:TWISTING [Phenomenon or Process]

Phrase: "for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "followed by centrifugation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0007703:Centrifugation [Laboratory Procedure]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "at 17500g"

Phrase: "for 15min."
Processing 00000000.tx.338: The supernatant fractions were then combined with 50l protein G sepharose 4 fast flow (Amersham), pre-incubated with 5 g mouse monoclonal anti-myc, anti-FLAG or anti-V5 antibody followed by rotating overnight at 4C. 

Phrase: "The supernatant fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "combined with 50l protein G sepharose 4 fast flow"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   764   C0060916:protein g [Amino Acid, Peptide, or Protein]
   762 E C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0015663:Fast [Finding]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0036681:Sepharose [Carbohydrate]
   742   C0205195:Combined [Qualitative Concept]
   742   C0439267:g% [Quantitative Concept]
   742   C0456962:Fast [Qualitative Concept]
   742   C0806140:Flow [Natural Phenomenon or Process]
   708 E C0336789:Combine [Manufactured Object]

Phrase: "(Amersham"

Phrase: ")"

Phrase: ","

Phrase: "pre-incubated with 5 g mouse monoclonal anti-myc,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   742   C0025914:Mouse [Mammal]
   742   C0025929:mouse [Mammal]
   742   C0026809:Mouse [Mammal]
   742   C0332152:Pre [Temporal Concept]
   742   C0439267:g% [Quantitative Concept]
   742   C0740175:Pre [Qualitative Concept]
   742   C0746619:monoclonal [Finding]
   742   C1439852:Incubated [Laboratory Procedure]
   742   C2257086:PRE [Genetic Function]

Phrase: "anti-FLAG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708067:Flag [Functional Concept]

Phrase: "or"

Phrase: "anti-V5 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "followed by rotating"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0231458:rotating [Spatial Concept]
   756 E C1719822:Follow [Intellectual Product]
   718 E C0040480:Twisting [Physiologic Function]
   718 E C0231467:Twisted [Spatial Concept]
   718 E C1265748:Twisting [Pathologic Function]
   718 E C1881716:TWISTING [Phenomenon or Process]

Phrase: "overnight at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439583:Overnight [Temporal Concept]
Processing 00000000.tx.339: The protein G sepharose complex was pelleted and washed once with IP buffer supplemented with 500mM NaCl, twice with IP buffer alone and three times with PBS. 

Phrase: "The protein G sepharose complex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C1523872:protein complex [Cell Component]
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "was"

Phrase: "pelleted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0441436:Pellet [Manufactured Object]
   966   C0993610:Pellet [Biomedical or Dental Material]
   966   C1998480:Pellet [Quantitative Concept]

Phrase: "and"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "once with IP buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0021069:Immunoprecipitation [Laboratory Procedure]
   770   C1720092:Once [Intellectual Product]
   770   C1948045:Once [Temporal Concept]

Phrase: "supplemented with 500mM NaCl,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   770   C1959973:% NaCl [Quantitative Concept]
   737   C0242295:Supplement [Food]
   737   C1947943:Supplement [Intellectual Product]
   737   C2348609:Supplement [Functional Concept]

Phrase: "twice with IP buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0021069:Immunoprecipitation [Laboratory Procedure]
   770   C1720725:Twice [Intellectual Product]
   770   C1948050:Twice [Quantitative Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "and"

Phrase: "three times with PBS."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0040223:times [Temporal Concept]
   770   C1632851:Times [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]
Processing 00000000.tx.340: Immunoprecipitates or inputs (1% total lysate) were resolved by SDSPAGE and subjected to western blot analysis. 

Phrase: "Immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "or"

Phrase: "inputs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708517:Input [Conceptual Entity]

Phrase: "(1% total lysate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: ")"

Phrase: "were"

Phrase: "resolved by SDSPAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1514893:Resolved [Idea or Concept]
   790   C2699488:Resolved [Conceptual Entity]

Phrase: "and"

Phrase: "subjected to western blot analysis."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]
Processing 00000000.tx.341: Bands were visualized by enhanced chemiluminescence (Amersham). 

Phrase: "Bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0175723:Bands [Medical Device]
   966 E C0439645:Band [Spatial Concept]
   966 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "visualized by enhanced chemiluminescence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   770   C0234621:Visualized [Functional Concept]
   770   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   770   C2349975:Enhanced [Activity]

Phrase: "(Amersham"

Phrase: ")."
Processing 00000000.tx.342: Quantitation of protein expression was performed using densitometry analysis software (AlphaImager, Alpha Innotech Corp.) and data were analyzed by Student's t-test to determine differences between groups. 

Phrase: "Quantitation of protein expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709793:Quantitation [Quantitative Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "densitometry analysis software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(AlphaImager,"

Phrase: "Alpha Innotech Corp.)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0683758:Corp. [Organization]

Phrase: "and"

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "analyzed by Student's t-test to"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0022885:Test [Laboratory Procedure]
   753   C0038492:student [Professional or Occupational Group]
   753   C0039593:Test [Functional Concept]
   753   C0392366:test [Intellectual Product]
   753   C0936012:Analyzed [Research Activity]
   753   C1551041:student [Idea or Concept]
   753   C1552573:student [Intellectual Product]

Phrase: "determine"

Phrase: "differences between groups."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.343: Where indicated, SH-SY5Y cells were treated for 24h with MG132 (5M; Affiniti Research), hydrogen peroxide (Sigma), MPP+ (Sigma), SNAP (Calbiochem) or DMSO-PBS as a control where appropriate, prior to harvesting in IP buffer and submitting to IP, as described earlier. 

Phrase: "Where"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "SH-SY5Y cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated for 24h"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0332293:treated [Therapeutic or Preventive Procedure]
   790   C0456696:/24h [Temporal Concept]
   790   C1442770:24H [Temporal Concept]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "with MG132"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0246694:MG132 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(5M"

Phrase: "; Affiniti Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "hydrogen peroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "MPP+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0022023:Ion [Element, Ion, or Isotope]
   812   C1700702:ION [Functional Concept]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "SNAP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2603362:S' [Clinical Attribute]

Phrase: "(Calbiochem"

Phrase: ")"

Phrase: "or"

Phrase: "DMSO-PBS as a control"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1720830:PBS [Disease or Syndrome]
   760   C1823521:PBS [Gene or Genome]

Phrase: "where appropriate"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1548787:Appropriate [Qualitative Concept]
   789 E C0814634:appropriateness [Qualitative Concept]

Phrase: ","

Phrase: "prior to harvesting"

Phrase: "in IP buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "submitting to IP,"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "earlier."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]
Processing 00000000.tx.344: Cross-linking assay Soluble cell lysates were quantitated using the BCA kit (Pierce) with BSA standards. 

Phrase: "Cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "Soluble cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "quantitated"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the BCA kit (Pierce"

Phrase: ")"

Phrase: "with BSA standards."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0038137:standards [Intellectual Product]
   861   C0175675:Standards [Qualitative Concept]
   827 E C1442989:Standard [Qualitative Concept]
   827 E C2828392:Standard [Intellectual Product]
Processing 00000000.tx.345: Equal quantities of lysate were incubated with DSS (Pierce) for 2h at 4C. 

Phrase: "Equal quantities of lysate"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C1265611:QUANTITIES [Quantitative Concept]
   737 E C1554108:Quantity [Intellectual Product]
   737 E C1561573:Quantity [Intellectual Product]

Phrase: "were"

Phrase: "incubated with DSS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0058479:disuccinimidyl suberate [Organic Chemical,Pharmacologic Substance]
   770   C0947344:Suberate [Organic Chemical]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "(Pierce"

Phrase: ")"

Phrase: "for 2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.346: The reaction was quenched by incubation with 50mM TrisHCl, pH 7.5 for 15min at room temperature. 

Phrase: "The reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "quenched by incubation"

Phrase: "with 50mM TrisHCl,"

Phrase: "pH 7.5 for 15min"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1882074:pH 7 [Qualitative Concept]
   760   C0020283:[pH] [Quantitative Concept]
   760   C0450407:ph+ [Finding]
   760   C0450408:ph++ [Finding]
   760   C0450409:ph+++ [Finding]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.347: Lysates were analyzed by western blotting with anti-myc or anti-DJ-1 (N) antibody. 

Phrase: "Lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "analyzed by western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with anti-myc"

Phrase: "or"

Phrase: "anti-DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1424222:DJ-1 [Gene or Genome]
   901   C3541418:DJ-1 [Gene or Genome]
   827   C0012836:DJ [Geographic Area]

Phrase: "(N) antibody."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N not otherwise specified Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.348: For co-immunoprecipitation experiments, cells were transfected with 2g of pcDNA3.1-Myc-DJ-1 and pcDNA3-FLAG-parkin plasmids, and after 48h, cells were harvested in IP buffer (1% Triton X-100). 

Phrase: "For co-immunoprecipitation experiments,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C1449705:Co-Immunoprecipitation [Laboratory Procedure]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with 2g of pcDNA3.1-Myc-DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1424222:DJ-1 [Gene or Genome]
   762   C3541418:DJ-1 [Gene or Genome]
   742   C0012836:DJ [Geographic Area]

Phrase: "and"

Phrase: "pcDNA3-FLAG-parkin plasmids,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and after 48h,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1442464:48H [Temporal Concept]
   790   C1515981:And [Idea or Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested in IP buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0021069:Immunoprecipitation [Laboratory Procedure]
   737   C1512335:Harvest [Health Care Activity]

Phrase: "(1% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: ")."
Processing 00000000.tx.349: Equivalent soluble lysates (3mg total protein) were incubated with 5mM DSS for 2h, quenched with 100mM TrisHCl, pH 7.5, and IP was performed with an anti-myc antibody. 

Phrase: "Equivalent soluble lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1881488:Lysate [Physical Object]

Phrase: "(3mg total protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0555903:Total protein [Laboratory Procedure]
   901   C1261360:total protein [Laboratory or Test Result]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439175:% total [Quantitative Concept]
   827   C0439810:Total [Qualitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "incubated with 5mM DSS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0058479:disuccinimidyl suberate [Organic Chemical,Pharmacologic Substance]
   760   C0947344:Suberate [Organic Chemical]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 2h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: "quenched with 100mM TrisHCl,"

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "IP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "was"

Phrase: "performed with an anti-myc antibody."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0884358:Performed [Functional Concept]
   719 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.350: Immunoprecipitates were stringently washed five times with IP buffer supplemented with 500mM NaCl and once with PBS, and analyzed by western blotting. 

Phrase: "Immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "stringently"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "five times with IP buffer"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "supplemented with 500mM NaCl"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   770   C1959973:% NaCl [Quantitative Concept]
   737   C0242295:Supplement [Food]
   737   C1947943:Supplement [Intellectual Product]
   737   C2348609:Supplement [Functional Concept]

Phrase: "and"

Phrase: "once with PBS,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1720092:Once [Intellectual Product]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   790   C1948045:Once [Temporal Concept]

Phrase: "and"

Phrase: "analyzed by western blotting."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]
Processing 00000000.tx.351: Ubiquitination assay SH-SY5Y cells were transfected with 2g of pcDNA3.1-Myc-DJ-1, pRK5-HA-ubiquitin or pcDNA3-FLAG-parkin plasmids. 

Phrase: "Ubiquitination assay SH-SY5Y cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with 2g of pcDNA3.1-Myc-DJ-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1424222:DJ-1 [Gene or Genome]
   762   C3541418:DJ-1 [Gene or Genome]
   742   C0012836:DJ [Geographic Area]

Phrase: "pRK5-HA-ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "pcDNA3-FLAG-parkin plasmids."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.352: After 48h, cells were harvested in IP buffer (1% Triton X-100, 1x Complete protease inhibitor cocktail, in PBS) and IP was performed with an anti-myc antibody. 

Phrase: "After 48h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested in IP buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0021069:Immunoprecipitation [Laboratory Procedure]
   737   C1512335:Harvest [Health Care Activity]

Phrase: "(1% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "1x Complete protease inhibitor cocktail,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0678420:Cocktail [Food]

Phrase: "in PBS)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "and"

Phrase: "IP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "was"

Phrase: "performed with an anti-myc antibody."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0884358:Performed [Functional Concept]
   719 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.353: Immunoprecipitates were stringently washed five times in IP buffer supplemented with 500mM NaCl and once with PBS, and submitted to western blotting with anti-HA and anti-myc antibodies. 

Phrase: "Immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "stringently"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "five times in IP buffer"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "supplemented with 500mM NaCl"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   770   C1959973:% NaCl [Quantitative Concept]
   737   C0242295:Supplement [Food]
   737   C1947943:Supplement [Intellectual Product]
   737   C2348609:Supplement [Functional Concept]

Phrase: "and"

Phrase: "once with PBS,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1720092:Once [Intellectual Product]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   790   C1948045:Once [Temporal Concept]

Phrase: "and"

Phrase: "submitted to western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1515023:Submitted [Functional Concept]
   770   C1705493:Western [Spatial Concept]

Phrase: "with anti-HA"

Phrase: "and"

Phrase: "anti-myc antibodies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.354: For preparation of detergent-insoluble fractions from cells, the 1% Triton X-100-insoluble pellet fraction was solubilized by sonication and boiling in 100l 2x SDS sample buffer containing -mercaptoethanol. 

Phrase: "For preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]

Phrase: "of detergent-insoluble fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "from cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "the 1% Triton X-100-insoluble pellet fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C1264633:Fraction [Quantitative Concept]
   795   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "solubilized by sonication"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0037680:Sonication [Research Activity]

Phrase: "and"

Phrase: "boiling in 100l 2x SDS sample buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C0242301:Boil [Disease or Syndrome]
   714   C1546559:Boil [Intellectual Product]

Phrase: "containing -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "mercaptoethanol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025402:Mercaptoethanol [Organic Chemical]
Processing 00000000.tx.355: Equivalent detergent-insoluble fractions were analyzed by western blotting. 

Phrase: "Equivalent detergent-insoluble fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1264633:Fractions [Quantitative Concept]
   779 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "analyzed by western blotting."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]
Processing 00000000.tx.356: Human brain tissue Human brain tissue was obtained through the brain donation program of the Morris K. 

Phrase: "Human brain tissue Human brain tissue"

Phrase: "was"

Phrase: "obtained through the brain donation program of the Morris K."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   739   C0006104:Brain [Body Part, Organ, or Organ Component]
   739   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   739   C0680854:donation [Quantitative Concept]
   739   C1269537:Brain [Body Part, Organ, or Organ Component]
   739   C1301820:Obtained [Functional Concept]
   739   C1708601:K' [Quantitative Concept]
   739   C1709697:Program [Conceptual Entity]
   739   C2728259:Program [Pharmacologic Substance]
   739   C3484370:Program [Functional Concept]
   706 E C1706701:Obtain [Activity]
Processing 00000000.tx.357: Udall Parkinson's Disease Research Center at Johns Hopkins Medical Institutions (JHMI) according to HIPAA regulations. 

Phrase: "Udall Parkinson's Disease Research Center at Johns Hopkins Medical Institutions (JHMI)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0683939:research center [Manufactured Object,Organization]
   757   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   757   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   739   C0205099:Center [Spatial Concept]

Phrase: "according to HIPAA regulations."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0220905:regulations [Regulation or Law]
   861   C0851285:Regulations [Governmental or Regulatory Activity]
   827 E C1327622:Regulation [Biologic Function]
Processing 00000000.tx.358: This research proposal involves anonymous autopsy material that lacks identifiers of gender, race, or ethnicity. 

Phrase: "This research proposal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035174:Research Proposal [Intellectual Product]
   861   C1555306:proposal [Idea or Concept]
   861   C1948033:Proposal [Intellectual Product]

Phrase: "involves"

Phrase: "anonymous autopsy material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0520510:Material [Substance]

Phrase: "that"

Phrase: "lacks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "identifiers of gender,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0600091:identifiers [Intellectual Product]
   756 E C1554104:Identifier [Idea or Concept]
   756 E C1554159:Identifier [Idea or Concept]

Phrase: "race,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034510:Race [Population Group]
  1000   C1706779:RACE [Gene or Genome]

Phrase: "or"

Phrase: "ethnicity."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015031:Ethnicity [Population Group]
  1000   C0243103:ethnicity [Qualitative Concept]
   928 E C0680174:ethnic [Finding]
Processing 00000000.tx.359: The JHMI Joint Committee on Clinical Investigations decided that the studies in this proposal are exempt from Human Subjects Approval because of Federal Register 46.101 exemption number 4. 

Phrase: "The JHMI Joint Committee on Clinical Investigations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C2699414:Committee [Group]

Phrase: "decided"

Phrase: "that"

Phrase: "the studies in this proposal"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "exempt from Human"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0086418:Human [Human]
   790   C2348482:Exempt [Conceptual Entity]

Phrase: "Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "Approval because of Federal Register 46.101 exemption number 4."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0205540:Approval [Qualitative Concept]
   739   C2346845:Approval [Intellectual Product]
Processing 00000000.tx.360: Tissue from six control brains, two AD brains and five PD/DLB brains were utilized for western blot analysis. 

Phrase: "Tissue from six control brains,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   797   C0440746:brains tissue [Tissue]
   781 E C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   760   C0040300:Tissue [Tissue]
   760   C1547928:Tissue [Intellectual Product]

Phrase: "two AD brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0006104:Brains [Body Part, Organ, or Organ Component]
   793 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "five PD/DLB brains"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   853   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   788 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   748   C0011265:dementia [Mental or Behavioral Dysfunction]
   748   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "were"

Phrase: "utilized for western blot analysis."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]
Processing 00000000.tx.361: Table1 shows clinical details of subjects used in this study. 

Phrase: "Table1"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "clinical details of subjects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1522508:Details [Qualitative Concept]
   737 E C1561567:detail [Functional Concept]

Phrase: "used in this study."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.362: Frontal cortex tissue from four AR-JP brains was collected at the Department of Neurology and Department of Pathology, Juntendo University School of Medicine, Japan (Table1). 

Phrase: "Frontal cortex tissue from four AR-JP brains"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   754   C0440746:brains tissue [Tissue]
   738   C0040300:Tissue [Tissue]
   738   C1547928:Tissue [Intellectual Product]
   737 E C0459385:Brain tissue [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "collected at the Department of Neurology"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0587475:Neurology department [Health Care Related Organization]
   753   C0027855:Neurology [Biomedical Occupation or Discipline]
   753   C1516695:Collected [Idea or Concept]
   753   C1516698:Collected [Functional Concept]
   753   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Department of Pathology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0587487:Pathology department [Health Care Related Organization]
   790   C1704729:Department [Organization]

Phrase: "Juntendo University School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036375:School [Manufactured Object,Organization]

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "(Table1"

Phrase: ")."
Processing 00000000.tx.363: AR-JP cases 1 and 3 each carry a homozygous deletion of parkin exon 4, whereas cases 2 and 4 each carry a homozygous deletion of parkin exon 3, as described previously (7,59,67). 

Phrase: "AR-JP cases 1"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   818   C0441748:Autosomal recessive [Intellectual Product]
   818   C3149653:Juvenile onset [Finding]
   795   C0332162:Onset [Qualitative Concept]
   795   C0596142:autosomal [Cell Component]
   795   C0868928:Cases [Functional Concept]
   795   C1533148:Cases [Quantitative Concept]
   795   C3146221:Juvenile [Age Group]
   762 E C1706255:CASE [Medical Device]
   762 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "each"

Phrase: "carry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:carry [Finding]

Phrase: "a homozygous deletion of parkin exon 4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1442161:Deletion [Cell or Molecular Dysfunction]
   748   C1511760:Deletion [Genetic Function]
   748   C1880274:Deletion [Activity]

Phrase: "whereas"

Phrase: "cases 2"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "4"

Phrase: "each"

Phrase: "carry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:carry [Finding]

Phrase: "a homozygous deletion of parkin exon 3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1442161:Deletion [Cell or Molecular Dysfunction]
   748   C1511760:Deletion [Genetic Function]
   748   C1880274:Deletion [Activity]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(7,"

Phrase: "59,"

Phrase: "67"

Phrase: ")."
Processing 00000000.tx.364: Fractionation experiments Detergent-soluble and -insoluble fractions were prepared from human brain tissue by homogenization of samples in TNE buffer (10mM TrisHCl, pH 7.4; 150mM NaCl; 5mM EDTA) containing Complete protease inhibitor cocktail (Roche) and detergent (0.5% NP-40). 

Phrase: "Fractionation experiments Detergent-soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1749467:soluble [Cell Component]
   812   C1948047:Soluble [Qualitative Concept]

Phrase: "and -"

Phrase: "insoluble fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "prepared from human brain tissue"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0440746:Brain tissue [Tissue]
   806   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   797   C0440744:Human tissue [Tissue]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0040300:Tissue [Tissue]
   760   C0086418:Human [Human]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1547928:Tissue [Intellectual Product]
   726   C1521827:Prepare [Functional Concept]

Phrase: "by homogenization"

Phrase: "of samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "in TNE buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(10mM TrisHCl,"

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "; 150mM NaCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "; 5mM EDTA)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "Complete protease inhibitor cocktail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0678420:Cocktail [Food]

Phrase: "(Roche"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331965:Roche [Health Care Related Organization]

Phrase: ")"

Phrase: "and"

Phrase: "detergent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011740:Detergent [Chemical Viewed Functionally]

Phrase: "(0.5% NP-40"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0068941:NP-40 [Organic Chemical,Pharmacologic Substance]
   861   C0444499:0/5 [Quantitative Concept]
   812   C0439509:/40 [Temporal Concept]
   812   C1706141:NP [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.365: The homogenate was centrifuged (20min at 100000g), and the resulting pellet (P1) and supernatant (S1, detergent-soluble) fractions were collected. 

Phrase: "The homogenate"

Phrase: "was"

Phrase: "centrifuged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "(20min at 100000g"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the resulting pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441436:Pellet [Manufactured Object]
   861   C0993610:Pellet [Biomedical or Dental Material]
   861   C1998480:Pellet [Quantitative Concept]

Phrase: "(P1)"

Phrase: "and"

Phrase: "supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "(S1,"

Phrase: "detergent-soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1749467:soluble [Cell Component]
   861   C1948047:Soluble [Qualitative Concept]

Phrase: ")"

Phrase: "fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "collected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]
Processing 00000000.tx.366: The P1 fraction was washed once in TNE buffer containing detergent, and the resulting pellet (P2, detergent-insoluble) was homogenized and further solubilized by sonication and boiling in TNE buffer containing 1% SDS and 0.5% sodium deoxycholate. 

Phrase: "The P1 fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "once in TNE buffer containing detergent,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0011740:Detergent [Chemical Viewed Functionally]
   753   C0332256:Containing [Functional Concept]
   753   C1720092:Once [Intellectual Product]
   753   C1948045:Once [Temporal Concept]
   753   C2700400:Containing [Activity]

Phrase: "and"

Phrase: "the resulting pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441436:Pellet [Manufactured Object]
   861   C0993610:Pellet [Biomedical or Dental Material]
   861   C1998480:Pellet [Quantitative Concept]

Phrase: "(P2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1384585:P2 [Immunologic Factor]
  1000   C1419693:P2 [Gene or Genome]
  1000   C1539372:p2 [Gene or Genome]

Phrase: "detergent-insoluble"

Phrase: ")"

Phrase: "was"

Phrase: "homogenized"

Phrase: "and"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "solubilized by sonication"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0037680:Sonication [Research Activity]

Phrase: "and"

Phrase: "boiling in TNE buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0242301:Boil [Disease or Syndrome]
   737   C1546559:Boil [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1% SDS"

Phrase: "and"

Phrase: "0.5% sodium deoxycholate."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0037500:SODIUM DESOXYCHOLATE [Pharmacologic Substance,Steroid]
   812   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   812   C0086123:Deoxycholate [Hormone,Pharmacologic Substance,Steroid]
   812   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.367: Fractions were quantitated using the BCA kit (Pierce) with BSA standards, and analyzed by western blotting.  

Phrase: "Fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "quantitated"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the BCA kit (Pierce"

Phrase: ")"

Phrase: "with BSA standards,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0038137:standards [Intellectual Product]
   861   C0175675:Standards [Qualitative Concept]
   827 E C1442989:Standard [Qualitative Concept]
   827 E C2828392:Standard [Intellectual Product]

Phrase: "and"

Phrase: "analyzed by western blotting."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]
Processing 00000000.tx.368: ACKNOWLEDGEMENTS  The authors would like to thank Drs K. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "would like to"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Drs K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.369: Chung and O. 

Phrase: "Chung"

Phrase: "and"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.370: Pletnikova for provision and preparation of human brain fractions. 

Phrase: "Pletnikova for provision"

Phrase: "and"

Phrase: "preparation of human brain fractions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0455052:Preparation [Health Care Activity]
   760   C1521827:Preparation [Functional Concept]
Processing 00000000.tx.371: This work was directly supported by grants from the USPHS NS38377 and NS43691, and by grant AG05146 awarded to the Johns Hopkins University (JHU) Alzheimer's Disease Research Center. 

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "supported by grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from the USPHS NS38377"

Phrase: "and"

Phrase: "NS43691,"

Phrase: "and by grant AG05146"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0018173:Grant [Quantitative Concept]
   770   C1515981:And [Idea or Concept]
   770   C1548284:Grant [Idea or Concept]

Phrase: "awarded to the Johns Hopkins University (JHU) Alzheimer's Disease Research Center."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0002395:Alzheimer's Disease [Disease or Syndrome]
   760   C0683939:research center [Manufactured Object,Organization]
   760   C1521724:Alzheimer's Disease [Pathologic Function]
   739   C0004446:awarded [Manufactured Object]
   739   C0012634:Disease [Disease or Syndrome]
   739   C0035168:research [Research Activity]
   739   C0041740:University [Manufactured Object,Organization]
   739   C0205099:Center [Spatial Concept]
   739   C0242481:Research [Research Activity]
Processing 00000000.tx.372: D.J.M. is supported by the Herbert Freidberg Fellowship. 

Phrase: "D.J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "is"

Phrase: "supported by the Herbert Freidberg Fellowship."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0015770:Fellowship [Educational Activity]
   753   C0331828:Herbert [Health Care Related Organization]
   753   C1521721:Supported [Conceptual Entity]
   719 E C0183683:Support [Medical Device]
Processing 00000000.tx.373: T.M.D. is the Leonard and Madlyn Abramson Professor of Neurodegenerative Diseases at JHU.  

Phrase: "T.M.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C1512018:M.D. [Intellectual Product]

Phrase: "is"

Phrase: "the Leonard"

Phrase: "and"

Phrase: "Madlyn Abramson Professor of Neurodegenerative Diseases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0599518:Professor [Professional or Occupational Group]

Phrase: "at JHU."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]
Processing 00000000.tx.374: REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Lang, A.E. and Lozano, A.M. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Lang,"

Phrase: "A.E."

Phrase: "and"

Phrase: "Lozano,"

Phrase: "A.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.375: (1998) Parkinson's disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.376: First of two parts. 

Phrase: "First of two parts."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205435:First [Quantitative Concept]
   770   C1279901:First [Qualitative Concept]
Processing 00000000.tx.377: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.378: Engl. 

Phrase: "Engl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414400:ENGL [Gene or Genome]
Processing 00000000.tx.379: J. 

Phrase: "J."
Processing 00000000.tx.380: Med., 339, 10441053.[Free FullText] Lang, A.E. and Lozano, A.M. 

Phrase: "Med.,"

Phrase: "339,"

Phrase: "10441053."

Phrase: "[Free FullText"

Phrase: "] Lang,"

Phrase: "A.E."

Phrase: "and"

Phrase: "Lozano,"

Phrase: "A.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.381: (1998) Parkinson's disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.382: Second of two parts. 

Phrase: "Second of two parts."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205436:Second [Quantitative Concept]
   770   C0457385:Second [Temporal Concept]
   770   C0565930:/second [Quantitative Concept]
   770   C1561503:second [Idea or Concept]
   770   C1705190:Second [Qualitative Concept]
Processing 00000000.tx.383: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.384: Engl. 

Phrase: "Engl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414400:ENGL [Gene or Genome]
Processing 00000000.tx.385: J. 

Phrase: "J."
Processing 00000000.tx.386: Med., 339, 11301143.[Free FullText] Spillantini, M.G., Crowther, R.A., Jakes, R., Hasegawa, M. and Goedert, M. 

Phrase: "Med.,"

Phrase: "339,"

Phrase: "11301143."

Phrase: "[Free FullText"

Phrase: "] Spillantini,"

Phrase: "M."

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A.,"

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hasegawa,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.387: (1998) -Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. 

Phrase: "(1998"

Phrase: ") -"

Phrase: "Synuclein in filamentous inclusions of Lewy bodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "from Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "and"

Phrase: "dementia with lewy bodies."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   865 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]
Processing 00000000.tx.388: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.389: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.390: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.391: USA, 95, 64696473.[Abstract/Free FullText] Gasser, T. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "95,"

Phrase: "64696473."

Phrase: "[Abstract/Free FullText"

Phrase: "] Gasser,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.392: (2003) Overview of the genetics of parkinsonism. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Overview of the genetics of parkinsonism."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0814812:overview [Intellectual Product]
Processing 00000000.tx.393: Adv. 

Phrase: "Adv."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001483:ADV [Virus]
Processing 00000000.tx.394: Neurol., 91, 143152.[ISI][Medline] Dawson, T.M. and Dawson, V.L. 

Phrase: "Neurol.,"

Phrase: "91,"

Phrase: "143152."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "T.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "V.L."
Processing 00000000.tx.395: (2003) Rare genetic mutations shed light on the pathogenesis of Parkinson disease. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Rare genetic mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0026882:genetic mutations [Genetic Function]
           Mutations
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "shed"

Phrase: "light on the pathogenesis of Parkinson disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0023693:Light [Natural Phenomenon or Process]
   748   C1306462:Light [Functional Concept]
   748   C1881376:Light [Qualitative Concept]
Processing 00000000.tx.396: J. 

Phrase: "J."
Processing 00000000.tx.397: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.398: Invest., 111, 145151.[Free FullText] Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R. etal. 

Phrase: "Invest.,"

Phrase: "111,"

Phrase: "145151."

Phrase: "[Free FullText"

Phrase: "] Polymeropoulos,"

Phrase: "M."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lavedan,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Leroy,"

Phrase: "E.,"

Phrase: "Ide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "S."

Phrase: "E.,"

Phrase: "Dehejia,"

Phrase: "A.,"

Phrase: "Dutra,"

Phrase: "A.,"

Phrase: "Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Root,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040452:Root [Body Part, Organ, or Organ Component]
  1000   C0242726:Root [Plant]
  1000   C1318154:Root [Body Part, Organ, or Organ Component]
  1000   C1705917:Root [Idea or Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rubenstein,"

Phrase: "J.,"

Phrase: "Boyer,"

Phrase: "R. etal."
Processing 00000000.tx.399: (1997) Mutation in the -synuclein gene identified in families with Parkinson's disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Mutation in the -synuclein gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0596611:Gene Mutation [Genetic Function]
   760   C0026882:Mutation [Genetic Function]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "identified in families"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0015576:Families [Family Group]
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]
   790   C1704727:Family [Conceptual Entity]
   706 E C0241888:Familial [Functional Concept]

Phrase: "with Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.400: Science, 276, 20452047.[Abstract/Free FullText] Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y. and Shimizu, N. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "276,"

Phrase: "20452047."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kitada,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Asakawa,"

Phrase: "S."

Phrase: ","

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Matsumine,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yamamura,"

Phrase: "Y.,"

Phrase: "Minoshima,"

Phrase: "S."

Phrase: ","

Phrase: "Yokochi,"

Phrase: "M."

Phrase: ","

Phrase: "Mizuno,"

Phrase: "Y."

Phrase: "and"

Phrase: "Shimizu,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.401: (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Mutations in the parkin gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0596611:gene mutations [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "autosomal recessive juvenile parkinsonism."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   923   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   861   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   812   C0242422:Parkinsonism [Disease or Syndrome]
Processing 00000000.tx.402: Nature, 392, 605608.[CrossRef][ISI][Medline] Bonifati, V., Rizzu, P., van Baren, M.J., Schaap, O., Breedveld, G.J., Krieger, E., Dekker, M.C., Squitieri, F., Ibanez, P., Joosse, M. etal. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "392,"

Phrase: "605608."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bonifati,"

Phrase: "V.,"

Phrase: "Rizzu,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "van Baren,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Schaap,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Breedveld,"

Phrase: "G.J.,"

Phrase: "Krieger,"

Phrase: "E.,"

Phrase: "Dekker,"

Phrase: "M.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Squitieri,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Ibanez,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Joosse,"

Phrase: "M. etal."
Processing 00000000.tx.403: (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Mutations in the DJ-1 gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C0596611:gene mutations [Genetic Function]
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "associated with autosomal recessive early-onset parkinsonism."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   814   C1838631:Parkinsonism, early-onset [Finding]
   804   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C0441748:Autosomal recessive [Intellectual Product]
   778   C1833334:Early-onset [Finding]
   748   C0242422:Parkinsonism [Disease or Syndrome]
   748   C0332162:Onset [Qualitative Concept]
   748   C0596142:autosomal [Cell Component]
   748   C1279919:Early [Temporal Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.404: Science, 299, 256259.[Abstract/Free FullText] Valente, E.M., Abou-Sleiman, P.M., Caputo, V., Muqit, M.M., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A.R., Healy, D.G. etal. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "299,"

Phrase: "256259."

Phrase: "[Abstract/Free FullText"

Phrase: "] Valente,"

Phrase: "E.M.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Abou-Sleiman,"

Phrase: "P.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Caputo,"

Phrase: "V.,"

Phrase: "Muqit,"

Phrase: "M."

Phrase: "M."

Phrase: ","

Phrase: "Harvey,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Gispert,"

Phrase: "S."

Phrase: ","

Phrase: "Ali,"

Phrase: "Z.,"

Phrase: "Del Turco,"

Phrase: "D."

Phrase: ","

Phrase: "Bentivoglio,"

Phrase: "A.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Healy,"

Phrase: "D."

Phrase: "G. etal."
Processing 00000000.tx.405: (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Hereditary early-onset Parkinson's disease"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   897   C0019247:Hereditary Disease [Disease or Syndrome]
   875   C0679245:early disease [Temporal Concept]
   840   C0030567:Parkinson Disease [Disease or Syndrome]
   840   C1521736:Parkinson's Disease [Functional Concept]
   840   C2681933:PARKINSON DISEASE [Gene or Genome]
   804   C0012634:Disease [Disease or Syndrome]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]
   704   C1021144:Parkinsonia [Plant]

Phrase: "caused by mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0026882:Mutations [Genetic Function]
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in PINK1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422771:PINK1 [Gene or Genome]
Processing 00000000.tx.406: Science, 304, 11581160.[Abstract/Free FullText] Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., Przuntek, H., Epplen, J.T., Schols, L. and Riess, O. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "304,"

Phrase: "11581160."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kruger,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kuhn,"

Phrase: "W.,"

Phrase: "Muller,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Woitalla,"

Phrase: "D."

Phrase: ","

Phrase: "Graeber,"

Phrase: "M."

Phrase: ","

Phrase: "Kosel,"

Phrase: "S."

Phrase: ","

Phrase: "Przuntek,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Epplen,"

Phrase: "J.T.,"

Phrase: "Schols,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Riess,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.407: (1998) Ala30Pro mutation in the gene encoding -synuclein in Parkinson's disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Ala30Pro mutation in the gene encoding -synuclein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0596611:Gene Mutation [Genetic Function]
   748   C0026882:Mutation [Genetic Function]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.408: Nat. 

Phrase: "Nat."
Processing 00000000.tx.409: Genet., 18, 106108.[ISI][Medline] Zarranz, J.J., Alegre, J., Gomez-Esteban, J.C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atares, B. etal. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "18,"

Phrase: "106108."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zarranz,"

Phrase: "J.J.,"

Phrase: "Alegre,"

Phrase: "J.,"

Phrase: "Gomez-Esteban,"

Phrase: "J.C., Lezcano,"

Phrase: "E.,"

Phrase: "Ros,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Ampuero,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Vidal,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Hoenicka,"

Phrase: "J.,"

Phrase: "Rodriguez,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Atares,"

Phrase: "B. etal."
Processing 00000000.tx.410: (2004) The new mutation, E46K, of -synuclein causes Parkinson and Lewy body dementia. 

Phrase: "(2004"

Phrase: ")"

Phrase: "The new mutation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2985439:new mutation [Cell or Molecular Dysfunction]
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "E46K,"

Phrase: "of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "Parkinson"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   900   C1021144:Parkinsonia [Plant]

Phrase: "and"

Phrase: "Lewy body dementia."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0752347:Dementia, Lewy Body [Disease or Syndrome]
  1000   C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   901   C0085200:Lewy Body [Cell Component]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   827   C1268086:Body [Anatomical Structure]
   743 E C1995017:Bodies [Cell Component]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.411: Ann. 

Phrase: "Ann."
Processing 00000000.tx.412: Neurol., 55, 164173.[CrossRef][ISI][Medline] Farrer, M., Kachergus, J., Forno, L., Lincoln, S., Wang, D.S., Hulihan, M., Maraganore, D., Gwinn-Hardy, K., Wszolek, Z., Dickson, D. etal. 

Phrase: "Neurol.,"

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "164173."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Kachergus,"

Phrase: "J.,"

Phrase: "Forno,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Lincoln,"

Phrase: "S."

Phrase: ","

Phrase: "Wang,"

Phrase: "D.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Hulihan,"

Phrase: "M."

Phrase: ","

Phrase: "Maraganore,"

Phrase: "D."

Phrase: ","

Phrase: "Gwinn-Hardy,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Wszolek,"

Phrase: "Z.,"

Phrase: "Dickson,"

Phrase: "D. etal."
Processing 00000000.tx.413: (2004) Comparison of kindreds with parkinsonism and -synuclein genomic multiplications. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Comparison of kindreds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Comparison [Activity]

Phrase: "with parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "and -"

Phrase: "synuclein genomic multiplications."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2911648:Multiplication [Quantitative Concept]
Processing 00000000.tx.414: Ann. 

Phrase: "Ann."
Processing 00000000.tx.415: Neurol., 55, 174179.[CrossRef][ISI][Medline] Singleton, A.B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R. etal. 

Phrase: "Neurol.,"

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "174179."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Singleton,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0481462:singleton [Finding]
  1000   C1313913:Singleton [Family Group]

Phrase: "A.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1440044:A,B [Immunologic Factor]

Phrase: "Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Johnson,"

Phrase: "J.,"

Phrase: "Singleton,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0481462:singleton [Finding]
  1000   C1313913:Singleton [Family Group]

Phrase: "A.,"

Phrase: "Hague,"

Phrase: "S."

Phrase: ","

Phrase: "Kachergus,"

Phrase: "J.,"

Phrase: "Hulihan,"

Phrase: "M."

Phrase: ","

Phrase: "Peuralinna,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Dutra,"

Phrase: "A.,"

Phrase: "Nussbaum,"

Phrase: "R. etal."
Processing 00000000.tx.416: (2003) -Synuclein locus triplication causes Parkinson's disease. 

Phrase: "(2003"

Phrase: ") -"

Phrase: "Synuclein locus triplication"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.417: Science, 302, 841.[Free FullText] Bonifati, V., De Michele, G., Lucking, C.B., Durr, A., Fabrizio, E., Ambrosio, G., Vanacore, N., De Mari, M., Marconi, R., Capus, L. etal. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "302,"

Phrase: "841."

Phrase: "[Free FullText"

Phrase: "] Bonifati,"

Phrase: "V.,"

Phrase: "De Michele,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Lucking,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0870824:luck [Qualitative Concept]

Phrase: "C.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Durr,"

Phrase: "A.,"

Phrase: "Fabrizio,"

Phrase: "E.,"

Phrase: "Ambrosio,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Vanacore,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "De Mari,"

Phrase: "M."

Phrase: ","

Phrase: "Marconi,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Capus,"

Phrase: "L. etal."
Processing 00000000.tx.418: (2001) The parkin gene and its phenotype. 

Phrase: "(2001"

Phrase: ")"

Phrase: "The parkin gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1418270:parkin gene [Gene or Genome]
  1000   C2983548:Parkin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "its phenotype."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031437:Phenotype [Organism Attribute]
  1000   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.419: Italian PD Genetics Study Group, French PD Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease. 

Phrase: "Italian PD Genetics Study Group,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C0441833:Group [Idea or Concept]
   804   C0557651:Study [Manufactured Object]
   804   C0687744:group [Population Group]
   804   C1257890:Group [Population Group]
   804   C1552516:Group [Health Care Related Organization]
   804   C1705428:Group [Conceptual Entity]
   804   C1705429:Group [Population Group]
   804   C2603343:Study [Research Activity]

Phrase: "French PD Genetics Study Group"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C0441833:Group [Idea or Concept]
   804   C0557651:Study [Manufactured Object]
   804   C0687744:group [Population Group]
   804   C1257890:Group [Population Group]
   804   C1552516:Group [Health Care Related Organization]
   804   C1705428:Group [Conceptual Entity]
   804   C1705429:Group [Population Group]
   804   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "the European Consortium on Genetic Susceptibility"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1513822:Consortium [Professional or Occupational Group]
   753   C1880171:Consortium [Professional or Occupational Group]

Phrase: "in Parkinson's Disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.420: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.421: Sci., 22, 5152.[CrossRef][ISI][Medline] Mizuno, Y., Hattori, N., Mori, H., Suzuki, T. and Tanaka, K. 

Phrase: "Sci.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]

Phrase: "22,"

Phrase: "5152."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mizuno,"

Phrase: "Y.,"

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Mori,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Tanaka,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.422: (2001) Parkin and Parkinson's disease. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.423: Curr. 

Phrase: "Curr."
Processing 00000000.tx.424: Opin. 

Phrase: "Opin."
Processing 00000000.tx.425: Neurol., 14, 477482.[CrossRef][ISI][Medline] Zhang, Y., Gao, J., Chung, K.K., Huang, H., Dawson, V.L. and Dawson, T.M. 

Phrase: "Neurol.,"

Phrase: "14,"

Phrase: "477482."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zhang,"

Phrase: "Y.,"

Phrase: "Gao,"

Phrase: "J.,"

Phrase: "Chung,"

Phrase: "K.K.,"

Phrase: "Huang,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "V.L."

Phrase: "and"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "T.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.426: (2000) Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "functions as an E2-dependent ubiquitin-protein ligase"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   800   C0077678:ubiquitin-protein ligase [Amino Acid, Peptide, or Protein,Enzyme]
   800   C1256818:Ubiquitin Protein Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   800   C1307637:Ubiquitin-Protein Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   800   C1442769:ubiquitin-protein ligase [Gene or Genome]
   767   C0815043:function protein [Amino Acid, Peptide, or Protein]
   767   C1527118:Protein Function [Molecular Function]
   744   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0031843:function [Physiologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0542341:Function [Functional Concept]
   744   C0700205:FUNCTION [Classification]
   744   C0851827:Dependent [Qualitative Concept]
   744   C1701901:Dependent [Qualitative Concept]
   744   C1705273:Function [Intellectual Product]
   744   C3244310:dependent [Functional Concept]
   744   C3539520:E2 [Gene or Genome]

Phrase: "and"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the degradation of the synaptic vesicle-associated protein,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0597297:Protein Degradation [Molecular Function]
   767   C0597304:Protein Degradation [Molecular Function]
   767   C1623036:Protein Degradation [Molecular Function]
   744   C0243125:degradation [Functional Concept]
   744   C0699900:Degradation [Organism Function]

Phrase: "CDCrel-1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3273594:CDCREL-1 [Gene or Genome]
           CDCREL
  1000   C3273595:CDCrel-1 [Amino Acid, Peptide, or Protein]
   861   C1539748:CDCREL [Gene or Genome]
Processing 00000000.tx.427: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.428: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.429: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.430: USA, 97, 1335413359.[Abstract/Free FullText] Shimura, H., Hattori, N., Kubo, S., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K. etal. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "97,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: "1335413359."

Phrase: "[Abstract/Free FullText"

Phrase: "] Shimura,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kubo,"

Phrase: "S."

Phrase: ","

Phrase: "Mizuno,"

Phrase: "Y.,"

Phrase: "Asakawa,"

Phrase: "S."

Phrase: ","

Phrase: "Minoshima,"

Phrase: "S."

Phrase: ","

Phrase: "Shimizu,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Iwai,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Chiba,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tanaka,"

Phrase: "K. etal."
Processing 00000000.tx.431: (2000) Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Familial Parkinson disease gene product,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1416989:MAL gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   804   C1514468:product [Entity]
   804   C1704444:Product [Quantitative Concept]

Phrase: "parkin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "a ubiquitin-protein ligase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0077678:ubiquitin-protein ligase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1256818:Ubiquitin Protein Ligase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1307637:Ubiquitin-Protein Ligase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1442769:ubiquitin-protein ligase [Gene or Genome]
   827   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.432: Nat. 

Phrase: "Nat."
Processing 00000000.tx.433: Genet., 25, 302305.[CrossRef][ISI][Medline] Imai, Y., Soda, M. and Takahashi, R. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "25,"

Phrase: "302305."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Imai,"

Phrase: "Y.,"

Phrase: "Soda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683086:soda [Food]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Takahashi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.434: (2000) Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "unfolded protein stress-induced cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0007587:Cell Death [Cell Function]
   799   C0007634:Cell [Cell]
   799   C0011065:Death [Organism Function]
   799   C1269647:Cell [Cell]
   799   C1306577:Death, NOS [Finding]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]

Phrase: "through its E3 ubiquitin-protein ligase activity."
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   937   C1150685:ubiquitin-protein ligase activity [Molecular Function]
           ubiquitin-ligase activity
   875   C1325411:ubiquitin activity [Molecular Function]
   853   C1537044:protein activity [Molecular Function]
   840   C1150651:ligase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   722   C0077678:E3 Ubiquitin Ligase [Amino Acid, Peptide, or Protein,Enzyme]
           ubiquitin-protein ligase
           E3 Ligase
   722   C1418270:E3 ubiquitin ligase [Gene or Genome]
   717   C1256818:Ubiquitin Protein Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1307637:Ubiquitin-Protein Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1442769:ubiquitin-protein ligase [Gene or Genome]
Processing 00000000.tx.435: J. 

Phrase: "J."
Processing 00000000.tx.436: Biol. 

Phrase: "Biol."
Processing 00000000.tx.437: Chem., 275, 3566135664.[Abstract/Free FullText] Shimura, H., Schlossmacher, M.G., Hattori, N., Frosch, M.P., Trockenbacher, A., Schneider, R., Mizuno, Y., Kosik, K.S. and Selkoe, D.J. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "275,"

Phrase: "3566135664."

Phrase: "[Abstract/Free FullText"

Phrase: "] Shimura,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Schlossmacher,"

Phrase: "M."

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Frosch,"

Phrase: "M."

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Trockenbacher,"

Phrase: "A.,"

Phrase: "Schneider,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Mizuno,"

Phrase: "Y.,"

Phrase: "Kosik,"

Phrase: "K.S."

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.438: (2001) Ubiquitination of a new form of -synuclein by parkin from human brain: implications for Parkinson's disease. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Ubiquitination of a new form of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1519751:Ubiquitination [Molecular Function]

Phrase: "by parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "from human brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "implications for Parkinson's disease."
Processing 00000000.tx.439: Science, 293, 263269.[Abstract/Free FullText] Chung, K.K., Zhang, Y., Lim, K.L., Tanaka, Y., Huang, H., Gao, J., Ross, C.A., Dawson, V.L. and Dawson, T.M. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "293,"

Phrase: "263269."

Phrase: "[Abstract/Free FullText"

Phrase: "] Chung,"

Phrase: "K.K.,"

Phrase: "Zhang,"

Phrase: "Y.,"

Phrase: "Lim,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449205:LIM [Body Location or Region]
  1000   C1538613:LIM [Gene or Genome]

Phrase: "K.L., Tanaka,"

Phrase: "Y.,"

Phrase: "Huang,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Gao,"

Phrase: "J.,"

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "C."

Phrase: "A.,"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "V.L."

Phrase: "and"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "T.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.440: (2001) Parkin ubiquitinates the -synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "ubiquitinates"

Phrase: "the -synuclein-interacting protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "synphilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420277:SYNPHILIN 1 [Gene or Genome]
           synphilin
  1000   C3541909:Synphilin-1 [Amino Acid, Peptide, or Protein]

Phrase: ":"

Phrase: "implications for Lewy-body formation"

Phrase: "in Parkinson disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.441: Nat. 

Phrase: "Nat."
Processing 00000000.tx.442: Med., 7, 11441150.[CrossRef][ISI][Medline] Imai, Y., Soda, M., Inoue, H., Hattori, N., Mizuno, Y. and Takahashi, R. 

Phrase: "Med.,"

Phrase: "7,"

Phrase: "11441150."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Imai,"

Phrase: "Y.,"

Phrase: "Soda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683086:soda [Food]

Phrase: "M."

Phrase: ","

Phrase: "Inoue,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Mizuno,"

Phrase: "Y."

Phrase: "and"

Phrase: "Takahashi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.443: (2001) An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of parkin. 

Phrase: "(2001"

Phrase: ")"

Phrase: "An unfolded putative transmembrane polypeptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "which"

Phrase: "can"

Phrase: "lead to endoplasmic reticulum stress,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   760   C0038435:Stress [Finding]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "a substrate of parkin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.444: Cell, 105, 891902.[CrossRef][ISI][Medline] Staropoli, J.F., McDermott, C., Martinat, C., Schulman, B., Demireva, E. and Abeliovich, A. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "105,"

Phrase: "891902."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Staropoli,"

Phrase: "J.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "McDermott,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Martinat,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Schulman,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Demireva,"

Phrase: "E."

Phrase: "and"

Phrase: "Abeliovich,"

Phrase: "A."
Processing 00000000.tx.445: (2003) Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "a component of an SCF-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449432:Component [Manufactured Object]
   760   C1705248:Component [Conceptual Entity]

Phrase: "like ubiquitin ligase complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1167313:ubiquitin ligase complex [Cell Component]
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "protects"

Phrase: "postmitotic neurons from kainate excitotoxicity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0027882:Neurons [Cell]
Processing 00000000.tx.446: Neuron, 37, 735749.[ISI][Medline] Ren, Y., Zhao, J. and Feng, J. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "37,"

Phrase: "735749."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ren,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022646:Ren [Body Part, Organ, or Organ Component]
  1000   C1419338:REN [Gene or Genome]
  1000   C1427479:REN [Gene or Genome]

Phrase: "Y.,"

Phrase: "Zhao,"

Phrase: "J."

Phrase: "and"

Phrase: "Feng,"

Phrase: "J."
Processing 00000000.tx.447: (2003) Parkin binds to / tubulin and increases their ubiquitination and degradation. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "to / tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2937342:tubulin [Cell Component]

Phrase: "and"

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "their ubiquitination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519751:Ubiquitination [Molecular Function]

Phrase: "and"

Phrase: "degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]
Processing 00000000.tx.448: J. 

Phrase: "J."
Processing 00000000.tx.449: Neurosci., 23, 33163324.[Abstract/Free FullText] Corti, O., Hampe, C., Koutnikova, H., Darios, F., Jacquier, S., Prigent, A., Robinson, J.C., Pradier, L., Ruberg, M., Mirande, M. etal. 

Phrase: "Neurosci.,"

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "33163324."

Phrase: "[Abstract/Free FullText"

Phrase: "] Corti,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Hampe,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Koutnikova,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Darios,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Jacquier,"

Phrase: "S."

Phrase: ","

Phrase: "Prigent,"

Phrase: "A.,"

Phrase: "Robinson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443050:Robinson [Intellectual Product]

Phrase: "J.C., Pradier,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Ruberg,"

Phrase: "M."

Phrase: ","

Phrase: "Mirande,"

Phrase: "M. etal."
Processing 00000000.tx.450: (2003) The p38 subunit of the aminoacyl-tRNA synthetase complex is a parkin substrate: linking protein biosynthesis and neurodegeneration. 

Phrase: "(2003"

Phrase: ")"

Phrase: "The p38 subunit of the aminoacyl-tRNA synthetase complex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1711351:Subunit [Quantitative Concept]

Phrase: "is"

Phrase: "a parkin substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710236:Substrate [Manufactured Object]

Phrase: ":"

Phrase: "linking"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "protein biosynthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0597295:Protein Biosynthesis [Molecular Function]
   861   C0005572:biosynthesis [Functional Concept]
   861   C0220781:Biosynthesis [Biologic Function]

Phrase: "and"

Phrase: "neurodegeneration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
Processing 00000000.tx.451: Hum. 

Phrase: "Hum."
Processing 00000000.tx.452: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.453: Genet., 12, 14271437.[Abstract/Free FullText] Tsai, Y.C., Fishman, P.S., Thakor, N.V. and Oyler, G.A. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "12,"

Phrase: "14271437."

Phrase: "[Abstract/Free FullText"

Phrase: "] Tsai,"

Phrase: "Y.C., Fishman,"

Phrase: "P.S.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0234833:P s [Organ or Tissue Function]
  1000   C0722388:P & S [Organic Chemical,Pharmacologic Substance]

Phrase: "Thakor,"

Phrase: "N.V."

Phrase: "and"

Phrase: "Oyler,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "A."
Processing 00000000.tx.454: (2003) Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "facilitates"

Phrase: "the elimination of expanded polyglutamine proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0221102:Elimination [Physiologic Function]

Phrase: "and"

Phrase: "leads to preservation of proteasome function."
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   783   C3640044:Lead Function [Conceptual Entity]
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0031843:function [Physiologic Function]
   753   C0033085:Preservation [Laboratory Procedure]
   753   C0181586:leads [Medical Device]
   753   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1325620:proteasome [Cell Component]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1514402:Preservation [Laboratory Procedure]
   753   C1522538:Lead [Functional Concept]
   753   C1705273:Function [Intellectual Product]
   753   C1752727:Proteasome [Molecular Function]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.455: J. 

Phrase: "J."
Processing 00000000.tx.456: Biol. 

Phrase: "Biol."
Processing 00000000.tx.457: Chem., 278, 2204422055.[Abstract/Free FullText] Huynh, D.P., Scoles, D.R., Nguyen, D. and Pulst, S.M. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "278,"

Phrase: "2204422055."

Phrase: "[Abstract/Free FullText"

Phrase: "] Huynh,"

Phrase: "D.P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1512024:D.P. [Intellectual Product]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Scoles,"

Phrase: "D.R.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Nguyen,"

Phrase: "D."

Phrase: "and"

Phrase: "Pulst,"

Phrase: "S.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.458: (2003) The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI. 

Phrase: "(2003"

Phrase: ")"

Phrase: "The autosomal recessive juvenile Parkinson disease gene product,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0017361:Recessive gene [Gene or Genome]
   818   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0017337:Gene [Gene or Genome]
   795   C1514468:product [Entity]
   795   C1704444:Product [Quantitative Concept]
   790   C1416989:MAL gene [Gene or Genome]
   747   C1868675:Autosomal Recessive Juvenile Parkinson Disease [Disease or Syndrome]

Phrase: "parkin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "interacts with"

Phrase: "and"

Phrase: "ubiquitinates"

Phrase: "synaptotagmin XI."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0539651:synaptotagmin XI [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1426106:synaptotagmin XI [Gene or Genome]
   861   C1720296:Xi [Intellectual Product]
Processing 00000000.tx.459: Hum. 

Phrase: "Hum."
Processing 00000000.tx.460: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.461: Genet., 12, 25872597.[Abstract/Free FullText] Imai, Y., Soda, M., Hatakeyama, S., Akagi, T., Hashikawa, T., Nakayama, K.I. and Takahashi, R. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "12,"

Phrase: "25872597."

Phrase: "[Abstract/Free FullText"

Phrase: "] Imai,"

Phrase: "Y.,"

Phrase: "Soda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683086:soda [Food]

Phrase: "M."

Phrase: ","

Phrase: "Hatakeyama,"

Phrase: "S."

Phrase: ","

Phrase: "Akagi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hashikawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Nakayama,"

Phrase: "K.I."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Takahashi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.462: (2002) CHIP is associated with parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity. 

Phrase: "(2002"

Phrase: ")"

Phrase: "CHIP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600596:Chip [Research Device]

Phrase: "is"

Phrase: "associated with parkin,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1418270:PARKIN [Gene or Genome]
   790   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "a gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "responsible for familial Parkinson's disease,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "and"

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "its ubiquitin ligase activity."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1150685:ubiquitin-ligase activity [Molecular Function]
   913   C1325411:ubiquitin activity [Molecular Function]
   901   C1150651:ligase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.463: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.464: Cell, 10, 5567.[ISI][Medline] Hague, S., Rogaeva, E., Hernandez, D., Gulick, C., Singleton, A., Hanson, M., Johnson, J., Weiser, R., Gallardo, M., Ravina, B. etal. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "10,"

Phrase: "5567."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hague,"

Phrase: "S."

Phrase: ","

Phrase: "Rogaeva,"

Phrase: "E.,"

Phrase: "Hernandez,"

Phrase: "D."

Phrase: ","

Phrase: "Gulick,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Singleton,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0481462:singleton [Finding]
  1000   C1313913:Singleton [Family Group]

Phrase: "A.,"

Phrase: "Hanson,"

Phrase: "M."

Phrase: ","

Phrase: "Johnson,"

Phrase: "J.,"

Phrase: "Weiser,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Gallardo,"

Phrase: "M."

Phrase: ","

Phrase: "Ravina,"

Phrase: "B. etal."
Processing 00000000.tx.465: (2003) Early-onset Parkinson's disease caused by a compound heterozygous DJ-1 mutation. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Early-onset Parkinson's disease"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   902   C0679245:early disease [Temporal Concept]
   861   C0030567:Parkinson Disease [Disease or Syndrome]
   861   C1521736:Parkinson's Disease [Functional Concept]
   861   C2681933:PARKINSON DISEASE [Gene or Genome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
   712   C1021144:Parkinsonia [Plant]

Phrase: "caused by a compound heterozygous DJ-1 mutation."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C1424222:DJ-1 [Gene or Genome]
   770   C3541418:DJ-1 [Gene or Genome]
   744   C0012836:DJ [Geographic Area]
   744   C0019425:Heterozygous [Organism Attribute]
   744   C0026882:Mutation [Genetic Function]
   744   C0205198:Compound [Qualitative Concept]
   744   C1705285:Mutation [Cell or Molecular Dysfunction]
   744   C1706082:Compound [Chemical]
   711   C0015127:cause [Functional Concept]
   711   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.466: Ann. 

Phrase: "Ann."
Processing 00000000.tx.467: Neurol., 54, 271274.[CrossRef][ISI][Medline] Abou-Sleiman, P.M., Healy, D.G., Quinn, N., Lees, A.J. and Wood, N.W. 

Phrase: "Neurol.,"

Phrase: "54,"

Phrase: "271274."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Abou-Sleiman,"

Phrase: "P.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Healy,"

Phrase: "D."

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Quinn,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Lees,"

Phrase: "A.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]

Phrase: "and"

Phrase: "Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0043217:Wood [Substance]
   944 E C0144237:Sylvan [Organic Chemical]
   916 E C0442548:Woods [Geographic Area]

Phrase: "N.W."
Processing 00000000.tx.468: (2003) The role of pathogenic DJ-1 mutations in Parkinson's disease. 

Phrase: "(2003"

Phrase: ")"

Phrase: "The role of pathogenic DJ-1 mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.469: Ann. 

Phrase: "Ann."
Processing 00000000.tx.470: Neurol., 54, 283286.[CrossRef][ISI][Medline] Hedrich, K., Djarmati, A., Schafer, N., Hering, R., Wellenbrock, C., Weiss, P.H., Hilker, R., Vieregge, P., Ozelius, L.J., Heutink, P. etal. 

Phrase: "Neurol.,"

Phrase: "54,"

Phrase: "283286."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hedrich,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Djarmati,"

Phrase: "A.,"

Phrase: "Schafer,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Hering,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wellenbrock,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Weiss,"

Phrase: "P.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Hilker,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Vieregge,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ozelius,"

Phrase: "L.J.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Heutink,"

Phrase: "P. etal."
Processing 00000000.tx.471: (2004) DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease. 

Phrase: "(2004"

Phrase: ")"

Phrase: "DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "(PARK7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:PARK7 [Gene or Genome]
  1000   C1853445:PARK7 [Disease or Syndrome]
  1000   C3538910:PARK7 [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: "mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "less frequent than Parkin (PARK2) mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332183:Frequent [Temporal Concept]
   745   C3178846:Mutation Frequencies [Qualitative Concept]

Phrase: "in early-onset Parkinson disease."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   902   C0679245:early disease [Temporal Concept]
   861   C0030567:Parkinson Disease [Disease or Syndrome]
   861   C1521736:Parkinson's Disease [Functional Concept]
   861   C2681933:PARKINSON DISEASE [Gene or Genome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
   712   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.472: Neurology, 62, 389394.[Abstract/Free FullText] Clark, L.N., Afridi, S., Mejia-Santana, H., Harris, J., Louis, E.D., Cote, L.J., Andrews, H., Singleton, A., Wavrant De-Vrieze, F., Hardy, J. etal. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "62,"

Phrase: "389394."

Phrase: "[Abstract/Free FullText"

Phrase: "] Clark,"

Phrase: "L.N., Afridi,"

Phrase: "S."

Phrase: ","

Phrase: "Mejia-Santana,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Harris,"

Phrase: "J.,"

Phrase: "Louis,"

Phrase: "E."

Phrase: "D."

Phrase: ","

Phrase: "Cote,"

Phrase: "L.J.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Andrews,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Singleton,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0481462:singleton [Finding]
  1000   C1313913:Singleton [Family Group]

Phrase: "A.,"

Phrase: "Wavrant De-Vrieze,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Hardy,"

Phrase: "J. etal."
Processing 00000000.tx.473: (2004) Analysis of an early-onset Parkinson's disease cohort for DJ-1 mutations. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Analysis of an early-onset Parkinson's disease cohort"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0086027:Analysis, Cohort [Research Activity]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "for DJ-1 mutations."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]
   734   C1424222:DJ-1 [Gene or Genome]
   734   C3541418:DJ-1 [Gene or Genome]
Processing 00000000.tx.474: Movement Disord., 19, 796800.[CrossRef][ISI][Medline] Hedrich, K., Schafer, N., Hering, R., Hagenah, J., Lanthaler, A.J., Schwinger, E., Kramer, P.L., Ozelius, L.J., Bressman, S.B., Abbruzzese, G. etal. 

Phrase: "Movement Disord.,"

Phrase: "19,"

Phrase: "796800."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hedrich,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Schafer,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Hering,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hagenah,"

Phrase: "J.,"

Phrase: "Lanthaler,"

Phrase: "A.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]

Phrase: "Schwinger,"

Phrase: "E.,"

Phrase: "Kramer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331847:Kramer [Health Care Related Organization]

Phrase: "P.L., Ozelius,"

Phrase: "L.J.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Bressman,"

Phrase: "S."

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Abbruzzese,"

Phrase: "G. etal."
Processing 00000000.tx.475: (2004) The R98Q variation in DJ-1 represents a rare polymorphism. 

Phrase: "(2004"

Phrase: ")"

Phrase: "The R98Q variation in DJ-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205419:Variation [Qualitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a rare polymorphism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]
Processing 00000000.tx.476: Ann. 

Phrase: "Ann."
Processing 00000000.tx.477: Neurol., 55, 145.[Medline] Moore, D.J., Zhang, L., Dawson, T.M. and Dawson, V.L. 

Phrase: "Neurol.,"

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "145."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Moore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443030:moore [Intellectual Product]

Phrase: "D.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Zhang,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "T.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "V.L."
Processing 00000000.tx.478: (2003) A missense mutation (L166P) in DJ-1, linked to familial Parkinson's disease, confers reduced protein stability and impairs homo-oligomerization. 

Phrase: "(2003"

Phrase: ")"

Phrase: "A missense mutation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599155:Missense Mutation [Genetic Function]
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(L166P"

Phrase: ")"

Phrase: "in DJ-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "linked to familial Parkinson's disease,"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   806   C0030567:Parkinson Disease [Disease or Syndrome]
   806   C1521736:Parkinson's Disease [Functional Concept]
   806   C2681933:PARKINSON DISEASE [Gene or Genome]
   797   C0277558:Familial disease [Disease or Syndrome]
   762 E C0344339:disease family [Finding]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "confers"

Phrase: "reduced protein stability"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C2350440:Protein Stability [Qualitative Concept]
   827   C0205360:Stability [Qualitative Concept]
   827   C2347098:Stability [Qualitative Concept]
   755 E C1547311:Stable [Intellectual Product]

Phrase: "and"

Phrase: "impairs"

Phrase: "homo-oligomerization."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1300203:Homo [Mammal]
   861   C3245470:HOMO [Finding]
Processing 00000000.tx.479: J. 

Phrase: "J."
Processing 00000000.tx.480: Neurochem., 87, 15581567.[CrossRef][ISI][Medline] Miller, D.W., Ahmad, R., Hague, S., Baptista, M.J., Canet-Aviles, R., McLendon, C., Carter, D.M., Zhu, P.P., Stadler, J., Chandran, J. etal. 

Phrase: "Neurochem.,"

Phrase: "87,"

Phrase: "15581567."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "D.W.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Ahmad,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hague,"

Phrase: "S."

Phrase: ","

Phrase: "Baptista,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Canet-Aviles,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "McLendon,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Carter,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "Zhu,"

Phrase: "P.P.,"

Phrase: "Stadler,"

Phrase: "J.,"

Phrase: "Chandran,"

Phrase: "J. etal."
Processing 00000000.tx.481: (2003) L166P mutant DJ-1, causative for recessive Parkinson's disease, is degraded through the ubiquitin-proteasome system. 

Phrase: "(2003"

Phrase: ")"

Phrase: "L166P mutant DJ-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1424222:DJ-1 [Gene or Genome]
   861   C3541418:DJ-1 [Gene or Genome]
   812   C0012836:DJ [Geographic Area]
   812   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "causative for recessive Parkinson's disease,"

Phrase: "is"

Phrase: "degraded through the ubiquitin-proteasome system."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0449913:System [Functional Concept]
   753   C1325620:proteasome [Cell Component]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]
   753   C1752727:Proteasome [Molecular Function]
   753   C1881707:DEGRADED [Phenomenon or Process]
Processing 00000000.tx.482: J. 

Phrase: "J."
Processing 00000000.tx.483: Biol. 

Phrase: "Biol."
Processing 00000000.tx.484: Chem., 278, 3658836595.[Abstract/Free FullText] Macedo, M.G., Anar, B., Bronner, I.F., Cannella, M., Squitieri, F., Bonifati, V., Hoogeveen, A., Heutink, P. and Rizzu, P. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "278,"

Phrase: "3658836595."

Phrase: "[Abstract/Free FullText"

Phrase: "] Macedo,"

Phrase: "M."

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Anar,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Bronner,"

Phrase: "I.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Cannella,"

Phrase: "M."

Phrase: ","

Phrase: "Squitieri,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Bonifati,"

Phrase: "V.,"

Phrase: "Hoogeveen,"

Phrase: "A.,"

Phrase: "Heutink,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Rizzu,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.485: (2003) The DJ-1L166P mutant protein associated with early onset Parkinson's disease is unstable and forms higher-order protein complexes. 

Phrase: "(2003"

Phrase: ")"

Phrase: "The DJ-1L166P mutant protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "associated with early onset Parkinson's disease"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   814   C0814120:early disease onset [Disease or Syndrome]
   790   C0030567:Parkinson Disease [Disease or Syndrome]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1521736:Parkinson's Disease [Functional Concept]
   790   C1833334:Early-onset [Finding]
   790   C2681933:PARKINSON DISEASE [Gene or Genome]
   783   C0243083:associated disease [Pathologic Function]
   783   C0277793:disease onset [Temporal Concept]
   783   C0679245:early disease [Temporal Concept]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0332162:Onset [Qualitative Concept]
   753   C1279919:Early [Temporal Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "is"

Phrase: "unstable"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443343:Unstable [Finding]
  1000   C1883468:UNSTABLE [Phenomenon or Process]

Phrase: "and"

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "higher-order protein complexes."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1523872:protein complex [Cell Component]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1704241:Complexes [Chemical Viewed Structurally]
   779 E C0439855:Complex [Qualitative Concept]
Processing 00000000.tx.486: Hum. 

Phrase: "Hum."
Processing 00000000.tx.487: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.488: Genet., 12, 28072816.[Abstract/Free FullText] Gorner, K., Holtorf, E., Odoy, S., Nuscher, B., Yamamoto, A., Regula, J.T., Beyer, K., Haass, C. and Kahle, P.J. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "12,"

Phrase: "28072816."

Phrase: "[Abstract/Free FullText"

Phrase: "] Gorner,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Holtorf,"

Phrase: "E.,"

Phrase: "Odoy,"

Phrase: "S."

Phrase: ","

Phrase: "Nuscher,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "A.,"

Phrase: "Regula,"

Phrase: "J.T.,"

Phrase: "Beyer,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Haass,"

Phrase: "C."

Phrase: "and"

Phrase: "Kahle,"

Phrase: "P.J."
Processing 00000000.tx.489: (2004) Differential effects of Parkinson's disease-associated mutations on stability and folding of DJ-1. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Differential effects of Parkinson's disease-associated mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on stability"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0205360:Stability [Qualitative Concept]
  1000   C2347098:Stability [Qualitative Concept]
   928 E C1547311:Stable [Intellectual Product]

Phrase: "and"

Phrase: "folding of DJ-1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185026:Folding [Therapeutic or Preventive Procedure]
Processing 00000000.tx.490: J. 

Phrase: "J."
Processing 00000000.tx.491: Biol. 

Phrase: "Biol."
Processing 00000000.tx.492: Chem., 279, 69436951.[Abstract/Free FullText] Olzmann, J.A., Brown, K., Wilkinson, K.D., Rees, H.D., Huai, Q., Ke, H., Levey, A.I., Li, L. and Chin, L.S. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "279,"

Phrase: "69436951."

Phrase: "[Abstract/Free FullText"

Phrase: "] Olzmann,"

Phrase: "J."

Phrase: "A.,"

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Wilkinson,"

Phrase: "K.D.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Rees,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555622:Ree [Language]

Phrase: "H.D.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Huai,"

Phrase: "Q.,"

Phrase: "Ke,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022558:KE [Geographic Area]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Levey,"

Phrase: "A.I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Chin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008114:Chin [Body Location or Region]
  1000   C1284862:Chin [Body Location or Region]

Phrase: "L.S."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439394:L/s [Quantitative Concept]
           l's
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.493: (2004) Familial Parkinson's disease-associated L166P mutation disrupts DJ-1 protein folding and function. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Familial Parkinson's disease-associated L166P mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0026882:Mutation [Genetic Function]
   799   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "disrupts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "DJ-1 protein folding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0162847:protein folding [Molecular Function]
   812   C0185026:Folding [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.494: J. 

Phrase: "J."
Processing 00000000.tx.495: Biol. 

Phrase: "Biol."
Processing 00000000.tx.496: Chem., 279, 85068515.[Abstract/Free FullText] Tao, X. and Tong, L. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "279,"

Phrase: "85068515."

Phrase: "[Abstract/Free FullText"

Phrase: "] Tao,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   944   C0041165:Troleandomycin [Antibiotic,Organic Chemical]
   916 E C0040021:taos [Disease or Syndrome]
   916 E C1551534:Taos [Population Group]

Phrase: "X."

Phrase: "and"

Phrase: "Tong,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0183964:Tong [Medical Device]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.497: (2003) Crystal structure of human DJ-1, a protein associated with early onset Parkinson's disease. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Crystal structure of human DJ-1,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0444626:Crystal Structure [Chemical Viewed Structurally]
           Crystal
   753   C0427896:Crystal [Body Substance]
   753   C0678594:Structure [Spatial Concept]
   753   C1533132:Crystal [Body Substance]
   753   C1704641:Crystal [Manufactured Object]

Phrase: "a protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "associated with early onset Parkinson's disease."
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   814   C0814120:early disease onset [Disease or Syndrome]
   790   C0030567:Parkinson Disease [Disease or Syndrome]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1521736:Parkinson's Disease [Functional Concept]
   790   C1833334:Early-onset [Finding]
   790   C2681933:PARKINSON DISEASE [Gene or Genome]
   783   C0243083:associated disease [Pathologic Function]
   783   C0277793:disease onset [Temporal Concept]
   783   C0679245:early disease [Temporal Concept]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0332162:Onset [Qualitative Concept]
   753   C1279919:Early [Temporal Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.498: J. 

Phrase: "J."
Processing 00000000.tx.499: Biol. 

Phrase: "Biol."
Processing 00000000.tx.500: Chem., 278, 3137231379.[Abstract/Free FullText] Honbou, K., Suzuki, N.N., Horiuchi, M., Niki, T., Taira, T., Ariga, H. and Inagaki, F. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "278,"

Phrase: "3137231379."

Phrase: "[Abstract/Free FullText"

Phrase: "] Honbou,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N.N., Horiuchi,"

Phrase: "M."

Phrase: ","

Phrase: "Niki,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Taira,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2998461:Taira [Eukaryote]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ariga,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Inagaki,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.501: (2003) The crystal structure of DJ-1, a protein related to male fertility and Parkinson's disease. 

Phrase: "(2003"

Phrase: ")"

Phrase: "The crystal structure of DJ-1,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0444626:Crystal Structure [Chemical Viewed Structurally]
           Crystal
   753   C0427896:Crystal [Body Substance]
   753   C0678594:Structure [Spatial Concept]
   753   C1533132:Crystal [Body Substance]
   753   C1704641:Crystal [Manufactured Object]

Phrase: "a protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "related to male fertility"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   833   C1955321:Male fertility [Clinical Attribute]
   770   C0015895:Fertility [Organism Function]
   770   C0024554:Male [Finding]
   770   C0086582:male [Population Group]
   770   C0200069:Fertility [Diagnostic Procedure]
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   770   C1706180:Male [Qualitative Concept]
   770   C1706428:Male [Qualitative Concept]
   770   C1706429:Male [Organism Attribute]
   770   C2986895:Fertility [Idea or Concept]
   737 E C0163712:Relate [Organic Chemical]

Phrase: "and"

Phrase: "Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.502: J. 

Phrase: "J."
Processing 00000000.tx.503: Biol. 

Phrase: "Biol."
Processing 00000000.tx.504: Chem., 278, 3138031384.[Abstract/Free FullText] Wilson, M.A., Collins, J.L., Hod, Y., Ringe, D. and Petsko, G.A. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "278,"

Phrase: "3138031384."

Phrase: "[Abstract/Free FullText"

Phrase: "] Wilson,"

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Collins,"

Phrase: "J.L., Hod,"

Phrase: "Y.,"

Phrase: "Ringe,"

Phrase: "D."

Phrase: "and"

Phrase: "Petsko,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "A."
Processing 00000000.tx.505: (2003) The 1.1-A resolution crystal structure of DJ-1, the protein mutated in autosomal recessive early onset Parkinson's disease. 

Phrase: "(2003"

Phrase: ")"

Phrase: "The 1.1-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "A resolution crystal structure of DJ-1,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0444626:Crystal Structure [Chemical Viewed Structurally]
           Crystal
   748   C0427896:Crystal [Body Substance]
   748   C0678594:Structure [Spatial Concept]
   748   C1533132:Crystal [Body Substance]
   748   C1704641:Crystal [Manufactured Object]

Phrase: "the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "mutated in autosomal recessive early onset Parkinson's disease."
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   881   C1868675:Parkinson Disease Autosomal Recessive, Early Onset [Disease or Syndrome]
   789   C0814120:early disease onset [Disease or Syndrome]
   770   C0030567:Parkinson Disease [Disease or Syndrome]
   770   C0441748:Autosomal recessive [Intellectual Product]
   770   C1521736:Parkinson's Disease [Functional Concept]
   770   C1833334:Early-onset [Finding]
   770   C2681933:PARKINSON DISEASE [Gene or Genome]
   767   C0277793:disease onset [Temporal Concept]
   767   C0679245:early disease [Temporal Concept]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0332162:Onset [Qualitative Concept]
   744   C0596142:autosomal [Cell Component]
   744   C1279919:Early [Temporal Concept]
   744   C1705285:Mutated [Cell or Molecular Dysfunction]
   711 E C1513776:Mutate [Genetic Function]
Processing 00000000.tx.506: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.507: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.508: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.509: USA, 100, 92569261.[Abstract/Free FullText] Huai, Q., Sun, Y., Wang, H., Chin, L.S., Li, L., Robinson, H. and Ke, H. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "100,"

Phrase: "92569261."

Phrase: "[Abstract/Free FullText"

Phrase: "] Huai,"

Phrase: "Q.,"

Phrase: "Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "Y.,"

Phrase: "Wang,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Chin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008114:Chin [Body Location or Region]
  1000   C1284862:Chin [Body Location or Region]

Phrase: "L.S.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439394:L/s [Quantitative Concept]
           l's
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Robinson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443050:Robinson [Intellectual Product]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Ke,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022558:KE [Geographic Area]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.510: (2003) Crystal structure of DJ-1/RS and implication on familial Parkinson's disease. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Crystal structure of DJ-1/RS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0444626:Crystal Structure [Chemical Viewed Structurally]
           Crystal
   753   C0427896:Crystal [Body Substance]
   753   C0678594:Structure [Spatial Concept]
   753   C1533132:Crystal [Body Substance]
   753   C1704641:Crystal [Manufactured Object]

Phrase: "and"

Phrase: "implication on familial Parkinson's disease."
Processing 00000000.tx.511: FEBS Lett., 549, 171175.[CrossRef][ISI][Medline] Lee, S.J., Kim, S.J., Kim, I.K., Ko, J., Jeong, C.S., Kim, G.H., Park, C., Kang, S.O., Suh, P.G., Lee, H.S. etal. 

Phrase: "FEBS Lett.,"

Phrase: "549,"

Phrase: "171175."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lee,"

Phrase: "S."

Phrase: "J.,"

Phrase: "Kim,"

Phrase: "S."

Phrase: "J.,"

Phrase: "Kim,"

Phrase: "I.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Ko,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416746:KO [Gene or Genome]
  1000   C1862225:Ko [Body System]

Phrase: "J.,"

Phrase: "Jeong,"

Phrase: "C.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Kim,"

Phrase: "G.H.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0560020:g h [Quantitative Concept]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Kang,"

Phrase: "S."

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Suh,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416171:SUH [Gene or Genome]
  1000   C1422188:SUH [Gene or Genome]

Phrase: "P.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Lee,"

Phrase: "H.S. etal."
Processing 00000000.tx.512: (2003) Crystal structures of human DJ-1 and Escherichia coli Hsp31, which share an evolutionarily conserved domain. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Crystal structures of human DJ-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0444626:Crystal Structure [Chemical Viewed Structurally]
           Crystal
   753   C0427896:Crystal [Body Substance]
   753   C0678594:structures [Spatial Concept]
   753   C1533132:Crystal [Body Substance]
   753   C1704641:Crystal [Manufactured Object]

Phrase: "and"

Phrase: "Escherichia coli Hsp31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0014834:Escherichia coli [Bacterium]

Phrase: "which"

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "an evolutionarily conserved domain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.513: J. 

Phrase: "J."
Processing 00000000.tx.514: Biol. 

Phrase: "Biol."
Processing 00000000.tx.515: Chem., 278, 4455244559.[Abstract/Free FullText] Wilson, M.A., St Amour, C.V., Collins, J.L., Ringe, D. and Petsko, G.A. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "278,"

Phrase: "4455244559."

Phrase: "[Abstract/Free FullText"

Phrase: "] Wilson,"

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "St Amour,"

Phrase: "C.V., Collins,"

Phrase: "J.L., Ringe,"

Phrase: "D."

Phrase: "and"

Phrase: "Petsko,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "A."
Processing 00000000.tx.516: (2004) The 1.8-A resolution crystal structure of YDR533Cp from Saccharomyces cerevisiae: a member of the DJ-1/ThiJ/PfpI superfamily. 

Phrase: "(2004"

Phrase: ")"

Phrase: "The 1.8-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "A resolution crystal structure of YDR533Cp"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0444626:Crystal Structure [Chemical Viewed Structurally]
           Crystal
   753   C0427896:Crystal [Body Substance]
   753   C0678594:Structure [Spatial Concept]
   753   C1533132:Crystal [Body Substance]
   753   C1704641:Crystal [Manufactured Object]

Phrase: "from Saccharomyces cerevisiae"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036025:Saccharomyces cerevisae [Fungus]
   861   C0036024:Saccharomyces [Fungus]

Phrase: ":"

Phrase: "a member of the DJ-1/ThiJ/PfpI superfamily."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0680022:member [Population Group]
   742   C2698041:Member [Professional or Occupational Group]
Processing 00000000.tx.517: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.518: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.519: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.520: USA, 101, 15311536.[Abstract/Free FullText] Kinumi, T., Kimata, J., Taira, T., Ariga, H. and Niki, E. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "101,"

Phrase: "15311536."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kinumi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kimata,"

Phrase: "J.,"

Phrase: "Taira,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2998461:Taira [Eukaryote]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ariga,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Niki,"

Phrase: "E."
Processing 00000000.tx.521: (2004) Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical vein endothelial cells. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Cysteine-106 of DJ-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1424222:DJ-1 [Gene or Genome]
   806   C3541418:DJ-1 [Gene or Genome]
   760   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0012836:DJ [Geographic Area]

Phrase: "is"

Phrase: "the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1709915:Residue [Conceptual Entity]
   739   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "in vivo in human umbilical vein endothelial cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1515655:In Vivo [Spatial Concept]
           vivo
   703   C3179121:Human Umbilical Vein Endothelial Cells [Cell]
Processing 00000000.tx.522: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.523: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.524: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.525: Commun., 317, 722728.[CrossRef][ISI][Medline] Taira, T., Saito, Y., Niki, T., Iguchi-Ariga, S.M., Takahashi, K. and Ariga, H. 

Phrase: "Commun.,"

Phrase: "317,"

Phrase: "722728."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Taira,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2998461:Taira [Eukaryote]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Saito,"

Phrase: "Y.,"

Phrase: "Niki,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Iguchi-Ariga,"

Phrase: "S.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Takahashi,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Ariga,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.526: (2004) DJ-1 has a role in antioxidative stress to prevent cell death. 

Phrase: "(2004"

Phrase: ")"

Phrase: "DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "has"

Phrase: "a role in antioxidative stress to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.527: EMBO Rep., 5, 213218.[Abstract/Free FullText] Mitsumoto, A. and Nakagawa, Y. 

Phrase: "EMBO Rep., 5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1744664:REP [Molecular Function]

Phrase: "213218."

Phrase: "[Abstract/Free FullText"

Phrase: "] Mitsumoto,"

Phrase: "A."

Phrase: "and"

Phrase: "Nakagawa,"

Phrase: "Y."
Processing 00000000.tx.528: (2001) DJ-1 is an indicator for endogenous reactive oxygen species elicited by endotoxin. 

Phrase: "(2001"

Phrase: ")"

Phrase: "DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "is"

Phrase: "an indicator for endogenous reactive oxygen species"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0021212:indicator [Indicator, Reagent, or Diagnostic Aid]
   748   C1235732:Indicator [Bird]
   748   C1522602:Indicator [Functional Concept]

Phrase: "elicited by endotoxin."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0449265:Elicited by [Qualitative Concept]
           elicited
   790   C0014264:Endotoxin [Carbohydrate,Hazardous or Poisonous Substance,Lipid]
Processing 00000000.tx.529: Free Radic. 

Phrase: "Free Radic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.530: Res., 35, 885893.[ISI][Medline] Mitsumoto, A., Nakagawa, Y., Takeuchi, A., Okawa, K., Iwamatsu, A. and Takanezawa, Y. 

Phrase: "Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]

Phrase: "35,"

Phrase: "885893."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mitsumoto,"

Phrase: "A.,"

Phrase: "Nakagawa,"

Phrase: "Y.,"

Phrase: "Takeuchi,"

Phrase: "A.,"

Phrase: "Okawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Iwamatsu,"

Phrase: "A."

Phrase: "and"

Phrase: "Takanezawa,"

Phrase: "Y."
Processing 00000000.tx.531: (2001) Oxidized forms of peroxiredoxins and DJ-1 on two-dimensional gels increased in response to sublethal levels of paraquat. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Oxidized forms of peroxiredoxins"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0348078:forms [Qualitative Concept]
   770   C0376315:Forms [Manufactured Object]
   737 E C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "DJ-1 on two-dimensional gels"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C1424222:DJ-1 [Gene or Genome]
   790   C1705052:2-Dimensional [Spatial Concept]
   790   C3541418:DJ-1 [Gene or Genome]
   753   C0012836:DJ [Geographic Area]
   753   C0017243:Gels [Biomedical or Dental Material]
   753   C0205448:Two [Quantitative Concept]
   719 E C1382104:Gel [Substance]

Phrase: "increased in response"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "to sublethal levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of paraquat."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030493:Paraquat [Hazardous or Poisonous Substance,Organic Chemical]
Processing 00000000.tx.532: Free Radic. 

Phrase: "Free Radic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.533: Res., 35, 301310.[ISI][Medline] Yokota, T., Sugawara, K., Ito, K., Takahashi, R., Ariga, H. and Mizusawa, H. 

Phrase: "Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]

Phrase: "35,"

Phrase: "301310."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yokota,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sugawara,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ito,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415618:ITO [Gene or Genome]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Takahashi,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Ariga,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Mizusawa,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.534: (2003) Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Down regulation of DJ-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0013081:Down-Regulation [Cell Function,Molecular Function]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]
   704   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   704   C2626739:Lanugo [Eukaryote]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "cell death by oxidative stress,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0007587:Cell Death [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0011065:Death [Organism Function]
   760   C1269647:Cell [Cell]
   760   C1306577:Death, NOS [Finding]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "ER stress,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0038435:Stress [Finding]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "proteasome inhibition."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]
Processing 00000000.tx.535: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.536: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.537: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.538: Commun., 312, 13421348.[CrossRef][ISI][Medline] Zhang, Y., Dawson, V.L. and Dawson, T.M. 

Phrase: "Commun.,"

Phrase: "312,"

Phrase: "13421348."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zhang,"

Phrase: "Y.,"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "V.L."

Phrase: "and"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "T.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.539: (2000) Oxidative stress and genetics in the pathogenesis of Parkinson's disease. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "genetics in the pathogenesis of Parkinson's disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0019247:genetics disease [Disease or Syndrome]
   748   C0017398:Genetics [Biomedical Occupation or Discipline]
   748   C0017399:genetics [Biologic Function]
Processing 00000000.tx.540: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.541: Dis., 7, 240250.[CrossRef][ISI][Medline] Dawson, T.M. and Dawson, V.L. 

Phrase: "Dis.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]

Phrase: "7,"

Phrase: "240250."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "T.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "V.L."
Processing 00000000.tx.542: (2003) Molecular pathways of neurodegeneration in Parkinson's disease. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Molecular pathways of neurodegeneration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   816   C1704259:molecular pathway [Molecular Function]
           Pathways
   770   C1705987:Pathways [Conceptual Entity]

Phrase: "in Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.543: Science, 302, 819822.[Abstract/Free FullText] Sherer, T.B., Kim, J.H., Betarbet, R. and Greenamyre, J.T. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "302,"

Phrase: "819822."

Phrase: "[Abstract/Free FullText"

Phrase: "] Sherer,"

Phrase: "T.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "Kim,"

Phrase: "J.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Betarbet,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Greenamyre,"

Phrase: "J.T."
Processing 00000000.tx.544: (2003) Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and -synuclein aggregation. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Subcutaneous rotenone exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0274281:Exposure, NOS [Injury or Poisoning]
   827   C0332157:Exposure [Clinical Attribute]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "highly selective dopaminergic degeneration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0011164:Degeneration [Pathologic Function]
   812   C1880269:Degeneration [Functional Concept]

Phrase: "and -"

Phrase: "synuclein aggregation."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332621:Aggregation [Functional Concept]
   861   C0439168:% aggregation [Quantitative Concept]
   789 E C0205418:Aggregate [Qualitative Concept]
Processing 00000000.tx.545: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.546: Neurol., 179, 916.[CrossRef][ISI][Medline] Sherer, T.B., Betarbet, R., Stout, A.K., Lund, S., Baptista, M., Panov, A.V., Cookson, M.R. and Greenamyre, J.T. 

Phrase: "Neurol.,"

Phrase: "179,"

Phrase: "916."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sherer,"

Phrase: "T.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "Betarbet,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Stout,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0452470:Stout [Food]

Phrase: "A.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Lund,"

Phrase: "S."

Phrase: ","

Phrase: "Baptista,"

Phrase: "M."

Phrase: ","

Phrase: "Panov,"

Phrase: "A.V.,"

Phrase: "Cookson,"

Phrase: "M."

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Greenamyre,"

Phrase: "J.T."
Processing 00000000.tx.547: (2002) An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered -synuclein metabolism and oxidative damage. 

Phrase: "(2002"

Phrase: ")"

Phrase: "An in vitro model of Parkinson's disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   814   C1515654:In Vitro Model [Research Activity]
   774   C0683033:disease model [Intellectual Product]
   774   C0684309:Disease model [Experimental Model of Disease]
   748   C3161035:Model [Intellectual Product]

Phrase: ":"

Phrase: "linking"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "mitochondrial impairment to altered -synuclein metabolism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0684336:Impairment [Pathologic Function]

Phrase: "and"

Phrase: "oxidative damage."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010957:Damage [Injury or Poisoning]
   861   C1883709:Damage [Functional Concept]
Processing 00000000.tx.548: J. 

Phrase: "J."
Processing 00000000.tx.549: Neurosci., 22, 70067015.[Abstract/Free FullText] Manning-Bog, A.B., McCormack, A.L., Li, J., Uversky, V.N., Fink, A.L. and Di Monte, D.A. 

Phrase: "Neurosci.,"

Phrase: "22,"

Phrase: "70067015."

Phrase: "[Abstract/Free FullText"

Phrase: "] Manning-Bog,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706414:Bog [Natural Phenomenon or Process]

Phrase: "A.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1440044:A,B [Immunologic Factor]

Phrase: "McCormack,"

Phrase: "A.L., Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "J.,"

Phrase: "Uversky,"

Phrase: "V.N., Fink,"

Phrase: "A.L."

Phrase: "and"

Phrase: "Di Monte,"

Phrase: "D.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.550: (2002) The herbicide paraquat causes up-regulation and aggregation of -synuclein in mice: paraquat and alpha-synuclein. 

Phrase: "(2002"

Phrase: ")"

Phrase: "The herbicide paraquat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030493:Paraquat [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "up-regulation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0041904:Up-Regulation [Cell Function,Molecular Function]
  1000   C0162493:Up-Regulation [Genetic Function]
   861   C0547043:Up [Spatial Concept]
   861   C0851285:Regulation [Governmental or Regulatory Activity]
   861   C1282911:Up [Spatial Concept]
   861   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "aggregation of -synuclein in mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "paraquat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030493:Paraquat [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "and"

Phrase: "alpha-synuclein."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439095:Alpha [Intellectual Product]
   861   C2003941:Alpha [Intellectual Product]
   861   C2350010:Alpha [Qualitative Concept]
Processing 00000000.tx.551: J. 

Phrase: "J."
Processing 00000000.tx.552: Biol. 

Phrase: "Biol."
Processing 00000000.tx.553: Chem., 277, 16411644.[Abstract/Free FullText] Lee, S.J. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "277,"

Phrase: "16411644."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lee,"

Phrase: "S."

Phrase: "J."
Processing 00000000.tx.554: (2003) -synuclein aggregation: a link between mitochondrial defects and Parkinson's disease? 

Phrase: "(2003"

Phrase: ") -"

Phrase: "synuclein aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332621:Aggregation [Functional Concept]
   861   C0439168:% aggregation [Quantitative Concept]
   789 E C0205418:Aggregate [Qualitative Concept]

Phrase: ":"

Phrase: "a link between mitochondrial defects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1517892:Link [Intellectual Product]
   760   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "Parkinson's disease?"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.555: Antioxid. 

Phrase: "Antioxid."
Processing 00000000.tx.556: Redox Signal, 5, 337348.[CrossRef][ISI][Medline] Betarbet, R., Sherer, T.B., Di Monte, D.A. and Greenamyre, J.T. 

Phrase: "Redox Signal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "337348."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Betarbet,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Sherer,"

Phrase: "T.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "Di Monte,"

Phrase: "D.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Greenamyre,"

Phrase: "J.T."
Processing 00000000.tx.557: (2002) Mechanistic approaches to Parkinson's disease pathogenesis. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Mechanistic approaches to Parkinson's disease pathogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449445:Approaches [Spatial Concept]
   753   C1292724:Approaches [Functional Concept]
Processing 00000000.tx.558: Brain Pathol., 12, 499510.[ISI][Medline] Betarbet, R., Sherer, T.B., MacKenzie, G., Garcia-Osuna, M., Panov, A.V. and Greenamyre, J.T. 

Phrase: "Brain Pathol.,"

Phrase: "12,"

Phrase: "499510."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Betarbet,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Sherer,"

Phrase: "T.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "MacKenzie,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Garcia-Osuna,"

Phrase: "M."

Phrase: ","

Phrase: "Panov,"

Phrase: "A.V."

Phrase: "and"

Phrase: "Greenamyre,"

Phrase: "J.T."
Processing 00000000.tx.559: (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Chronic systemic pesticide exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0274281:Exposure, NOS [Injury or Poisoning]
   812   C0332157:Exposure [Clinical Attribute]

Phrase: "reproduces"

Phrase: "features of Parkinson's disease."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C1521970:Feature [Qualitative Concept]
   737   C1706388:Feature [Conceptual Entity]
   737   C2346469:Feature [Qualitative Concept]
   737   C2348519:Feature [Qualitative Concept]
Processing 00000000.tx.560: Nat. 

Phrase: "Nat."
Processing 00000000.tx.561: Neurosci., 3, 13011306.[CrossRef][ISI][Medline] Chung, K.K., Thomas, B., Li, X., Pletnikova, O., Troncoso, J.C., Marsh, L., Dawson, V.L. and Dawson, T.M. 

Phrase: "Neurosci.,"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "13011306."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chung,"

Phrase: "K.K.,"

Phrase: "Thomas,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "X.,"

Phrase: "Pletnikova,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Troncoso,"

Phrase: "J.C., Marsh,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1721089:Marsh [Natural Phenomenon or Process]
   743 E C0024530:Malaria [Disease or Syndrome]
   743 E C2984572:Malaria [Functional Concept]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "V.L."

Phrase: "and"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "T.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.562: (2004) S-Nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. 

Phrase: "(2004"

Phrase: ")"

Phrase: "S-"

Phrase: "Nitrosylation of parkin"

Phrase: "regulates"

Phrase: "ubiquitination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519751:Ubiquitination [Molecular Function]

Phrase: "and"

Phrase: "compromises"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945640:compromise [Finding]

Phrase: "parkin's protective function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.563: Science, 304, 13281331.[Abstract/Free FullText] Canet-Aviles, R.M., Wilson, M.A., Miller, D.W., Ahmad, R., McLendon, C., Bandyopadhyay, S., Baptista, M.J., Ringe, D., Petsko, G.A. and Cookson, M.R. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "304,"

Phrase: "13281331."

Phrase: "[Abstract/Free FullText"

Phrase: "] Canet-Aviles,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "M."

Phrase: ","

Phrase: "Wilson,"

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "D.W.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Ahmad,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "McLendon,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Bandyopadhyay,"

Phrase: "S."

Phrase: ","

Phrase: "Baptista,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Ringe,"

Phrase: "D."

Phrase: ","

Phrase: "Petsko,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "A."

Phrase: "and"

Phrase: "Cookson,"

Phrase: "M."

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.564: (2004) The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. 

Phrase: "(2004"

Phrase: ")"

Phrase: "The Parkinson's disease protein DJ-1"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   884   C3538910:Protein DJ-1 [Amino Acid, Peptide, or Protein]
   847   C1425075:MALS-1 [Gene or Genome]
   840   C0030567:Parkinson Disease [Disease or Syndrome]
   840   C1424222:DJ-1 [Gene or Genome]
   840   C1521736:Parkinson's Disease [Functional Concept]
   840   C2681933:PARKINSON DISEASE [Gene or Genome]
   840   C3541418:DJ-1 [Gene or Genome]
   804   C0012634:Disease [Disease or Syndrome]
   804   C0012836:DJ [Geographic Area]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]
   704   C1021144:Parkinsonia [Plant]

Phrase: "is"

Phrase: "neuroprotective due to cysteine-sulfinic acid-"

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "mitochondrial localization."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1657244:mitochondrial localization [Biologic Function]
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]
Processing 00000000.tx.565: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.566: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.567: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.568: USA, 101, 91039108.[Abstract/Free FullText] Shimura, H., Hattori, N., Kubo, S., Yoshikawa, M., Kitada, T., Matsumine, H., Asakawa, S., Minoshima, S., Yamamura, Y., Shimizu, N. etal. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "101,"

Phrase: "91039108."

Phrase: "[Abstract/Free FullText"

Phrase: "] Shimura,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kubo,"

Phrase: "S."

Phrase: ","

Phrase: "Yoshikawa,"

Phrase: "M."

Phrase: ","

Phrase: "Kitada,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Matsumine,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Asakawa,"

Phrase: "S."

Phrase: ","

Phrase: "Minoshima,"

Phrase: "S."

Phrase: ","

Phrase: "Yamamura,"

Phrase: "Y.,"

Phrase: "Shimizu,"

Phrase: "N. etal."
Processing 00000000.tx.569: (1999) Immunohistochemical and subcellular localization of Parkin protein: absence of protein in autosomal recessive juvenile parkinsonism patients. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Immunohistochemical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441616:Immunohistochemical [Laboratory Procedure]

Phrase: "and"

Phrase: "subcellular localization of Parkin protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0597704:protein localisation [Cell Function]
   797   C1159772:Protein Localization [Cell Function]
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: ":"

Phrase: "absence of protein"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "in autosomal recessive juvenile parkinsonism patients."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0030705:Patients [Patient or Disabled Group]
   771   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   722   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
Processing 00000000.tx.570: Ann. 

Phrase: "Ann."
Processing 00000000.tx.571: Neurol., 45, 668672.[CrossRef][ISI][Medline] Hering, R., Strauss, K.M., Tao, X., Bauer, A., Woitalla, D., Mietz, E.M., Petrovic, S., Bauer, P., Schaible, W., Muller, T. etal. 

Phrase: "Neurol.,"

Phrase: "45,"

Phrase: "668672."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hering,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Strauss,"

Phrase: "K.M.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Tao,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   944   C0041165:Troleandomycin [Antibiotic,Organic Chemical]
   916 E C0040021:taos [Disease or Syndrome]
   916 E C1551534:Taos [Population Group]

Phrase: "X.,"

Phrase: "Bauer,"

Phrase: "A.,"

Phrase: "Woitalla,"

Phrase: "D."

Phrase: ","

Phrase: "Mietz,"

Phrase: "E.M.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Petrovic,"

Phrase: "S."

Phrase: ","

Phrase: "Bauer,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Schaible,"

Phrase: "W.,"

Phrase: "Muller,"

Phrase: "T. etal."
Processing 00000000.tx.572: (2004) Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson disease (PARK7). 

Phrase: "(2004"

Phrase: ")"

Phrase: "Novel homozygous p.E64D mutation in DJ1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C2985438:Novel Mutation [Cell or Molecular Dysfunction]
   748   C0026882:Mutation [Genetic Function]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in early onset Parkinson disease"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   902   C0679245:early disease [Temporal Concept]
   861   C0030567:Parkinson Disease [Disease or Syndrome]
   861   C1521736:Parkinson's Disease [Functional Concept]
   861   C2681933:PARKINSON DISEASE [Gene or Genome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
   712   C1021144:Parkinsonia [Plant]

Phrase: "(PARK7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:PARK7 [Gene or Genome]
  1000   C1853445:PARK7 [Disease or Syndrome]
  1000   C3538910:PARK7 [Amino Acid, Peptide, or Protein]

Phrase: ")."
Processing 00000000.tx.573: Hum. 

Phrase: "Hum."
Processing 00000000.tx.574: Mutat., 24, 321329.[CrossRef][ISI][Medline] Bonifati, V., Oostra, B.A. and Heutink, P. 

Phrase: "Mutat.,"

Phrase: "24,"

Phrase: "321329."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bonifati,"

Phrase: "V.,"

Phrase: "Oostra,"

Phrase: "B.A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Heutink,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.575: (2004) Linking DJ-1 to neurodegeneration offers novel insights for understanding the pathogenesis of Parkinson's disease. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Linking DJ-1 to neurodegeneration"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1424222:DJ-1 [Gene or Genome]
   806   C3541418:DJ-1 [Gene or Genome]
   760   C0012836:DJ [Geographic Area]
   760   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]

Phrase: "offers"

Phrase: "novel insights for understanding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0233820:insights [Mental Process]

Phrase: "the pathogenesis of Parkinson's disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0543483:pathogenesis [Functional Concept]
   760   C0699748:Pathogenesis [Pathologic Function]
Processing 00000000.tx.576: J. 

Phrase: "J."
Processing 00000000.tx.577: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.578: Med., 82, 163174.[CrossRef][ISI][Medline] Tofaris, G.K., Layfield, R. and Spillantini, M.G. 

Phrase: "Med.,"

Phrase: "82,"

Phrase: "163174."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tofaris,"

Phrase: "G.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Layfield,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Spillantini,"

Phrase: "M."

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.579: (2001) -Synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome. 

Phrase: "(2001"

Phrase: ") -"

Phrase: "Synuclein metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "is"

Phrase: "linked to ubiquitin-independent degradation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0085862:Independent [Idea or Concept]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]
   760   C1299583:Independent [Finding]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]

Phrase: "by the proteasome."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.580: FEBS Lett., 509, 2226.[CrossRef][ISI][Medline] David, D.C., Layfield, R., Serpell, L., Narain, Y., Goedert, M. and Spillantini, M.G. 

Phrase: "FEBS Lett.,"

Phrase: "509,"

Phrase: "2226."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] David,"

Phrase: "D.C.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012358:D & C [Therapeutic or Preventive Procedure]
  1000   C0012764:D.C. [Geographic Area]
  1000   C1444662:D/C [Finding]
  1000   C1512015:D.C. [Intellectual Product]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Layfield,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Serpell,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Narain,"

Phrase: "Y.,"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Spillantini,"

Phrase: "M."

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.581: (2002) Proteasomal degradation of tau protein. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Proteasomal degradation of tau protein."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0597297:Protein Degradation [Molecular Function]
   797   C0597304:Protein Degradation [Molecular Function]
   797   C1623036:Protein Degradation [Molecular Function]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]
Processing 00000000.tx.582: J. 

Phrase: "J."
Processing 00000000.tx.583: Neurochem., 83, 176185.[CrossRef][ISI][Medline] Pawlyk, A.C., Giasson, B.I., Sampathu, D.M., Perez, F.A., Lim, K.L., Dawson, V.L., Dawson, T.M., Palmiter, R.D., Trojanowski, J.Q. and Lee, V.M. 

Phrase: "Neurochem.,"

Phrase: "83,"

Phrase: "176185."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pawlyk,"

Phrase: "A.C.,"

Phrase: "Giasson,"

Phrase: "B.I.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2347469:/B [Quantitative Concept]

Phrase: "Sampathu,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "Perez,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "A.,"

Phrase: "Lim,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449205:LIM [Body Location or Region]
  1000   C1538613:LIM [Gene or Genome]

Phrase: "K.L., Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1551910:Dawson [Language]

Phrase: "V.L.,"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "T.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]

Phrase: "Palmiter,"

Phrase: "R.D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Trojanowski,"

Phrase: "J.Q."

Phrase: "and"

Phrase: "Lee,"

Phrase: "V.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2349138:V/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.584: (2003) Novel monoclonal antibodies demonstrate biochemical variation of brain parkin with age. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Novel monoclonal antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0746619:monoclonal [Finding]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "demonstrate"

Phrase: "biochemical variation of brain parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205419:Variation [Qualitative Concept]

Phrase: "with age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]
Processing 00000000.tx.585: J. 

Phrase: "J."
Processing 00000000.tx.586: Biol. 

Phrase: "Biol."
Processing 00000000.tx.587: Chem., 278, 4812048128.[Abstract/Free FullText] Rizzu, P., Hinkle, D.A., Zhukareva, V., Bonifati, V., Severijnen, L.A., Martinez, D., Ravid, R., Kamphorst, W., Eberwine, J.H., Lee, V.M. etal. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "278,"

Phrase: "4812048128."

Phrase: "[Abstract/Free FullText"

Phrase: "] Rizzu,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hinkle,"

Phrase: "D.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Zhukareva,"

Phrase: "V.,"

Phrase: "Bonifati,"

Phrase: "V.,"

Phrase: "Severijnen,"

Phrase: "L.A.,"

Phrase: "Martinez,"

Phrase: "D."

Phrase: ","

Phrase: "Ravid,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kamphorst,"

Phrase: "W.,"

Phrase: "Eberwine,"

Phrase: "J.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Lee,"

Phrase: "V.M. etal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C2349138:V/m [Quantitative Concept]
Processing 00000000.tx.588: (2004) DJ-1 colocalizes with tau inclusions: a link between parkinsonism and dementia. 

Phrase: "(2004"

Phrase: ")"

Phrase: "DJ-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "colocalizes with tau inclusions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1720655:Tau [Intellectual Product]
   770   C1947974:Tau [Research Activity]
   737   C1512693:Inclusion [Qualitative Concept]

Phrase: ":"

Phrase: "a link between parkinsonism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1517892:Link [Intellectual Product]
   770   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "dementia."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.589: Ann. 

Phrase: "Ann."
Processing 00000000.tx.590: Neurol., 55, 113118.[CrossRef][ISI][Medline] Neumann, M., Muller, V., Gorner, K., Kretzschmar, H.A., Haass, C. and Kahle, P.J. 

Phrase: "Neurol.,"

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "113118."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Neumann,"

Phrase: "M."

Phrase: ","

Phrase: "Muller,"

Phrase: "V.,"

Phrase: "Gorner,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kretzschmar,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "A.,"

Phrase: "Haass,"

Phrase: "C."

Phrase: "and"

Phrase: "Kahle,"

Phrase: "P.J."
Processing 00000000.tx.591: (2004) Pathological properties of the Parkinson's disease-associated protein DJ-1 in -synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick's disease. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Pathological properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]

Phrase: "of the Parkinson's disease-associated protein DJ-1 in -synucleinopathies"

Phrase: "and"

Phrase: "tauopathies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949664:Tauopathies [Disease or Syndrome]

Phrase: ":"

Phrase: "relevance for multiple system atrophy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2347946:Relevance [Qualitative Concept]

Phrase: "and"

Phrase: "Pick's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0236642:Pick's Disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   861   C1707391:Pick [Activity]
   861   C1826583:PICK [Gene or Genome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.592: Acta Neuropathol. 

Phrase: "Acta Neuropathol."
Processing 00000000.tx.593: (Berl.), 107, 489496.[CrossRef][ISI][Medline] Hattori, N., Kitada, T., Matsumine, H., Asakawa, S., Yamamura, Y., Yoshino, H., Kobayashi, T., Yokochi, M., Wang, M., Yoritaka, A. etal. 

Phrase: "(Berl."

Phrase: ")"

Phrase: ","

Phrase: "107,"

Phrase: "489496."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kitada,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Matsumine,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Asakawa,"

Phrase: "S."

Phrase: ","

Phrase: "Yamamura,"

Phrase: "Y.,"

Phrase: "Yoshino,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kobayashi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yokochi,"

Phrase: "M."

Phrase: ","

Phrase: "Wang,"

Phrase: "M."

Phrase: ","

Phrase: "Yoritaka,"

Phrase: "A. etal."
Processing 00000000.tx.594: (1998) Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: evidence for variable homozygous deletions in the Parkin gene in affected individuals. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Molecular genetic analysis of a novel Parkin gene"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   800   C1513380:Molecular Genetic Analysis [Molecular Biology Research Technique]
           Molecular Analysis
   770   C0679560:genetic analysis [Laboratory Procedure]
   770   C0796344:Genetic Analysis [Laboratory Procedure]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "in Japanese families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]

Phrase: "with autosomal recessive juvenile parkinsonism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   923   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   861   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   812   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: ":"

Phrase: "evidence for variable homozygous deletions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "in the Parkin gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1418270:parkin gene [Gene or Genome]
  1000   C2983548:Parkin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "in affected individuals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]
Processing 00000000.tx.595: Ann. 

Phrase: "Ann."
Processing 00000000.tx.596: Neurol., 44, 935941.[ISI][Medline]

Phrase: "Neurol.,"

Phrase: "44,"

Phrase: "935941."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

